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SUMMARY
The majority of eukaryotic proteins are degraded by the ubiquitin-proteasome system. In
this pathway, cytosolic substrates are first earmarked for degradation by modification
with ubiquitin ('ubiquitylation') and subsequently degraded by the 26S proteasome, a
large protease residing in both the cytosol and the nucleus. ER-resident proteins are
similarly degraded but take the route of a specialized pathway coined ER-associated
degradation (ERAD). In order to reach the cytosolic ubiquitin/proteasome system, these
substrates must first relocate from the ER to the cytosol, possibly with the help of
protein conducting membrane channels. Previous work has shown that specific
ubiquitin-conjugating enzymes (e.g. Ubc6, Ubc7) and ubiquitin ligases (e.g. Hrd1) con-
tribute to ERAD, but how the substrates reach the proteasome remained to be clarified.
Besides its function as a quality control system in recognizing and eliminating aberrant
proteins, ERAD appears also to play a part in regulatory pathways.
This study focuses on the identification of novel components contributing to ERAD.
It could be demonstrated that the yeast protein Cdc48 (p97 in mammals), together with
its co-factors Ufd1 and Npl4, plays a key role in this process. Cdc48 belongs to the
large family of AAA-type ATPases and is believed to function as a chaperone-like
enzyme. Previous work has shown that the Cdc48 complex specifically acts on
ubiquitylated substrates. This study indicates that the Cdc48 complex takes part in mo-
bilization of ERAD substrates from the ER membrane for proteasomal targeting. Fur-
thermore, degradation of some ERAD substrates involves the multiubiquitylation factor
E4/Ufd2 and proteasome targeting factors of the Rad23 protein family.
Another aspect of this work addresses the regulatory functions of ERAD. The fatty
acid desaturase Ole1, an integral membrane protein of the ER, was identified as a novel
ERAD substrate. Intriguingly, ERAD of Ole1 is specifically regulated since the protein is
particularly short lived in the presence of high levels of unsaturated fatty acids, the
products of Ole1. Thus, this feedback loop provides an additional mechanism, by which
the cell regulates the amount of unsaturated fatty acids. The t-SNARE (syntaxin) protein
Ufe1 was characterized as another substrate of ERAD. This protein is required for
homotypic membrane fusion of ER vesicles. Notably, Ufe1 degradation is negatively
controlled by its binding partner Sly1, a member of the SM (Sec1/Munc18) protein fam-
ily. Reciprocal mutations in the Ufe1-Sly1 interaction face result in rapid degradation of
Ufe1 by ERAD. Conversely, strong overproduction of Ufe1 was found to be detrimental
for cellular growth. These findings suggest that one important function of Sly1 is to con-
trol Ufe1 SNARE levels in order to ensure cellular homeostasis. In conclusion, analysis
of the degradation of Ole1 and Ufe1 revealed an important contribution of ERAD to es-
sential regulatory pathways.
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1. INTRODUCTION
To ensure a dynamic state, cells have to provide regulatory mechanisms to adapt their
functional state to intracellular requirements and environmental changes. This can be
accomplished on one hand by altering gene expression, thereby turning on the syn-
thesis of a different subset of proteins that execute distinct functions. On the other hand,
every regulated process needs to become inactivated after it has fulfilled its function. At
the protein level, this can be achieved by modulating the activity of proteins or, ulti-
mately, by degrading them. Thus, in order to act efficiently in this regulatory process in-
tracellular protein degradation must be highly selective.
Cellular proteases often recognize their target proteins directly by a specific amino
acid sequence located close to the cleavage site ('primary signal'). However, this type of
proteolysis is less suited to mediate the down regulation of a broad spectrum of
substrates. In fact, this task is executed by a specialized system evolved in all
eukaryotes that segregates substrate recognition from degradation and proceeds in a
two-step reaction: Substrates are recognized on the basis of a primary signal by the
ubiquitin-conjugating system that subsequently tags the target protein by the addition of
the small protein ubiquitin ('secondary signal'). Once modified by several ubiquitin moie-
ties, the earmarked protein is targeted to the 26S proteasome independently of their
primary sequence. This large multi-subunit protease complex harbors a number of dif-
ferent proteolytic active sites in a high local concentration within a gated chamber. Thus,
this specific molecular architecture provides high efficiency through processive peptide
hydrolysis while it prevents unwarranted degradation by sequestering the active sites
within the cavity (Pickart and Cohen, 2004). How substrate recognition and degradation
particularly are accomplished will be discussed in the following chapters.
1.1. The ubiquitin-conjugating system
1.1.1. A hierarchical enzymatic cascade controls the ubiquitylation of
substrates
Ubiquitin is a small, heat-stable protein with a globular, robust fold and is highly con-
served within all eukaryotes. In Saccharomyces cerevisiae ubiquitin is encoded by a
gene family. All members of this family encode for fusions of two or more proteins that
become post-translationally processed. The genes UBI1, UBI2 and UBI3 provide most
of the ubiquitin for vegetative growth, and their gene products all include small carboxyl
extension proteins, which are found in their matured form as ribosomal subunit proteins
(Finley et al., 1989). Cellular stress induces the expression of the multiubiquitin gene
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UBI4 that encodes five tandemly repeated copies of the ubiquitin coding sequence
(Finley et al., 1987). Therefore, ubiquitylation generally requires the proteolytic process-
ing of the carboxy terminus from the ubiquitin precursors, yielding the mature form of a
peptide of 76 amino acids that ends with a double glycine residue motif (Pickart, 2001).
Processed ubiquitin is conjugated to proteins via a reversible isopeptide linkage
between its C-terminal glycine residue and a lysine chain of the target protein. This
modification requires the subsequent action of three classes of enzymes. The first step
requires the ubiquitin-activating enzyme (E1), which catalyzes the formation of a
ubiquitin-adenylate intermediate through ATP hydrolysis. The ubiquitin-AMP intermedi-
ate is subsequently transferred to a conserved cysteine residue within the E1 enzyme
yielding a stable E1-ubiquitin thioester (McGrath et al., 1991). In all eukaryotes the E1
enzyme is encoded by one essential gene (in S. cerevisiae UBA1, ubiquitin activating
enzyme 1) (Pickart, 2001). In a second step, activated ubiquitin is passed by trans-
esterfication to a cysteine residue of a ubiquitin conjugating enzyme (UBC or E2), which
binds specifically to the ubiquitin-loaded E1 molecule. In S. cerevisiae there exist 13
different UBC proteins sharing a conserved core domain of about 150 amino acids.
They all conjugate either ubiquitin, or the ubiquitin-like proteins SUMO (Ubc9), or RUB1
(Ubc12), respectively (Jentsch, 1992; Johnson, E. S. and Blobel, 1997; Liakopoulos et
al., 1998; Schwarz et al., 1998). In vitro the transfer of ubiquitin to substrates can some-
times be carried out directly by the E2 enzyme, but in vivo this reaction is in most cases
Figure 1-1: The enzymatic thioester cascade of the ubiquitin conjugation system. Ubiquitin is
activated by Uba1 (E1) and then passed to several UBCs (E2s). Ubiquitylation of substrates occurs
usually in conjunction with ubiquitin ligases (E3s), which are most responsible for substrate specificity.
Some multiubiquitylation reactions may require an additional factor (E4). See text for details.
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accomplished in conjunction with another class of enzymes, called ubiquitin ligases
(E3). This group of enzymes recognizes both the target protein and the E2-ubiquitin-
thioester, thereby mediating the transfer of ubiquitin to a lysine -amino group of the
substrate. The transfer occurs either directly from the E2 to the substrate in the case of
so-called RING finger E3s, or includes the formation of an E3-ubiquitin thioester
intermediate analogous to the UBCs, when catalyzed by members of HECT E3 ligase
family, (see 1.1.3.) (Pickart, 2001). Once conjugated by this enzymatic cascade
ubiquitin itself is often targeted for further ubiquitylation reactions by using one of its
internal lysine residues for modification, often by employing the same E2 and E3
constituents of the preceding reaction. However, in some cases, an additional factor
(E4) is required, which functions as a multiubiquitylation factor in conjunction with the
common ubiquitylation machinery (Koegl et al., 1999; Imai et al., 2002; Hoppe et al.,
2004). Successive conjugating reactions result in the formation of a multiubiquitin chain
on the substrate and are a prerequisite for the successful targeting to the 26S
proteasome.
Besides ubiquitin, there exist several ubiquitin-like (UBL) proteins. Although they
show only a weak sequence homology to ubiquitin, they share a similar three-dimen-
sional protein fold. Likewise, SUMO (small ubiquitin modifier) and RUB1 (related to
ubiquitin) are also attached to substrates by an analogous conjugation machinery.
However, modification by these UBLs does not result in targeting to the 26S protea-
some but fulfills rather a function in regulating the interaction of the substrates with other
proteins (for a review see Jentsch and Pyrowolakis, 2000).
1.1.2. The ubiquitylation machinery recognizes specific degradation signals
The selectivity of the ubiquitylation reaction is ensured by the specific recognition of a
degradation signal within the target protein. All degradation signals consist at least of
two distinct parts: a recognition motif for the E2/E3 enzymes (ubiquitylation or primary
signal) and one or more appropriate lysine residue(s), at which ubiquitin moieties can be
conjugated (ubiquitylation site).
The recognition motif or degron can be located within the polypeptide in a se-
quence- or structure-confined manner mediating the constitutive turnover of the target
protein (Laney and Hochstrasser, 1999). Degradation of such substrates depends
therefore primarily on the presence and activity of the E3. An example for this type of
recognition is the C-terminal domain (CTD) of the large subunit of yeast RNA po-
lymerase II. The CTD contains the heptapeptide repeat sequence SPTSPSY, which is
necessary and sufficient for ubiquitylation (Huibregtse et al., 1997). Conversely, sub-
strates may be only degraded after they have been targeted through post-translational
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modification mediated by a specific signal transduction cascade. This regulatory
mechanism allows coordinating protein degradation with specific cellular events (e.g.
cell cycle progression) and is found for instance in polypeptides containing the PEST
(proline-, aspartate-, serine- and threonine-rich) sequence that directs phosphorylation
and subsequent degradation of various proteins (Rogers et al., 1986). Alternatively, the
recognition motif of a substrate may be masked by its binding to a partner protein. Upon
the dissociation of the partner, the degron becomes solvent-exposed and is recognized
by its cognate E3. This situations is found for the yeast transcription factor 2 that is
only stable when another transcription factor, a1, is bound to the hydrophobic Deg1 se-
quence of 2 (Chen, P. et al., 1993). Similarly, a hydrophobic stretch being naturally
buried within the protein core might be recognized as degradation signal after it has be-
come exposed, e.g. under denaturing conditions or after misfolding of the protein.
Recognition of these non-native structures might be generally implemented in protein
quality control and may explain how aberrant proteins are specifically recognized and
degraded (Laney and Hochstrasser, 1999).
1.1.3. E3 ligases determine the substrate specificity
Among the different cellular UBCs involved in ubiquitylation, only Ubc3 (Cdc34) is
essential for viability in S. cerevisiae. However, the other UBCs do not simply represent
isoenzymes with redundant functions. In contrast, the disparate phenotypes of the
corresponding UBC mutants demonstrate, that they are involved in different cellular
processes. However, substrate specificity is still predominantly mediated by the large
class of E3 enzymes being directly involved in recognition of and binding to the degra-
dation motif of the individual substrate.
E3 enzymes have a modular composition that can be divided into a variable sub-
strate recognition domain and into a conserved catalytic domain that consists of either a
HECT or a RING finger motif. Although unrelated in sequence or structure, both cata-
lytic modules recognize similarly their cognate E2-ubiquitin partners, while they differ
considerably in the mechanism of the conjugation reaction (Pickart, 2001).
All members of the HECT (homologous to E6-AP carboxy terminus) E3 family in-
clude a C-terminal ~350 amino acid catalytic domain with a conserved cysteine, which
undergoes a thioester intermediate with ubiquitin during the conjugation mechanism.
The founding member of this class, the human E6-AP (E6 associated protein), pro-
motes in conjunction with the viral protein E6 the degradation of the tumor suppressor
p53 (Huibregtse et al., 1995; Scheffner et al., 1995). In all HECT family members, the
N-terminal region is responsible for the specific interaction with substrates and includes
specific protein-protein interaction motifs. One well-characterized HECT E3 is the yeast
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Rsp5 enzyme, which is essential for viability and involved in several pathways. Rsp5
contains three WW domains that are known to bind to phosphoserines and phos-
phothreonines. According to this finding, some substrates of Rsp5 (e.g. plasma mem-
brane receptors) have been shown to be degraded in a phosphorylation-dependent
manner (Pickart, 2001). Other motifs recognized by WW domains are proline-rich se-
quences. This type of recognition signal is found for example in the transcription factors
Spt23 and Mga2, which both display a (P)PXY motif and are ubiquitylated by Rsp5
(Hoppe et al., 2000; Shcherbik et al., 2004).
The other class of ubiquitin ligases is characterized by a RING (really interesting
new gene) finger motif that encompasses a series of histidine and cysteine residues
being involved in the coordination of two zinc ions. In contrast to the HECT domain the
RING finger does not form a thioester with ubiquitin. Instead it serves as a molecular
scaffold for the specific and catalytically productive binding of the E2 enzyme (Pickart,
2001).
Several RING finger proteins are part of multi-subunit E3s (Feldman et al., 1997;
Skowyra et al., 1997), in which the demands for the recognition of a broad substrate
spectrum are addressed by the use of different exchangeable modular adaptors. The
Figure 1-2: Ubiquitin transfer by HECT and RING finger ubiquitin ligases.
A. HECT ligase. B. Monomeric RING finger ligase. C and D multimeric RING finger ligases: SCF complex
(C), APC/C complex (D). See text for details.
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most prominent members are the SCF (Skp1-Cul1-F-box) and the APC/C (anaphase
promoting complex/cyclosome) complex. Both comprise a central scaffold subunit be-
longing to the cullin family. In the SCF complex, the cullin Cul1 (Cdc53 in yeast) binds
with its C-terminus to the RING finger protein Roc1 (Rbx1 or Hrt1) and with its N-termi-
nus to Skp1, which serves as an adaptor for different substrate recruitment factors
called F-box proteins. Similarly, the APC/C includes the cullin-related protein Apc2, the
RING finger protein (Apc11) and one of the exchangeable substrate recruitment factors
Cdc20 and Hct1. Besides these basal components, further subunits are enclosed in the
APC/C, whose functions mostly remain to be clarified (Petroski and Deshaies, 2005). A
common feature of nearly all multi-subunit RING E3s is that they recognize and
ubiquitylate their substrates in a regulated fashion. Post-translational modifications of
substrates, like phosphorylation, operate as molecular switches and direct the sub-
strates to their cognate recruitment factors like the various F-box proteins in case of the
SCF complex (Petroski and Deshaies, 2005).
1.1.4. The mode of ubiquitylation dictates the fate of the conjugated protein
So far the best understood function of ubiquitin is its role in substrate targeting for pro-
teasome-dependent degradation by the attachment of a multiubiquitin chain. However,
meanwhile it became evident that ubiquitylation provides besides its proteolytic property
further 'non-conventional' functions, indicating a general role in cellular protein targeting.
Remarkably, its different functions can be mechanistically discriminated by the mode of
how ubiquitin is attached to the target protein: whether the substrate is modified by a
single (mono-ubiquitylation) or by several moieties (multiubiquitylation), and aside which
internal lysine residue is used for chain formation. The outcome of the modification
differs considerably in terms of signaling. A multiubiquitin chain is structurally not
recognized as a multiplied signal of a single ubiquitin molecule but represents an
entirely different signal and chains linked differently by the use of distinct lysine residues
even alter remarkably in their structure (Pickart, 2001).
Multiubiquitylation can proceed by different lysine linkages. Among ubiquitin's 7
lysine residues, only K48 is essential for viability (Finley et al., 1994), and a single K48-
linked multiubiquitin chain is sufficient to target a substrate to proteasomes (Chau et al.,
1989). This indicates that the K48 chain linkage represents the 'canonical' signal for
proteasome-dependent proteolysis. However, apart from K48-linked chains other multi-
ubiquitin chains have been observed. K29-linked chains seem also to be involved in
proteasome targeting even though it is not yet clear whether they are only involved in
chain initiation while further chain extension is conducted by a switch to K48-linkage
(Koegl et al., 1999; Saeki et al., 2004). Similarly, K11-linked chains can signal protea-
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somal degradation in vitro, nevertheless a specific in vivo function has not been ad-
dressed so far (Baboshina and Haas, 1996). Conversely, substrates being modified by
K6-linked chains are directed to proteasomes but not degraded, and this modification
has been implicated in DNA repair (Morris, J. R. and Solomon, 2004; Nishikawa et al.,
2004). Likewise, ubiquitin chains linked by K63 (the most abundant chains after K48
linkage) provide entirely non-proteolytic functions. They are known to signal in different
pathways like DNA damage tolerance, the inflammatory response, protein trafficking,
and ribosomal protein synthesis (Pickart and Fushman, 2004). For instance, upon DNA
damage, the polymerase processivity factor PCNA (proliferating cell nuclear antigen)
that serves as a molecular scaffold for other factors, can selectively be modified either
by mono- or K63-linked multiubiquitin, thereby recruiting different translesion po-
lymerases (Hoege et al., 2002). Similarly, K63-linked chains on TRAF6 are directly im-
plicated in the recruitment of competent signaling complexes during the NF- B signal
transduction pathway, which in turn leads to the phosphorylation and activation of the
I B  kinase (IKK) and thereby to the degradation of the NF- B inhibitory subunit I B
(Deng et al., 2000; Wang, C. et al., 2001).
Besides multiubiquitylation mono-ubiquitylation provides also distinct regulatory non-
proteasomal targeting functions. This type of modification is implicated in diverse
cellular pathways as DNA damage (as mentioned before for PCNA), chromatin modifi-
cation, transcription or endocytosis.
Histone 2A (H2A) was the first substrate discovered to be ubiquitylated, but the
function of these modification was mysterious for long time, since it does not influence
the H2A stability (Goldknopf and Busch, 1977). Meanwhile, other histone proteins (H1,
H2B, H3 and the histone variant H2A.Z) were found to be similarly mono-ubiquitylated.
Ubiquitylation of H2B requires in vitro and in vivo the E2 Ubc2/Rad6 (Jentsch et al.,
1987; Robzyk et al., 2000) and is a prerequisite for methylation of H3 at K4, which is re-
quired for the establishment of silent chromatin at telomeres (Sun and Allis, 2002). This
observation led to the assumption that modification by ubiquitin contributes aside other
post-translational modifications to the 'histone code' (Jenuwein and Allis, 2001). The
outcome of histone ubiquitylation might result in an altered structure of histones either
directly, or indirectly by the subsequent recruitment of other modifying enzymes, con-
trolling thereby the transcriptionally active state of chromatin (Osley, 2004).
Besides its contribution to the general chromatin status through histone modifica-
tion, mono-ubiquitylation influences as well the transcriptional activity of some transcrip-
tion factors. In S. cerevisiae the heterologous transcription factor VP16 is only active
after mono-ubiquitylation by the SCFMET30 E3 ligase (Salghetti et al., 2001). Likewise, the
yeast transcription factor Spt23 exists after its mobilization as a mono-ubiquitylated
protein (see 1.3.1.) (Hoppe et al., 2000). These observations raised the idea, that mono-
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ubiquitylation is involved in 'licensing' of certain transcription factors, which might be
necessary to recruit other co-factors to DNA at the promoter. However, the contribution
of ubiquitylation to transcriptional activation might be more complex. Indeed, in some
cases also a requirement for proteasomal activity or a recruitment of proteasomal sub-
particles to active promoters have been reported (Gonzalez, F. et al., 2002; Morris, M.
C. et al., 2003). Interestingly, most of the unstable transcription factors studied so far
show a sequence overlap between their transcriptional activation domain (TAD) and the
degradation signal (Salghetti et al., 2000), and recently an E3 ligase activity has been
observed to associate with RNA polymerase (Brower et al., 2002). These intriguing
findings give rise to the suicidal model , in which a transcription activation signal re-
sembles to a degradation signal, thereby restricting the activity of a transcription factor
to a short time window (Muratani and Tansey, 2003).
Finally, the function of mono-ubiquitylation has been comprehensively studied in
receptor-mediated endocytosis and lysosomal targeting. In yeast several plasma-mem-
brane-bound receptors are mono-ubiquitylated by the E3 ligase Rsp5 at their cytoplas-
mic tails. Mono-ubiquitylation has been shown to induce the internalization of these re-
ceptors (Hicke and Dunn, 2003). This modification is subsequently recognized by the
so-called UIM (ubiquitin-interacting motif) sequence present in several members of the
intracellular endocytotic apparatus (Hofmann and Falquet, 2001; Shih et al., 2002). After
sorting into early endosomes, the ubiquitylated receptors are incorporated into
lysosomes and after invagination of the membranes into multi-vesicular bodies (MVBs),
degraded by lysosomal proteases. Notably, targeting of ubiquitylated proteins into the
MVBs requires also the sequential recognition of the ubiquitin moiety by three 'endoso-
mal complexes required for transport' (ESCRT-I-III) (Katzmann et al., 2001; Babst et al.,
2002a; Babst et al., 2002b). Interestingly, this pathway is also endured for sorting from
the trans-Golgi network directly to the vacuole; however, for this route rather multi-
ubiquitylation seems to be the sorting signal, which is mediated by Rsp5 in conjunction
with two other factors, Bul1 and Bul2 (Helliwell et al., 2001).
In conclusion, ubiquitylation generally represents a targeting or recruitment signal
mediating protein-protein interaction. Like phosphorylation, this modification is re-
versible by the action of de-ubiquitylation enzymes, thereby ensuring that only appro-
priately conjugated proteins meet their targets. The fate of ubiquitin-conjugates depends
primarily on the mode of ubiquitylation. Whereas mono-ubiquitylation is preferentially
involved in trafficking or sorting, multiubiquitylation (with the exception of K63- and K6-
linked chains) usually targets conjugates to proteasomal proteolysis. However, as ob-
served for instance for transcription factors, both types of modifications together might
be combined, resulting in a complex regulatory system.
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1.2. The 26S proteasome
1.2.1. Multiubiquitylated substrates are degraded in a coordinated manner
Multiubiquitylated proteins are targeted to 26S proteasomes that are present in the
cytosol and the nucleus of every eukaryote. This multi-subunit, self-compartmentalized
protease comprises a 20S core complex bearing different, rather non-specific proteolytic
sites within its cavity, and two axial 19S regulatory caps (Pickart and Cohen, 2004).
The barrel-like core particle consists of a stack of 4 rings each composed of 7
homologous subunits: two central identical -rings and two distal identical  rings (Groll
et al., 1997). Although  and -subunits are sequence-related, only the -ring harbors
the proteolytic sites encoded by three different -subunit genes (in total 6 proteolytic
sites per core particle). The -subunits are implicated in forming the gate with their -
specific N-terminal extensions, thereby restricting the access to the proteolytic chamber
(Groll et al., 2000). In absence of the 19S regulatory particle the entry to the interior
chamber is closed.
The 19S regulatory complex includes at least 17 different subunits and is assembled
from two main subcomplexes: the base that contains 6 ATPase (Rpt1-6) forming a
hexameric ring plus 2 non-ATPase subunits (Rpn1-2), and the lid that sits on top of the
base and bears 8 non-ATPase subunits (Rpn2-9) (Pickart and Cohen, 2004). The
Rpn10 subunit is localized to the base-lid interface and contributes to the stable lid
association with the base (Glickman et al., 1998). The individual subunits provide differ-
ent functions: recognition of the ubiquitin conjugates, which is accomplished most
probably by several ubiquitin receptors; substrate unfolding by ATPase subunits of the
base; substrate translocation into the pore by opening the channel, which is controlled
by the ATPase Rpt2; recycling of the conjugated ubiquitin moieties by de-ubiquitylation
Figure 1-3: The 26S proteasome.
The 26S proteasome consists of the 20S catalytic
particle and the 19S regulatory particle. The 20S
particle harbors the proteolytic sites within a central
cavity formed by 4 stacked rings of 7  and  subunits
each. The 19S particle can be further subdivided into
base and lid. The lid is compromised of non-ATPase
(Rpn) subunits and is involved in de-ubiquitylation of
the multiubiquitin chain. The base mediates unfolding
of substrates and pore opening through its ATPase
(Rpt) subunits. In addition the base is implicated in
recognition of multiubiquitylated substrates. The protein
Rpn10 binds to both the lid and the base and promotes
their stable association. Apart from this function, Rpn10
serves as a soluble ubiquitin receptor.
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of the substrate executed by the lid subunit Rpn11 (other de-ubiquitylating enzymes that
associate with the proteasome may assist to this process) (Pickart and Cohen, 2004).
Polypeptides inserted into the central cavity are digested usually into peptides of a
length ranging from 3 to 22 amino acids (Kisselev et al., 1999).
Most notably, the different functions of the 26S proteasome are apparently coor-
dinated (Pickart and Cohen, 2004): substrate unfolding seems to be preceded by a suc-
cessful engagement with a loosely folded region of the substrate (which follows the
weak and reversible tethering of the multiubiquitin chain) and is itself a prerequisite for
translocation into the chamber. Likewise, de-ubiquitylation by Rpn11 that cleaves only
at the one ubiquitin moiety proximal to the substrate is strictly ATP-dependent and does
not occur before substrate unfolding. This observation suggests that upon engagement
and unfolding, the multiubiquitylated substrate is moved into a fixed position required for
successful processing of the ubiquitin chain. Even though ubiquitin itself can be princi-
pally unfolded and degraded by the 26S proteasome, this process occurs extremely
slowly due to ubiquitin's extraordinary stable fold, indicating that de-ubiquitylation also
provides a regulatory function during the substrate translocation into the proteolytic
cavity.
1.2.2. Several ubiquitin receptors are implicated in substrate targeting
Substrates modified by 4 ubiquitin moieties are efficiently targeted to the 26S protea-
some (Thrower et al., 2000). However, the question of which of the individual subunits
recognize the multiubiquitin signal has long been under debate. Rpn10 (S5a in meta-
zoans) has been proposed as a proteasomal ubiquitin receptor since it contains a UIM
(ubiquitin interacting motif), and the non-assembled subunit shows high affinity to
multiubiquitin chains (Deveraux et al., 1994; Hofmann and Falquet, 2001). Nonetheless,
the deletion of RPN10 is not lethal in yeast and displays only mild defects on protein
turnover (van Nocker et al., 1996). Moreover, as part of proteasomes Rpn10 has not
been found to be associated with multiubiquitin chains (Lam et al., 2002). Thus, it is un-
likely that Rpn10 represents the sole receptor for multiubiquitin. The yeast proteins
Rad23 and Dsk2 comprise also a specific recognition motif for ubiquitin conjugates, the
UBA (ubiquitin associated) domain (Hofmann and Falquet, 2001; Wilkinson, C. R. et al.,
2001). Additionally, they display a UBL (ubiquitin-like) motif that mediates their associa-
tion with proteasomes (Schauber et al., 1998; Kim et al., 2004). Although Rad23 and
Dsk2 are non-essential proteins and present in proteasomes markedly below
stoichiometric amounts (Schauber et al., 1998; Verma et al., 2004), mutants of Rad23
lacking the UBL domain indeed display synthetic defects with rpn10, suggesting that
both types of receptors function in a redundant manner in proteasome targeting
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(Lambertson et al., 2003). However, the recent discovery of the strong association of
the ATPase subunit Rpt5 (mammalian S6') with multiubiquitin chains when bound to
proteasomes implied that this candidate actually represents the primary receptor for
ubiquitin conjugates (Lam et al., 2002). Nonetheless, whether Rpt5 works in conjunction
with the other ubiquitin receptors or rather independently has still to be determined.
1.2.3. Non-conventional functions: the proteasome is implicated in processing
Substrates are usually proteolyzed within the central cavity into small fragments that are
small enough to exit the proteasome through its narrow ports. But surprisingly, some
ubiquitin-conjugates have been found to be only partially degraded by the 26S protea-
some. This process, referred to as regulated ubiquitin/proteasome-dependent process-
ing (RUP), was first discovered for the heterodimeric transcription factor NF- B. One of
its two subunits is translated as an inactive precursor protein (p105) and ubiquitin-
proteasome-dependent degradation of its C-terminal domain is required to convert p105
into its mature form p50 (Fan and Maniatis, 1991; Palombella et al., 1994). Remarkably,
two distant relatives of NF- B p105, the yeast transcription factor Spt23 and Mga2, are
similarly processed (Hoppe et al., 2000). They are synthesized in vivo as membrane-
bound precursors (p120) that are anchored by their C-terminus in the ER-membrane.
Activation requires their processing by the 26S proteasome yielding a soluble N-
terminal fragment (p90), which is subsequently translocated into the nucleus. This
raised the intriguing question of how protein domains are spared from proteasomal deg-
radation.
Notably, within the Rel homology domain residing in the N-terminus of p105, a
highly stable region was discovered that prevents complete proteolysis (Lin, L. and Ko-
bayashi, 2003). A structurally related motif, the IPT (Ig-like/plexin/transcription factor)
domain was found in Spt23 and Mga2, which seems to be equally important for regu-
lated processing (Rape et al., 2001; Rape and Jentsch, 2004). Since the N-terminus of
NF- B and Spt23/Mga2 is left intact while the C-terminus especially in the case of the
membrane-bound transcription factors is not accessible, it was concluded that degrada-
tion has to initiate from an internal, loosely folded polypeptide loop that could be easily
unfolded and transferred into the central proteasome cavity. Based on this assumption
degradation would proceed until the proteasome would reach those regions that resist
unfolding due to tightly folded domains. Segments beyond theses barriers would then
be not degraded but released from the proteasome (Rape and Jentsch, 2004).
1.3. Specialized pathway: ER-associated degradation (ERAD)
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1.3. Specialized pathway: ER-associated degradation (ERAD)
Since all components of the ubiquitin-proteasome system reside in the cytosol and/or
the nucleus, proteins from other compartments destined for proteasomal proteolysis
have to be re-translocated prior to their degradation. The endoplasmic reticulum (ER)
forms a specialized compartment for protein folding and maturation and about 20% of
the human genes have been predicted to encode for secretory proteins (Lander et al.,
2001). Due to the high protein content, misfolding of singular proteins or failures in the
assembly of multiprotein complexes ultimately provokes the formation of toxic protein
aggregates within the ER lumen. To avoid this situation, two quality control systems ex-
ist in the ER, which cooperate with each other: Hydrophobic patches of malfolded pro-
teins are immediately sensed by the unfolded protein response (UPR). Activation of the
UPR results in the transcriptional upregulation of specific proteins that increase the bio-
synthetic capacity of the ER (e.g. ER-resident chaperones). Concomitantly, aberrant
proteins are specifically recognized, exported to the cytoplasm and subsequently de-
graded by the ubiquitin/proteasome system. The last process has been referred to as
ER-associated degradation (ERAD) (Ellgaard and Helenius, 2003; Ahner and Brodsky,
2004). Interestingly, yeast cells can tolerate impairments of one of the two control sys-
tems under normal growth conditions, however, mutants defective in both are inviable
(Friedlander et al., 2000).
1.3.1. Substrate recognition differs between luminal and membrane proteins
Luminal and integrative membrane substrates of ERAD were initially thought not to
differ significantly in the way they are degraded - with one exception: the recognition of
aberrant soluble proteins takes exclusively place within the ER lumen. Thus, luminal
substrate recognition has to specifically address this circumstance. Whereas E2 en-
zymes involved in ERAD (see 1.3.3.) are almost entirely cytosolic, some membrane
spanning E3 enzymes face partially the ER lumen, supplying a potential contribution to
substrate recognition (Hampton, 2002). Nonetheless, additional factors play important
roles in recognition of abnormal proteins in the ER lumen. The Hsp70 chaperone BiP
(Kar2 in yeast) binds to hydrophobic stretches and regulates together with its Hsp40 co-
chaperones the binding and release of aggregation-prone misfolded proteins. Mutants
of those chaperones are actually impaired in degradation (Ahner and Brodsky, 2004).
Another mechanism of protein surveillance is provided by monitoring the retention time
of secretory proteins within the ER compartment. In higher eukaryotes, prolonged re-
tention of immature glycoproteins by calnexin and calreticulin results in trimming of
mannose residues and enables another lectin, EDEM, to bind to and target the trimmed
glycoprotein for degradation. A similar cycle seems to exist also for S. cerevisiae (Ahner
Introduction
14
and Brodsky, 2004). Surprisingly, some soluble substrates apparently are first trans-
ported to the Golgi and subsequently retrieved to the ER prior to their degradation
(Caldwell et al., 2001; Vashist et al., 2001).
Conversely, substrate recognition and degradation of several ER-membrane
proteins do not rely on luminal chaperones. Instead, these substrates require the cyto-
plasmatic Hsp70 Ssa1. In addition, E3 ligases seem to be primarily implicated in sub-
strate recognition, at least for ER-membrane proteins that expose their aberrant do-
mains to the cytosolic side (Ahner and Brodsky, 2004).
1.3.2. The identity of the protein channel involved in ER protein dislocation
To become accessible to the cytoplasmic degradation machinery, luminal proteins have
to be entirely translocated into the cytosol, whereas ER-membrane proteins have at
least to be extracted out of the membrane. Export of both types of ER proteins is
believed to occur by an aqueous channel, by which substrates are able to overcome the
hydrophobic barrier of the ER membrane. Genetic and biochemical data suggested that
the Sec61 ER import channel is also involved in the dislocation process (Wiertz et al.,
1996; Pilon et al., 1997; Plemper et al., 1997; Zhou and Schekman, 1999). This trans-
location channel also provides the ability of lateral opening, which would facilitate not
only the direct insertion of polytopic integral membrane proteins into the lipid bilayer
membrane, but also their extraction out of it (Menetret et al., 2000). However, consider-
ing the fact that this channel would have to operate in a bidirectional manner, a specific
regulation has to be presumed. Additionally, some ERAD substrates are still glycosy-
lated after translocation (Blom et al., 2004) and therefore it was concluded that any
channel involved in retrograde transport has to impart a pore size large enough to allow
the passage of glycosylated proteins (Hirsch et al., 2004).
Class I MHC molecules have been shown to be degraded by ERAD in human
cytomegalus virus (CMV)-infected cells. Recently, a polytopic ER protein, Derlin-1, was
found to interact with class I MHC molecules during their dislocation process. Interest-
ingly, Derlin-1 is also found in association with the CMV encoded protein US11 that
specifically targets class I MHC for ERAD (Lilley and Ploegh, 2004; Ye et al., 2004).
Based on this observation, it was hypothesized that Derlin-1 constitutes a pore for pro-
tein export. However, MHC-class I turnover induced by another CMV encoded protein,
US2, does not rely on Derlin–1 (Lilley and Ploegh, 2004). Moreover, the yeast homolog
of Derlin-1, Der1, has been shown to be involved only in the turnover of some luminal
ER proteins (Knop et al., 1996; Vashist et al., 2001; Taxis et al., 2003) and some mem-
brane spanning substrates that specifically dispose their aberrant domain towards the
ER lumen (Vashist and Ng, 2004). These findings make it rather unlikely that Derlin-1
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and Der1 are exclusively required for substrate dislocation. Likewise, any direct data
demonstrating that these proteins form a pore still are lacking, which leaves the ques-
tion about the identity of the protein conducting channel open.
Finally, the question of how retrograde transport through the pore occurs mecha-
nistically remains just as elusive. Import into the ER requires energy that is provided
either during co-translational translocation by the ribosomal translation machinery or
during post-translational translocation by ATP consumption of the ER-resident HSP70
chaperones Kar2 and Lhs1 through several rounds of substrate binding on the luminal
side (Wilkinson, B. M. et al., 1997). Thus the post-translational import mechanism might
operate according to the 'Brownian ratchet' model, by which a randomly for- and back-
ward slipping is converted into a vectorial motion (Neupert and Brunner, 2002). In
analogy, the attachment of ubiquitin moieties to a partially translocated substrate was
shown to be a prerequisite for retrotranslocation, possibly by preventing the polypeptide
from slipping back into the ER (Biederer et al., 1997). Alternatively, retrotranslocation
might involve also an active pulling force. Some of the energy is most likely supplied by
the ATP-depending processes of peptide unfolding and hydrolysis taken place at and
within the proteasome. Most notably, a direct involvement of the 26S proteasome in
membrane extraction of an integral membrane protein could be demonstrated (Mayer et
al., 1998). However, the question whether the proteasome activity is sufficient for the
removal of ERAD substrates has been remained unanswered.
1.3.3. ERAD occurs by a specific subset of E2/E3 enzymes
Aberrant proteins emerging at the cytosolic site of the ER membrane are ubiquitylated
by E2 and E3 enzymes specifically adapted for this task. UBC6 and UBC7 represent the
prototypes of UBCs involved in ERAD (Sommer and Jentsch, 1993; Biederer et al.,
1996). Both are tethered to the ER membrane either by a single transmembrane
domain (Ubc6) or by binding to the anchor protein Cue1 (Ubc7) (Biederer et al., 1997),
suggesting that a direct localization of these enzymes is a prerequisite for ERAD.
However, for some ERAD substrates, also a participation of the cytosolic E2 Ubc1 has
been demonstrated (Friedlander et al., 2000; Bays et al., 2001). How it is recruited to
the ER membrane remained obscure.
Two specific ERAD E3 ligases have been identified in S. cerevisiae. Both are RING
finger type E3s and integrated into the membrane by several transmembrane segments.
Degradation of several integral membrane proteins like Hmg2 (3-hydroxy-3-
methylglutaryl coenzyme A reductase) is controlled by an ubiquitin-ligase complex that
consists of the polytopic RING protein Hrd1 and the single membrane span protein
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Hrd3. The luminal domain of Hrd3 is assumed to function in substrate sensing as well
as in regulation of the cytosolic Hrd1 E3 ligase activity by a transmembrane signaling,
which is mechanistically so far not understood (Bays et al., 2001; Gardner et al.,
2001a). The substrate spectrum of the HRD complex is obviously not restricted to
membrane proteins, since a luminal substrate has been shown to be degraded in a
Hrd1-dependent manner as well (Friedlander et al., 2000). However, some known
ERAD substrates are not recognized by Hrd1/Hrd3, and recently another ER-resident
multi-spanning ubiquitin ligase, Doa10, was identified (Swanson et al., 2001). Interest-
ingly, mutants that are deficient for both, Hrd1 and Doa10, are more sensitive towards
ER stress and display a more elevated UPR than the respective single mutants, sug-
gesting overlapping functions (Friedlander et al., 2000).
How substrate recognition is mediated by these ubiquitin ligases could be already
partially addressed. The HRD complex seems to be able to discriminate between
distinct folding states of its substrates. In particular, Hmg2 that acts in the mevalonate
pathway is regulatory degraded by a negative feedback mechanism. High levels of the
mevalonate pathway intermediate farnesyl pyrophosphate (FPP) directly stimulate
Hmg2 ubiquitylation and degradation. Remarkably, degradation requires the membrane
spans of Hmg2, suggesting that the signal for degradation derives directly from the
membrane. Therefore the so-called 'structural transition model' has been proposed, by
which presence of FPP somehow alters the structure of Hmg2 thereby inducing a deg-
Figure 1-4. The ubiquitin conjugation system during ERAD.
Whereas luminal substrates are supposed to be ubiquitylated as they emerge at the cytosolic site,
membrane proteins might be modified even before they have completed their dislocation. Ubiquitylation is
largely mediated by the membrane-associated UBCs Ubc6 and Ubc7, which work in conjunction with
different E3s as the RING finger ubiquitin ligases Hrd1 or Doa10. Other factors like Hrd3 may also
contribute by influencing the substrate specificity or by regulating the ligase activity.
1.4 Other proteolytic factors within the ubiquitin-proteasome system
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radation signal recognized by the HRD complex (structural transition model) (Hampton,
2002). Such a quality control sensing mechanism could be principally envisaged also for
other substrates of the HRD complex, although the specific recognition motif within Hrd1
or Hrd3 has not been isolated so far.
Conversely, Doa10 appears to contain distinct protein-protein interaction motifs, by
which substrate recognition could occur. For instance it displays a putative WW motif. In
consistence with this finding, Ubc6 that is itself an ERAD substrate and contains a PPxY
motif is degraded in dependence on Doa10 (Swanson et al., 2001). However, Doa10
seems to provide also further determinants, as other substrates are discerned by a
different recognition motif. For instance, Doa10 recognizes the Deg1 signal derived from
the yeast 2 transcription factor and degrades variants bearing this degron.
Remarkably, Deg1 comprises an amphiphatic helix that possibly participates in coiled-
coil structures and Doa10 displays at its very N-terminus a short stretch predicted to
undergo coiled-coil interactions (Swanson et al., 2001).
1.4 Other proteolytic factors within the ubiquitin-proteasome system
Various genetic screens identified additional factors that are involved in ubiquitin-depen-
dent proteolysis or sorting, but surprisingly they neither belong to the E1/E2/E3 ubi-
quitin-conjugating system nor they are components of the proteasome. A great number
of these factors displays the property to recognize ubiquitylated substrates, suggesting
that they might function downstream of ubiquitin conjugation prior to proteasomal degra-
dation or signaling. Among them are several so-called UFD proteins (ubiquitin-fusion-
degradation) that were originally isolated in a screen searching for mutants stabilizing a
short-lived artificial ubiquitin-protein fusion (Johnson, E. S. et al., 1995; Ghislain et al.,
1996): The E4 Ufd2 exhibits a role in multiubiquitylation of oligo-ubiquitylated substrates
(Koegl et al., 1999), whereas Ufd1 was later found to function in conjunction with Npl4
as a substrate recruitment factor for ubiquitylated proteins in the oligomeric Cdc48Ufd1/Npl4
complex (Meyer et al., 2000; Hitchcock et al., 2001; Rape et al., 2001).
1.4.1. The Cdc48Ufd1/Npl4 complex untethers ubiquitylated proteins from non-
modified partners
Cdc48 (p97 in mammals) was originally identified by a screen for mutants with cell cycle
defects (cell division cycle). It belongs to the family of AAA-type ATPases (ATPase
associated with different cellular activities) and forms a homohexameric ring that
possesses chaperone-like activity (Zhang et al., 2000; DeLaBarre and Brunger, 2003).
Like other members of the large AAA family Cdc48 contains an N-terminal protein-
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protein interaction domain and two copies of the AAA-ATPase domain (Walker et al.,
1982). Upon concerted ATP hydrolysis, Cdc48 undergoes a rotational conformation
change, thereby converting chemical bond energy into physical force (Rouiller et al.,
2002). Its N-terminal domain serves to recruit discrete adaptor proteins that are as-
sumed to specify its function. Combined with the adaptor p47, mammalian p97 is in-
volved in membrane fusion (Kondo et al., 1997; Dreveny et al., 2004). In contrast, re-
cruitment of the heterodimeric adapter Ufd1-Npl4 was assumed to directs p97 to
ubiquitin-dependent proteolysis although its role in this pathway was initially not clear
(Meyer et al., 2000).
Insight into the molecular function of the Cdc48Ufd1/Npl4 complex was obtained by the
study on the regulation of the yeast transcription factors Spt23 and Mga2. Both tran-
scription factors function within a regulon called the OLE pathway that controls the syn-
thesis of unsaturated fatty acids by regulating the expression of the fatty acid desatu-
rase Ole1 (Hoppe et al., 2000). Spt23 and Mga2 are tethered to the ER membrane by a
single membrane span and form homo- or heterodimers. To become functionally active,
they have to be processed into the active p90 form by the 26S proteasome (see 1.2.3).
Processed p90 is still tethered to its non-cleaved p120 partner protein and needs to
become mobilized for its complete activation. Biochemical and genetic studies con-
verged to demonstrate that this step is accomplished by the chaperone-like complex
Cdc48Ufd1/Npl4. The chaperone recognizes Spt23 preferentially in its ubiquitylated form
and untethers processed p90 from the ER membrane in dependence of ATP  (Rape et
al., 2001). Interestingly, consistently with the observed function, the Ufd1/Npl4 dimer as
well as Cdc48 itself show a general preference for binding to ubiquitin, and thus the
Cdc48Ufd1/Npl4 complex might act on other ubiquitylated proteins so segregate them from
non-modified proteins (Rape et al., 2001; Meyer et al., 2002).
1.4.2. Cdc48/p97 cooperates with SNAREs in homotypic membrane fusion
Whereas Cdc48/p97 in conjunction with Ufd1/Npl4 has been linked to ubiquitin-depen-
dent proteolysis, p97 in complex with p47 was presumed to function ubiquitin-inde-
pendent in membrane fusion processes (Latterich et al., 1995; Kondo et al., 1997;
Hetzer et al., 2001).
Membrane fusion has been suggested to operate by a mechanism following the
SNARE hypothesis (Sollner et al., 1993; Rothman, 1994): SNARE ( SNAP receptor)
proteins are anchored on the opposing membranes of vesicles, which are about to fuse,
and form energetically favorable tetrahelical coiled-coil bundles through intermolecular
interactions of their SNARE domains. The SNARE assembly works like a molecular zip-
per (trans-SNARE complex formation) that brings the membranes into close proximity
1.4 Other proteolytic factors within the ubiquitin-proteasome system
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and promotes thereby fusion. After fusion, the SNARE proteins are found in a highly
stable cis-SNARE complex present on the newly formed membrane. Their recycling re-
quires the ATP-consuming segregation by the AAA-ATPase NSF (N-ethylmaleimide-
sensitive factor), which is recruited to the cis-SNARE complex via its co-factor SNAP
(soluble NSF-attachment protein). In yeast, the disassembly of SNARE complexes is
mediated by Sec18 and Sec17, respectively.
Whereas most membrane fusion processes rely exclusively on NSF, homotypic
membrane fusion of ER and Golgi vesicles requires (in addition) p97, which is actually
highly homologous to NSF, and has therefore been proposed to function by a similar
mechanism. Together with p47, p97 mediates the reassembly of mitotic Golgi fragments
(Kondo et al., 1997). p47 contributes apparently by recruiting p97 to the SNARE syn-
taxin 5, and by modulating the ATPase activity of p97 (Meyer et al., 1998; Rabouille et
al., 1998). Likewise, Cdc48 has been reported to mediate homotypic membrane fusion
of ER vesicles by binding to the syntaxin homolog Ufe1, most probably also in combina-
tion with an adaptor protein (Latterich et al., 1995; Patel, S. K. et al., 1998). In yeast, a
protein with considerable homology to p47, Shp1, has been identified and proposed to
function similarly to p47 (Kondo et al., 1997).
While p47 was initially supposed to function analogous to SNAP (Rabouille et al.,
1998), it was recently shown that p47 and its putative yeast homolog Shp1 bind
specifically to ubiquitin and ubiquitin-conjugates (Meyer et al., 2002; Hartmann-Petersen
et al., 2004; Schuberth et al., 2004). Moreover, cycles of ubiquitylation and de-ubiquity-
lation are required for mitotic Golgi reassembly, although the target has not been identi-
fied (Wang, Y. et al., 2004). Thus, it might be possible that either a regulatory factor or
SNARE proteins themselves are targeted by ubiquitylation, thereby regulating either the
assembly or disassembly of SNAREs. Remarkably, the syntaxin Ufe1 was recently re-
ported to be linked to ubiquitylation-dependent regulation (Lin, A. et al., 2001). Thus,
ubiquitin recognition and binding seems to be conserved throughout the cellular func-
tions of the different p97/Cdc48 complexes.
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Figure 1-5: SNARE-mediated membrane fusion.
Membrane-anchored SNARE proteins of opposing vesicles (v, vesicle; t, target membrane) form ternary
helical bundles by their SNARE domains resulting in a stable trans-SNARE complex. This brings the
membranes in close proximity and enables them to fuse. To allow new rounds of SNARE assemblies, the
cis-SNARE complex on the newly formed membrane has to be disassembled by a AAA ATPase under
ATP consumption. In case of heterotypic membrane fusion disassembly is promoted in mammals by
NSF, which is recruited to SNAREs via SNAP. In case of homotypic membrane fusion of Golgi or ER
vesicles, this process is mediated by p97 in conjunction with p47. SNARE molecules might be directly
recognized by p47. However, due to the ability of p47 to bind to ubiquitin-conjugates, SNARE recruitment
might probably be also regulated through SNARE ubiquitylation acting as a recruitment signal and/or
degradation signal.
1.5. Aim of this work
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1.5. Aim of this work
This study focuses on the identification of novel components in the ERAD pathway and
the investigation of its regulatory role in the turnover of newly identified ERAD sub-
strates.
Whereas previous work has addressed the means of substrate recognition and
ubiquitylation, the mechanisms how substrates are relocated from the ER and targeted
to the 26S proteasome are still elusive. The scope of this study is the investigation of
proteolytic factors having been recently isolated as ubiquitin-binding proteins with re-
spect to a possible contribution to ERAD. Particularly the potential function of the re-
cently identified ubiquitin-selective chaperone Cdc48Ufd1/Npl4 will be addressed (Rape et
al., 2001).
To date ERAD has been thought to be involved primarily in quality control; however,
recent findings anticipate an additional role in regulatory functions. Thus, another aspect
of this work is the identification of novel native (i.e. not abnormally folded) substrates of
ERAD and to study the regulated degradation of these ER proteins with respect to the
mechanisms and physiological functions. Among putative substrates, the –9 fatty acid
desaturase Ole1 is a likely candidate to be a short-lived protein due to the tight
transcriptional control of the OLE1 gene by the OLE pathway (Hoppe et al., 2000).
Moreover, the negative feedback regulation by unsaturated fatty acids at the expression
level of OLE1 assumes that Ole1 may be also regulated at the protein level
(McDonough et al., 1992; Gonzalez, C. I. and Martin, 1996; Hoppe et al., 2000; Rape et
al., 2001). Another candidate to be analyzed is the syntaxin homolog Ufe1 that resides
in the ER membrane. This SNARE protein is involved in homotypic membrane fusion,
which is mediated by the assistance of the AAA-type ATPase Cdc48 that physically and
genetically interacts with Ufe1 (Latterich et al., 1995; Patel, S. K. et al., 1998). The re-
cent finding that Ufe1 becomes unstable in a conditional mutant of the kinase Pkc1 (Lin,
A. et al., 2001) suggests that the half-life of Ufe1 may also be regulated by ERAD.
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2. RESULTS
2.1. The fatty acid desaturase Ole1 is a substrate of ERAD
The -9 fatty acid desaturase Ole1 is a polytopic integral membrane protein of the ER
with its catalytic center facing the cytosol. It catalyzes the conversion of saturated into
unsaturated fatty acids (UFAs) at the ER membrane and thereby determines UFA levels
within the yeast cell. The abundance of the essential Ole1 enzyme is controlled by a
regulon, coined the OLE pathway. This pathway is uniquely controlled by the ubiquitin-
proteasome system and requires a two-step mechanism for its activation: a cleavage of
the ER-membrane-bound transcription factors Spt23 and Mga2 achieved by the 26S
proteasome, and the mobilization of the processed transcription factors by the
chaperone-like complex Cdc48Ufd1/Npl4 (Hoppe et al., 2000; Rape et al., 2001). Activation
by this mechanism enables the active transcription factor to localize to the nucleus and
drive the expression of the OLE1 gene. Over- and underexpression of OLE1 is toxic for
yeast cells. Intriguingly, the OLE pathway is regulated by a negative feedback mecha-
nism by UFAs at different levels, i.e. the processing of the precursor transcription fac-
tors, the OLE1 transcription and the OLE1 mRNA half-life (McDonough et al., 1992;
Choi et al., 1996; Gonzalez, C. I. and Martin, 1996; Hoppe et al., 2000). Thus, in order
to respond appropriately to these multiple regulatory loops Ole1 would have to be a
short-lived protein.
2.1.1. Ole1 is a naturally short-lived protein
To test this hypothesis epitope-tagged 3mycOLE1 was expressed in WT yeast cells from
an extra copy, stably integrated into the genome under the control of the GAL1-10
promoter. This ensures that OLE1 expression is uncoupled from the OLE pathway and
independent of the fatty acid-regulated OLE1 mRNA decay that requires the 5'UTR of
OLE1. Furthermore, expression from such a heterologous system allows promoter shut-
off experiments since the GAL1-10 promoter is only active in the presence of galactose
but repressed upon addition of glucose to the medium. In combination with the transla-
tional inhibitor cycloheximide any de novo protein synthesis is efficiently blocked. This
permits to study exclusively the turnover of the protein. By following protein levels
3mycOle1 was indeed found to be short-lived in vivo under normal growth conditions (Fig-
ure 2-1A, left panel). To rule out the possibility that the short half-life is caused by al-
tered UFA levels upon the heterologous expression of OLE1, a similar experiment was
conducted with an enzymatically inactive mutant of Ole1. To generate this mutant, two
conserved essential histidine residues in the desaturase domain (Shanklin et al., 1994)
were exchanged to alanine residues by site-directed mutagenesis (Figure 2-1B).
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Figure 2-1. OLE1 is a short-lived in vivo.
(A) Expression shut-off experiments with WT cells
co-expressing 3mycOLE1 and the mutant variant
3mycole1–AA under the control of the GAL1-10 pro-
moter. Cells were grown in YPGal to an OD600 of 0.5
at 23°C and shifted for another 2 hours to 37°C. The
experiment was started by adding glucose and
cycloheximide to the medium. At each time point in-
dicated, the cellular level of both epitope-tagged
Ole1 variants was analyzed by anti-myc im-
munoblots (upper panel). As a control, the blots
were reprobed with an antibody against the stable
ER-membrane protein dolichol phosphate mannose
synthase, Dpm1 (lower panel). (B) Sequence com-
parison of 9-fatty acid-desaturases from different
organisms (Sc, Saccharomyces cerevisiae; Ce,
Caenorhabditis elegans; Dm, Drosophila mela-
nogaster; Mm, Mus musculus; Hs, Homo sapiens).
The two conserved His residues, which were re-
placed by Ala residues in the mutant ole1-AA
variant, are shaded in gray. (C) Growth of the ole1
deletion strain expressing either none, 3mycOLE1, or
mutant 3mycole1-AA in presence and absence of oleic acid, respectively. The lethal phenotype of ole1  in
absence of unsaturated fatty acids in the growth medium can only be suppressed by expressing the func-
tional desaturase.
The inability of the 3mycOle1-AA variant to produce UFAs in yeast cells was assessed by
expressing this mutant in a ole1 strain, which is only viable in the presence of oleic
acid in the medium. Whereas expression of WT epitope-tagged 3mycOle1 suppresses the
lethal phenotype of the ole1 deletion, the mutant protein 3mycOle1-AA did not show
complementation in the absence of oleic acid (Figure 2-1C). Albeit the mutation renders
this protein enzymatically inactive the half-life of 3mycOle1-AA was not altered when
compared with WT 3mycOle1 in a promoter shut-off experiment (Figure 2-1A, right panel).
Thus, the short half-life is an intrinsic property of the Ole1 protein and seems to be
essential to provide a tight regulation of UFA availability upon the needs of the cell.
2.1.2. The half-life of Ole1 is modulated by unsaturated fatty acids
The strict regulation of the cellular amount of fatty acid pools requires several levels of
regulation (e.g. transcription factor processing, OLE1 transcription, mRNA decay).
Therefore it was tempting to assume that Ole1 turnover might also be subject to a
negative feedback mechanism. To investigate whether UFAs influence the half-life of
Ole1, promoter shut-off experiments were performed with the physiological inactive
3mycOle1-AA variant in the absence and presence of palmitoleic acid (16:1) or oleic acid
(18:1), respectively, both being natural endproducts of the desaturase reaction (Figure
2-2A). Whereas the half-life of 3mycOle1-AA is about 30 min under normal growth
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conditions, it is reduced by a factor of about 0.5 in the presence of palmitoleic acid (t1/2
15 min; Figure 2-2B). Surprisingly, the presence of oleic acid did not cause a similar
effect; in contrast the turnover of 3mycOle1-AA was even diminished under this condition
(t1/2  40 min; Figure 2-2B). However, considering the different physical properties of
palmitoleic and oleic acid (see below), this result might be caused by a titration effect of
endogenous fatty acids. Fatty acids are usually taken up from the medium and incorpo-
rated into cellular lipid bilayer membranes. Especially high amounts of exogenous UFAs
cause directly a reduction of the endogenous fatty acids in membrane phospholipids
(Bossie and Martin, 1989). The lipid bilayer membrane is influenced in its physical
properties directly by its fatty acid constituents. Particularly, the number of unsaturated
chemical bonds and the length of the fatty acids affect both the fluidity and the thickness
of the membrane. Under normal growth conditions palmitoleic acid and oleic acid
together contribute equally to the cellular pool and make up already 70% of fatty
Figure 2-2. Unsaturated fatty acids (UFAs)
modulate the half-life of Ole1. (A) Promoter
shut-off with WT cells expressing 3mycole1-AA in
absence, or presence of 0.2% palmitoleic (16:1)
or oleic acid (18:1), respectively, in the medium.
(B) Quantification of the 3mycOle1-AA decay after
promoter shut-off experiments in absence or
presence of oleic acid (18:1) and palmitoleic acid
(16:1). Symbols and bars represent the mean
and the standard error (S.E.) of 4-5 independent
experiments. (C) Promoter shut-off experiments
similar to (A) but in presence of different ratios of
palmitoleic acid (16:1) and oleic acid (18:1), lino-
leic acid (18:2) and linolenic acid (18:3). The total
amount of single or combined unsaturated fatty
acids in the medium (YPD) was 0.2 (D) Similar to
(C) but cells were incubated for different time in-
tervals in medium supplemented with 0.2%
palmitoleic acid (16:1) before the promoter shut-
off was performed. (E) Similar to (C) but cells
were first incubated for several hours in medium
supplemented with 0,2% palmitoleic acid (16:1)
and, then transferred to UFA-free medium for
different time intervals before the promoter shut-
off was performed. The schemes below indicate
the order and time intervals of the different UFA
treatments prior to the start of the shut-off ex-
periment in (E) and (D).
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acids within the lipid bilayer membrane. Both fatty acids contain a single unsaturated
bond at the same position (C-9), but differ in their carbon chain length skeleton (16 and
18 C-atoms, respectively). Interestingly, it was previously shown that the OLE pathway
is stronger affected by palmitoleic acid than oleic acid (Gonzalez, C. I. and Martin, 1996;
Hoppe et al., 2000). Thus, the ratio between both UFAs within the membrane could be
critical for the regulation of the OLE pathway.
To test the idea whether an altered ratio of UFAs influences the half-life of Ole1,
promoter shut-off experiments were performed in the presence of varying concentra-
tions of oleic and palmitoleic supplied to the growth medium. Indeed, the turnover of
3mycOle1-AA directly correlated with the relative amount of palmitoleic acid. The degra-
dation of 3mycOle1-AA was also increased when the total amount of both fatty acids was
raised (Figure 2-2C; the ratio of 50:50 of 18:1 and 16:1 resulted in a reduction of the
half-life). Similarly, the number of double bonds within the fatty acid backbone corre-
lated with an increased turnover of 3mycOle1-AA, as shown for linoleic acid (18:2) and
linolenic acid (18:3) (Figure 2-2C, bottom lanes). In accordance with these dose-de-
pendent effects, the half-life of 3mycOle1-AA was also gradually reduced when cells had
been incubated in the presence of palmitoleic acid for longer time intervals before the
promoter shut-off experiment was started (Figure 2-2D). Intriguingly, this effect could be
steadily reversed when cells were kept in UFA-free medium for different time intervals
after an initial incubation in the presence of palmitoleic acid-supplemented medium
(Figure 2-2E).
Conversely, the half-life of 3mycOle1-AA was substantially prolonged when cells were
incubated in the presence of completely saturated palmitic acid (16:0) (data not shown).
Likewise, turnover of 3mycOle1-AA was affected in mutants deficient in the production of
endogenous UFAs by a defect in the OLE pathway: Deletion mutants of OLE1 or SPT23
and MGA2, respectively, were depleted for UFAs by shifting the cells to UFA-free
medium for 17 h before the 3mycOle1-AA turnover was examined (yeast cells tolerate
depletion of endogenous UFAs without affecting viability up to 20 cell divisions).
Figure 2-3. Half-life of 3mycOle1-AA is prolonged
in cells deficient of WT OLE1. Promoter shut-off
in WT, ole1 and sp23  mga2 cells expressing
3mycole1-AA. In order to deplete mutants defective
in endogenous UFA production cells were grown
for 17 h in absence of oleic acid in the medium
before the promoter shut-off experiment was per-
formed. The asterisk denotes a cross-reactive
band of the anti-myc antibody.
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In both deletion mutants, 3mycOle1-AA degradation was significantly slowed down
(Figure 2-3). Interestingly, 3mycOle1-AA degradation was even more affected in the
spt23 mga2 double mutant than in the ole1 mutant. Most notably, addition of UFAs
to the medium was unable to restore the WT degradation rate of 3mycOle1-AA in the
spt23 mga2 mutant (data not shown). These data suggest that Ole1 turnover is dere-
gulated in cells deficient of Spt23 and Mga2 and that both transcription factors may
have additional, redundant functions besides the transcriptional activation of OLE1, as
the single mutants behaves like WT cells in respect to 3mycOle1-AA turnover (data not
shown).
Taken together, UFAs display a negative feedback mechanism also on the Ole1
protein half-life. The extent of this regulation correlates on one hand reciprocally with
the length of the fatty acid skeleton and the saturation of the carbon atom bonds and on
the other hand directly with the relative amount of the respective fatty acid present
within the lipid bilayer membrane.
2.1.3. Turnover of Ole1 proceeds via ERAD
Luminal and integral membrane proteins of the ER destined for degradation are pre-
dominantly disposed by the ER-associated degradation (ERAD) pathway. Turnover
occurs by the cytosolic ubiquitin-proteasome pathway and requires the retrograde
translocation of the substrate prior to its degradation. To explore whether Ole1 turnover
is mediated by ERAD, several mutants deficient in ERAD were investigated. As shown
in Figure 2-4, 3mycOle1-AA was substantially stabilized in a mutant strain deficient in both
major ubiquitin conjugating enzymes involved in ERAD, Ubc6 and Ubc7 (Jungmann et
al., 1993; Sommer and Jentsch, 1993). A similar effect was observed for a deletion
mutant of CUE1 that encodes an ER-membrane anchor for Ubc7 (Biederer et al., 1997).
Several different E3 ligases have been reported to assist in ERAD including Hrd1,
Doa10 and Rsp5 (Gardner et al., 2001b; Swanson et al., 2001; Haynes et al., 2002),
however deletion mutants of those E3 enzymes displayed only a minor or no effect on
Ole1 degradation (Figure 2-4; data not shown). This implies that Ole1 down regulation
may involve additional ligases. 3mycOle1-AA was significantly stabilized in a temperature-
sensitive mutant of CIM5 that encodes an essential subunit of the 19S cap of the pro-
teasome (Ghislain et al., 1993). Likewise, strong stabilization of 3mycOle1-AA was ob-
served in sec61-R2, a strain carrying an allele of Sec61 that is known to exhibit strong
defects in retrograde translocation of ERAD substrates (Zhou and Schekman, 1999).
2.2. Ubiquitin-binding factors implicated in ERAD
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Figure 2-4. Ole1 turnover is mediated by ERAD. Expression shut-off experiments at 37°C with different
ERAD mutants expressing the mutant 3mycole1-AA variant. Experimental procedures were identical to
those described in Figure 2-1A. Shown are the protein levels for 3mycOle1-AA (upper panels) and as a
control for Dpm1 (lower panels). The left panel shows the quantification of the 3mycOle1-AA decay.
In conclusion, these data demonstrate that Ole1 is a naturally short-lived protein, which
is degraded by ERAD involving the ubiquitin-proteasome system and the Sec61
translocon. The degradation of the Ole1 protein is regulated by fatty acid pools - most
probably in the immediate vicinity of Ole1 at the membrane – and executed by ERAD,
emphasizing an important regulatory role for the ERAD pathway besides its function in
quality control.
2.2. Ubiquitin-binding factors implicated in ERAD
2.2.1. Requirement of the Cdc48Ufd1/Npl4 chaperone in degradation of Ole1
ERAD substrates have to be expelled from the ER prior to their degradation. Substrates
are assumed to take the route of a proteinous channel like the Sec61 translocon.
However, the precise mechanism of the dislocation process has not been resolved. In
particular, the means how energy for the retrograde transport is provided has remained
elusive. Recently, a chaperone-like complex, designated Cdc48Ufd1/Npl4, has been
described to bind preferentially ubiquitin-protein conjugates (Rape et al., 2001). This
complex comprises the catalytic subunit Cdc48, an AAA-type ATPase, and two
cofactors, Ufd1 and Npl4. It has been shown that  the Cdc48Ufd1/Npl4 complex is essential
for the OLE pathway by mediating the ATP-dependent liberation of the ubiquitylated
SPT23 transcription factor from the ER membrane (Rape et al., 2001). This specific
property – recruitment and ATP-dependent mobilization of ubiquitin-conjugates –
suspected the Cdc48Ufd1/Npl4 complex to be a possible candidate in promoting the
retrograde transport of ERAD substrates through the ER channel.
To test the idea whether the Cdc48Ufd1/Npl4 complex acts as a ubiquitin-dependent
chaperone at the cytosolic side for ERAD substrates, 3mycOLE1-AA was expressed in the
temperature-sensitive mutants cdc48-6, ufd1-2 and npl4-1 (Latterich et al., 1995;
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DeHoratius and Silver, 1996; Hoppe et al., 2000). The degradation of 3mycOle1-AA was
followed after the cells had been shifted to the non-permissive temperature for 3 hours.
As shown in Figure 2-5A, 3mycOle1-AA was significantly stabilized in all three mutants.
Since the Cdc48Ufd1/Npl4 complex is crucial for the activation of the OLE pathway, which
controls the production of UFAs (Rape et al., 2001), the observed stabilization of Ole1
may be caused unspecifically by a depletion of endogenous UFAs. However, a control
experiment performed in the presence of oleic acid led to the same result (Figure 2-5B).
These data demonstrate that the Cdc48Ufd1/Npl4 complex is directly involved in the degra-
dation of the ERAD substrate Ole1.
The mammalian homolog of Cdc48, p97, is known to form at least two distinct
complexes. Together with p47 it is implicated in homotypic membrane fusion (Kondo et
al., 1997), whereas in combination with Ufd1 and Npl4 it is involved in ubiquitin-de-
pendent proteolysis (Meyer et al., 2000). To investigate whether ERAD of Ole1 requires
specifically the Cdc48Ufd1/Npl4 complex or whether also the alternative Cdc48/p97p47 com-
plex may mediate ERAD, the yeast homolog of p47 was analyzed. The protein encoded
by the putative p47 homolog, Shp1, shares 30% identical (50% similar) residues with its
mammalian counterpart. Shp1 has recently been shown to interact with Cdc48 physi-
Figure 2-5. Involvement of the CDC48UFD1/NPL4 segregase in Ole1 degradation. (A) Expression shut-
off experiments with the ts mutants ufd1-2, npl4-1, cdc48-6 and the deletion strain shp1 expressing the
mutant 3mycole1-AA variant in absence of oleic acid (at 37°C). Shown are the protein levels for 3mycOle1-
AA (upper panels) and as a control for Dpm1 (lower panels). The left panel shows the quantification of
the 3mycOle1-AA decay. (B) The same experiment as in (A) was performed in the presence of 0.2% oleic
acid.
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cally as shown by two-hybrid assays and co-immunoprecipitation experiments (Braun et
al., 2002), suggesting that also yeast Cdc48 is able to form two complexes, Cdc48Ufd1/Npl4
and Cdc48Shp1. To examine whether SHP1 is involved in ERAD of Ole1, 3mycOLE1-AA
was expressed in a shp1 deletion mutant and its turnover was analyzed. As shown in
Figure 2-5 (A and B right panel), 3mycOle1-AA was as unstable in shp1 mutants as in WT
cells. From this data it can be concluded that ERAD of Ole1 does not involve Cdc48Shp1
but specifically requires the Cdc48Ufd1/Npl4 chaperone.
2.2.2. Accumulation of stabilized Ole1 at the membrane
Because Cdc48 as well as its adaptors Ufd1 and Npl4 bind specifically ubiquitylated
proteins (Rape et al., 2001; Richly et al., 2005), it is conceivable that the chaperone
functions downstream of the ubiquitylation event. In the case of ERAD of Ole1, the
Cdc48Ufd1/Npl4 complex might thus be involved in the removal of Ole1 from the ER
membrane. However, direct evidence for such a function of Cdc48Ufd1/Npl4 in the retro-
grade process so far was lacking. To address this particular question, cell fractionation
studies were performed with extracts from ufd1-2 cells expressing 3mycOle1–AA. As
shown in Figure 2-6 (left panel) stabilized 3mycOle1-AA was detected predominantly in
the microsomal pellet fraction, demonstrating that the dislocation process was not
completed in this mutant. This result indicates that the activity of the Cdc48Ufd1/Npl4
chaperone is required at the membrane prior to proteasomal degradation of the
substrate. Cdc48Ufd1/Npl4 might cooperate with the proteasome since it was shown in a
former study that ERAD substrates accumulate at the ER membrane in mutants
defective in proteasomal activity (Mayer et al., 1998) Indeed 3mycOle1-AA was found to
be stabilized at membranes in a mutant of PRE1, which encodes a subunit of the 20S
proteasome core complex (Figure 2-6 right panel). This observation suggests that retro-
grade transport and proteasomal degradation occur in a physically and mechanistically
coupled manner.
Figure 2-6. Accumulation of stabilized
OLE1 at the membrane. Shut-off
expression experiments were performed
at 37°C with WT, ufd1-2 and pre1-1 cells
expressing the 3mycole1-AA variant. 30
minutes after adding cycloheximide and
glucose, cells were harvested and
lysates subjected to cell fractionation.
Equal amounts of total extract (T), solu-
ble (S) and pellet (P) fraction were ana-
lyzed by immunoblotting with anti-myc
(upper panel) and anti-Dpm1 (lower
panel) antibodies.
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2.2.3. General role of the Cdc48Ufd1/Npl4 complex in ERAD
Since Spt23 mobilization and Ole1 extraction from the membrane are both mediated by
Cdc48Ufd1/Npl4 and in fact very similar, one may assume that they represent a unique
mechanism specifically adapted for the OLE pathway. Alternatively, the Cdc48Ufd1/Npl4-
mediated process of recognition and mobilization of ubiquitin-conjugates may be
broadly used in retrograde transport of ERAD substrates. To address this question, the
turnover of several well characterized yeast ERAD substrates was investigated in
mutants of the Cdc48Ufd1/Npl4 complex: The HMG-CoA reductase-2 (Hmg2) is a polytopic
integral membrane protein being involved in sterole biogenesis and has been shown to
be naturally short-lived (Hampton, 1998). DEG1Sec62FLAG (DSF) is an engineered short-
lived variant of the ER-membrane protein Sec62 (Mayer et al., 1998), bearing the Deg1
degradation signal derived from the short-lived transcription factor MAT 2 (Chen, P. et
Figure 2-7. General role of the CDC48UFD1/NPL4 segregase in ERAD. (A) Expression shut-off
(cycloheximide chase) at 37°C with WT and ufd1-2, npl4-1, cdc48-6 shp1 cells expressing 6mycHMG2.
After adding cycloheximide to the medium samples were taken at time points indicated and protein
extracts were prepared. The protein level of epitope-tagged 6mycHmg2 is shown by anti-myc immunoblots
(upper panel). As a control blots were reprobed with an antibody against Dpm1 (lower panel). The right
panel shows the quantification of the mycHMG2 decay. (B) Steady state level of the unstable Deg1Sec62FLAG
variant expresed in WT, ufd1-2, npl4-1, cdc48-6 and shp1 cells. The steady state level of the epitope-
tagged Sec62 variant was analyzed by using an anti-FLAG antibody (upper panel). As a control blots
were reprobed with an antibody against Dpm1 (lower panel). (C) Pulse chase experiment with WT, ufd1-2
and npl4-1 cells expressing CPY* from its endogenous locus. Cells were pulsed by adding 25 µCi/OD 35S-
methionine for 15 minutes. Samples were taken at time points indicated and subjected to
immunoprecipitation with a CPY-specific antibody under denaturing conditions. Shown here is the
radiogramm after SDS-PAGE.
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al., 1993). CPY* is a mutant form of the soluble vacuolar protease carboxypeptidase Y
that is retained within the lumen of the ER and immediately degraded via ERAD (Finger
et al., 1993). As shown in Figure 2-7, both membrane proteins, Hmg2 and DSF were
strongly stabilized in cdc48, ufd1 and npl4 mutants at their non-permissive temperature,
as demonstrated by a cycloheximide chase experiment and examination of steady state
levels, respectively (Figure 2-7A and B). Likewise, turnover of the soluble protein CPY*
was significantly diminished in ufd1-2 and npl4-1 mutants as judged by a pulse-chase
experiment (Figure 2-7C). Furthermore, none of the proteins tested were stabilized in
the shp1 mutant (Figure 2-7, right panels, and data not shown). In conclusion, the data
obtained by this set of experiments suggest that the ubiquitin-selective Cdc48Ufd1/Npl4
chaperone is generally involved in ERAD and represents a constitutive component of
the ERAD machinery.
2.2.4. Involvement of other ubiquitin-binding factors in ERAD
Recently, it was demonstrated that Cdc48 cooperates with other different ubiquitin-
binding factors in proteasome-targeting of various proteolytic substrates (Richly et al.,
2005). In particular, recruitment of ubiquitin-conjugates to Cdc48Ufd1/Npl4 is mediated
largely by the heterodimer Ufd1/Npl4 (see Figure 2-8A), which has also been shown to
bind like Cdc48 to ubiquitylated proteins (Meyer et al., 2000). Upon substrate recruit-
ment, Cdc48 directs proteins modified with 1-2 ubiquitin molecules to the ubiquitylation
processivity factor (E4) Ufd2 (Kögl et al., 1999; Figure 8-2B), thereby controlling the
formation of the multiubiquitin chain on the substrate. Finally, multiubiquitylated
substrates are delivered to soluble ubiquitin receptors as Rad23 (Figure 28C), which
has been known to mediate the direct transfer of substrates to the proteasome (Kim et
al., 2004). Cdc48 seems to play a central role in this pathway making contacts to all
ubiquitin binding proteins either directly (i.e. to Ufd1 and Ufd2) or indirectly (i.e. to
Rad23 via Ufd2; see Figure 2–8D and Richly et al., 2005). Due to the common role of
Cdc48 in the degradation of Ole1 and other ERAD substrates, it was tempting to
speculate that this pathway might also be utilized for ERAD.
In collaboration with Holger Richly, the contribution of Ufd2 and Rad23 to ERAD
was investigated by studying the degradation of several ERAD substrates in deletion
mutants of UFD2 and RAD23. Indeed, Ole1, Hmg2, and the engineered variant
Deg1–FLAGSec62 (which is analogous to Deg1Sec62FLAG except that it carries the FLAG epi-
tope N-terminally of Sec62) were found to be moderately, but significantly stabilized in
ufd2 and rad23 mutants, respectively (Figure 2-9A and B upper panel, and data
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Figure 2-8. Substrate handing over by
ubiquitin-binding proteins. (A) The inter-
action of CDC48 with ubiquitylated proteins
is reduced in ufd1-2 and npl4-1 mutant cells
grown at 37°C. Ubiquitin-conjugates were
immunoprecipitated from WT, npl4-1, and
ufd1-2 cells overexpressing myc-tagged
ubiquitin. Coprecipitated Ccd48 was detected
by anti-Ccd48 immunoblots in WT, but hardly
in ufd1-2 and npl4-1 cells. Control indicates
WT cells overexpressing non-tagged
ubiquitin. (B) Ufd2 binds Ubi-Pro gal with
lower affinity in ufd1-2 and npl4-1 mutant
cells. Ubi-Pro gal was immunoprecipitated
from cleared lysates with galactosidase-
specific antibodies. Coprecipitated Rad23
was detected by anti-Rad23 immunoblots.
Control indicates WT cells not expressing
Ubi-Pro gal. Temperature sensitive mutants
were shifted to 37°C for 3 hours in medium
supplemented with oleic acid. (C) Rad23
binds Ubi-Pro gal with lower affinity in ufd1-
2 , npl4-1, cdc48-6 and ufd2 mutant cells.
Experimental procedure as in (B). (D) Ufd2
can bind to Cdc48 and Rad23 simultane-
ously via different domains. Two-hybrid in-
teraction of full-length or C-terminal deletion
constructs of Ufd2 with Ccd48 and Rad23.
Empty vectors are indicated by '–'. The Ufd2
constructs used are schematically shown on
the right. The U-box located at the C-termi-
nus of Ufd2 is structurally similar to RING
finger domains and is required for the multi-
ubiquitylation activity of Ufd2.
The experiment shown in (B) was performed
by M.Rape.
not shown). Since Rad23 was known to display partially overlapping functions with a
related protein, Dsk2, ERAD was also examined in a dsk2 deletion mutant. Again, only
a minor effect could be observed for Deg1-FLAGSec62 and the two other substrates in the
dsk2 strain (Figure 2-9B, lower panel; data not shown). However, in the rad23 dsk2
double mutant, all three ERAD substrates were almost completely stabilized, indicating
that Rad23 and Dsk2 function in parallel pathways and thus are able to functionally re-
place each other. Notably, Deg1-FLAGSec62 was only marginally more stabilized in ufd2
rad23 and ufd2 dsk2 double mutants than in a ufd2 single mutant, substantiating
the finding that Ufd2 and Rad23/Dsk2 function in the same pathway (Figure 2-9B, upper
and lower panel). In addition to the Ufd2/Rad23-dependent degradation pathway,
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degradation can occur via an alternative ubiquitin receptor, Rpn10, which is partially
associated with proteasomes (Koegl et al., 1999; Elsasser et al., 2004; Richly et al.,
2005). Deg1-FLAGSec62 was hardly stabilized in a single deletion mutant of RPN10, but the
double mutant ufd2 rpn10 showed a strong stabilization of this substrate comparable
to the effect observed in the rad23 dsk2 mutant (Figure 2-9B, upper panel). Thus, at
least for some ERAD substrates as DEG1-FLAGSec62 and Ole1 (data not shown), both
degradation routes can be used to ensure efficient proteolysis. In conclusion, these data
demonstrate that, in addition to the Cdc48Ufd1/Npl4 chaperone, the downstream-acting
factors Ufd2, Rad23, and Dsk2 also contribute to ERAD pathways. Moreover, these
findings also indicate that Ufd2/Rad23- and Rpn10-dependent pathways are partially
redundant in ERAD.
Figure 2-9. Involvement of Ufd2, Rad23, Dsk2, and Rpn10 in ERAD. (A) Expression shut-off ex-
periments at 30°C with WT, ufd2, rpn10, rad23 single mutants, and ufd2 rpn10 and rad23 dsk2
double mutants expressing 6mycHMG2. Samples were taken at the time points indicated and analyzed by
anti-myc immunoblots. The stable ER-membrane protein DPM1 was used as control. (B) Expression
shut-off experiments similiar to (A) with cells expressing the ERAD substrates Deg1-FLAGSEC62. Samples
were analyzed by anti-FLAG immunoblots.
The graphs shows in (A) and (B) show the quantification of the 6mycHmg2 and Deg1-FLAGSec62 decay, re-
spectively (time point zero was set as 100%).
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In summary, downstream of the constitutive component Cdc48Ufd1/Npl4, ERAD proceeds
via an interplay of several ubiquitin-binding factors that function partially in parallel
degradation pathways. This mechanism may prevent the escape of substrates after
they have reached the cytosol and ensures thereby efficient targeting to the 26S pro-
teasome.
2.3. Proteolytic regulation of the ER SNARE Ufe1
The intriguing finding that Cdc48 functions at the ER membrane in several ubiquitin/
proteasome-dependent processes (i.e. transcription factor processing, ERAD) prompted
the study to analyze other substrates of Cdc48 with respect to regulation of ubiquityl-
ation. An excellent candidate was the membrane tail-anchored protein Ufe1 (unknown
function essential). This ER SNARE protein mediates together with Cdc48 homotypic
membrane fusion of ER vesicles (Patel, S. K. et al., 1998). Moreover, Ufe1 was report-
ed to be unstable in a conditional pkc1-2 mutant dependent on Ubc7 (Lin, A. et al.,
2001).
2.3.1. Ufe1 is ubiquitylated in WT cells
To assess the influence of ubiquitylation on Ufe1 regulation, it was first important to
address the question whether Ufe1 is ubiquitylated under normal growth conditions in
WT cells. So far it was only reported that in the conditional pkc1-2 mutant Ufe1 be-
comes unstable (Lin, A. et al., 2001).
In order to study ubiquitylation of Ufe1, an antibody was raised against the N-
terminal half of Ufe1 recombinantly expressed in E.coli. Immunoblots with this antibody
revealed that Ufe1 exists predominantly at steady state in a non-modified form in whole
cell extracts of WT cells (Figure 2-10A, left panel, lane 1). The specificity of the antibody
was demonstrated by expressing UFE1 chromosomally tagged with a C-terminal 6HA-
epitope (UFE16HA) that results in an up-shift of the Ufe1-specific band in the migration
pattern after SDS-PAGE (Figure 2-10A, left panel, lane 2). Interestingly, by co-express-
ing an N-terminal-tagged form of ubiquitin (mycUb), the mobility of an additional, faint
band in the immunoblot was changed to a slower migrating form (Figure 2-10A, lane 4
versus lane 3). This change in the mobility corresponds to 2-3 kDa, approximately the
size of the myc-tag. The difference in the mobility between non-modified Ufe1 and this
additional band corresponds to 8-12 kDa. Based on this finding Ufe1 was supposed to
form (mono-) ubiquitin-conjugates in WT cells.
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Figure 2-10. The ER SNARE Ufe1 protein is ubiquitylated in WT cells. (A) left panel: WT cells ex-
pressing non-modified or a C-terminal HA-epitope fusion of UFE1 from its chromosomal locus (lane 1 and
2). Right panel: WT cells co-expressing ubiquitin or an N-terminal myc-epitope-fusion of ubiquitin (lane 3
and 4). Steady state levels of Ufe1 were analyzed with a Ufe1-specific antibody (B) Immunoprecipitation
of Ufe16HA under denaturing conditions. Non-modified or HA-tagged UFE1 was expressed in ufe1 cells
from a CEN plasmid under the control of its own promoter. Cells were additionally expressing ubiquitin or
myc-tagged ubiquitin, respectively, from a 2µ plasmid under the control of the inducible copper promoter.
Denaturing condition were used for preparation of whole cell extracts and immunoprecipitations. The in-
put and the immunoprecipitated material were analyzed by immunoblots with anti-HA (left panel) and anti-
UFE1 (right panel) antibodies.
To confirm these data, UFE16HA was expressed in ufe1 cells and lysates were
subjected to anti-HA immunoprecipitations under denaturing conditions. When analyz-
ing the input and the immunoprecipiated material with an anti-HA antibody, besides
non-modified Ufe16HA additional bands were observed. These formed a ladder indicative
of ubiquitin-conjugates (Figure 2-10B, lane 2-3 and 5-6). This ladder was also detected
when the immunoprecipitated material was analyzed with an anti-Ufe1 antibody (Figure
2-10B, lane 8-9), but was absent when Ufe1 was expressed without an HA-tag (lane 1,
4 and 7). Moreover, co-expression of myc-ubiquitin led again to a significant up-shift of
the ladder (compare lane 2 with 3, lane 5 with 6 and lane 8 with 9). Thus, a minor pool
of Ufe1 is ubiquitylated at steady state. Although the ubiquitin conjugation appears not
to be restricted to mono-ubiquitin, there seems to be a preference for shorter chains.
Depending on the substrate, the ubiquitylation reaction may be restricted to a
specific lysine residue. In order to investigate this possibility for Ufe1, single arginine
replacement mutants of all 30 lysine residues of the coding sequence of UFE1 were
generated. However, in none of the single mutants the ubiquitylation pattern was de-
tectable changed (data not shown), indicating that alternate lysine residues in Ufe1 may
be used for the modification.
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2.3.2. The SM protein Sly1 controls the stability of Ufe1
Based on the finding that Ufe1 is ubiquitylated in WT cells, it was of particular interest to
test whether Ufe1 is a short-lived protein. To this end, a cycloheximide chase ex-
periment was performed. When WT cells were kept at room temperature, Ufe1 was
hardly turned over within a period of 2 hours (Figure 2-11A, upper left panel). However,
when cells were shifted to 37°C upon addition of cycloheximide, the turnover of Ufe1
was moderately, but significantly, increased (Figure 2-11A, upper right panel). Interest-
ingly, when the cycloheximide chase experiment was performed over a longer time pe-
riod, Ufe1 levels did not further decline, which may indicate that only a specific pool of
Ufe1 is subject to degradation (data not shown). The slightly increased degradation of
Figure 2-11. Ufe1 is nearly stable in WT cells but short-lived in a sly1-1 mutant. (A) Cycloheximide
chase experiment with WT (upper panel) and sly1-1 cells (lower panel). Cells were grown in YPD to an
OD600 of 0.5 at 23°C and kept at this temperature or shifted to 37°C after addition of cycloheximide. At
each indicated time point, the cellular level of Ufe1 was analyzed by anti-Ufe1 immunoblots. As a control,
the blots were reprobed with an antibody against the stable ER-membrane protein Dpm1. The asterisk
indicates a cross-reactive band. (B) Similar to (A) but with cells co-expressing C-terminally HA-tagged
UFE1 from a CEN plasmid under the control of its endogenous promoter. In addition, the blots were
reprobed with an antibody against the Golgi SNARE Sed5.
The graphs in (A) and (B) show the quantification of the decay of Ufe1 and Ufe16HA, respectively (time
point zero was set as 100%).
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Ufe1 at elevated temperatures suggests either that degradation may occur generally
faster caused by a stress response or that Ufe1 turnover may be linked to physiological
conditions, which proceeds faster at higher temperatures.
The moderate decay of the entire Ufe1 pool raised the question whether degra-
dation might reflect a rather unspecific quality control mechanism to dispose misfolded
Ufe1 molecules, or whether it might be part of an intrinsic regulation of the SNARE.
Therefore, Ufe1 stability was studied under conditions where its function is expected to
be compromised. Ufe1 is known to interact physically with Sly1, which belongs to the
family of SM (Sec18/Munc1) proteins and is also essential (Dascher et al., 1991; Yama-
guchi et al., 2002). In yeast 4 different SM proteins exist, which are all believed to assist
in membrane fusion processes, yet their precise molecular function is still poorly under-
stood. Ufe1 stability was examined in a temperature-sensitive mutant of SLY1. Inter-
estingly, steady state levels of Ufe1 were strongly reduced in the sly1-1 mutant when
cells were incubated for a short period at the non-permissive temperature (data not
shown). To analyze the half-life of Ufe1 in this mutant, a cycloheximide chase experi-
ment was performed. When cycloheximide was added to sly1-1 cells directly after they
have been shifted to the restrictive temperature, Ufe1 levels were found to decline im-
mediately, but not when cells were kept at the permissive temperature during the time
course (Figure 2-11A, lower panel). Similar results were obtained for the half-life of
Ufe16HA, indicating that the regulation of the epitope-tagged variant is unchanged (Fig-
ure 2-11B). Sly1 is known to interact also with another SNARE protein, Sed5 (Sogaard
et al., 1994; Yamaguchi et al., 2002), which is implicated in protein sorting from the ER
to the Golgi and represents the closest homolog to Ufe1. Notably, Sed5 is stable even
at elevated temperatures, and its turnover is not altered in the sly1-1 mutant (Figure 2-
11B). Thus, the Sly1-dependent regulation of Ufe1 stability seems to be an intrinsic
property of Ufe1 itself.
2.3.3. Ufe1 stability is directly linked to interaction with Sly1
Since Ufe1 is highly unstable in the temperature-sensitive sly1-1 mutant, it was tempting
to speculate that Sly1 binding to Ufe1 may directly influence its stability. Recent studies
have mapped the interaction between Sly1 and its cognate SNARE partners (Bracher
and Weissenhorn, 2002; Yamaguchi et al., 2002). Both, Ufe1 and Sed5 interact with
Sly1 via a short N-terminal stretch. Within this conserved binding motif, one
phenylalanine residue (F) is crucial for binding (F10 in Sed5 and F9 in Ufe1)
(Yamaguchi et al., 2002). Sly1 itself makes contact with this phenylalanine residue by
forming a hydrophobic binding pocket (Bracher and Weissenhorn, 2002). Therefore, re-
ciprocal mutations in the binding interface of Ufe1 and Sly1 (Ufe1-F9A; Sly1-L137R and
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Sly1-V156P) were generated to investigate the half-life of Ufe1 with respect to the inter-
action of Ufe1 with Sly1.
By performing yeast two-hybrid assays, both amino acid replacements within the
binding pocket of Sly1 were confirmed to affect the interaction with Ufe1 especially at
higher temperatures (Figure 2-12A, upper panel). Consistent with previous results
(Yamaguchi et al., 2002), the F9A mutation of Ufe1 similarly displayed only a weak in-
teraction with Sly1 (Figure 2-12A, lower panel). The temperature-sensitive sly1-1 mutant
was also found to be reduced in its interaction with Ufe1 although the R266K exchange
of the sly1-1 allele is located outside the hydrophobic pocket. This may suggest that
determinants outside the binding pocket of Sly1 are also important for interaction with
Ufe1.
Figure 2-12. Stable interaction between Ufe1 and Sly1 is required to prevent Ufe1 degradation. (A)
Yeast two-hybrid interaction of WT and mutant variants of SLY1 and UFE1. Transformants were spotted
onto SC–Leu-Trp- plates as control (co) and SC-Leu-Trp-His- (-his) plates to test for two-hybrid interaction
and incubated for 2-3 days at different temperatures as indicated. Empty vectors are denoted as "-". (B)
Upper panel: Cycloheximide chase experiments with sly1 cells expressing WT or mutant alleles of SLY1
fused to C-terminal epitope-tags from a single copy plasmid under the control of the endogenous
promoter. Cells were grown in YPD to an OD600 of 0.5 and shifted to 37°C upon addition of cycloheximide.
At each time point indicated, the cellular levels of Ufe1 and the respective Sly1 variant were analyzed with
antibodies against Ufe1 (left), the myc- or HA-epitope (right), respectively. Lower panel: Cycloheximide
chase at 30°C with WT cells co-expressing C-terminal HA-tagged variants of WT UFE1 and ufe1-F9A
from a CEN plasmid under the control of the UFE1 promoter. The cellular levels of the epitope-tagged
Ufe1 variants were analyzed by an anti-HA immunoblot. The graph shows the quantification of the decay
of endogenous Ufe1 and co-expressed Ufe1-F9A6HA in different strain backgrounds as indicated on the
right side of the panel (time point zero was set as 100%).
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To test the influence of the respective sly1 mutants on the turnover of endogenous
Ufe1, epitope-tagged variants of WT SLY1 or the different mutant sly1 alleles were
expressed in sly1 cells and cycloheximide chases were performed. All mutants caused
a significant destabilization of Ufe1 (Figure 2-12B, left panel), which correlates with the
ability of the respective Sly1 variants to bind to Ufe1. To rule out the possibility that de-
stabilization of Ufe1 might have been caused indirectly by a possible instability of the
Sly1 mutants themselves, the turnover of the Sly1 variants was examined in addition.
Immunoblots using antibodies against the respective epitope tags revealed that none of
the Sly1 mutant proteins were found to be short-lived (Figure 2–12B, right panel).
Notably, the expression of ufe1-F9A is not able to complement the ufe1 deletion
(data not shown), demonstrating that this mutation interferes with the essential function
of Ufe1. Therefore, in order to investigate the influence of the F9A mutation on the sta-
bility of Ufe1, ufe1-F9A was expressed as an epitope-tagged variant in WT cells, which
allows the detection of the mutant allele in the presence of the WT protein. Consistently,
the Ufe1-F9A protein was also found to be highly unstable (Figure 2-12B, lower panel).
These results demonstrate that binding of Sly1 to Ufe1 is essential for Ufe1 stability.
This may suggest that the balance between both proteins controls the regulation of
Ufe1. Based on this assumption, overexpression of Ufe1 would also cause the deg-
radation of Ufe1 molecules that exceed the amount of endogenous Sly1.
To test this idea, Ufe1 levels were raised step-wise, and steady state levels were
examined. When expressed from a high copy plasmid using the endogenous Ufe1 pro-
moter, steady state levels of Ufe1 were found to be significantly elevated compared to
the expression from its chromosomal locus or a low copy plasmid. (Figure 2-13A, com-
pare lane 3 with lane 1 and 2). However, only a marginal increase could be observed
when Ufe1 was expressed from a high copy plasmid using the strong GAL1-10 (Figure
2-13A, compare lane 4 with 3). In contrast, combined overexpression of UFE1 and
SLY1 under these conditions led to a considerable further increase of Ufe1 levels (Fig-
ure 2-13A, compare lane 8 with 4). Conversely, endogenous Ufe1 levels were not af-
fected by overexpressed SLY1, suggesting that under normal conditions Sly1 is not lim-
ited in binding to Ufe1 (Figure 2-13A, lane 9-12). These data suggest that overproduced
Ufe1 is unstable due to a lack of the Sly1 binding partner. To confirm these data, the
half-life of overproduced Ufe1 was examined in the absence or presence of equally
overproduced Sly1. As shown in Figure 2-13B, step-wise overexpression of UFE1 re-
sulted in the instability of the protein, confirming that indeed the half-life of Ufe1 is al-
tered when overproduced. As expected, the down-regulation could partially be over-
come by co-expressing Sly1.
In conclusion, these data demonstrate that an imbalance between Ufe1 and Sly1
results in the rapid degradation of excessive Ufe1.
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Figure 2-13. Overproduced Ufe1 is unstable but can be partially stabilized by concomitant over-
expression of SLY1. (A) Left panel: Steady state levels of UFE1 expressed in WT cells either from its
chromosomal locus (lane A), from a CEN plasmid under the control of its own promoter (lane B), from a
2µ plasmid under the control of its own promoter (lane C), or from a 2µ plasmid under the control of the
GAL1-10 promoter (lane D). Middle panel: As before, but with concomitant overexpression of SLY16HA
from a 2µ plasmid under the control of the GAL1-10 promoter. Right panel: UFE1 expressed steadily from
its chromosomal locus combined with SLY16HA expressed either from its chromosomal locus (lane A),
from a CEN plasmid under the control of its own promoter (lane B), from a 2µ plasmid under the control of
its own promoter (lane C), or from a 2µ plasmid under the control of the GAL1-10 promoter (lane D). Cells
were grown in SC media containing galactose to an OD600 of 0.5 at 30°C and protein samples were pre-
pared. Ufe1 and Sly16HA levels were analyzed by anti-Ufe1 and anti-HA-immunoblots, respectively. As a
control, blots were reprobed with an antibody against Dpm1. (B) Expression shut-off experiments with WT
cells expressing either solely UFE1 or UFE1 in combination with SLY16HA at different expression levels as
indicated. Cells were grown similar to (A); after adding cycloheximide (left and middle panel) or glucose
and cycloheximide (right panel), aliquots were taken at time points indicated and analyzed by anti-Ufe1
and anti-HA immunoblots. Note that in case of overexpression from the GAL1-10 promoter (denoted as “
+++ “), less protein sample was subjected to SDS-PAGE to avoid an overload of the gel. The asterisks
denote cross-reactive bands. The gray filled circle indicates a degradation product of UFE1 that co-
migrates with the cross-reactive band seen in the left and middle panel. The black filled circles refer to
possible SDS-resistant Ufe1 complexes, which might have been formed during the extract preparation.
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2.3.4. Sly1-unengaged Ufe1 is degraded by the ubiquitin/proteasome system
To investigate whether the observed degradation of Ufe1 is mediated by the
ubiquitin/proteasome system, several mutants defective in ERAD were introduced into
the sly1-1 background by crossing. As shown in Figure 2-14A, deletions of both E2 en-
coding genes, UBC6 and UBC7, substantially stabilized Ufe1 in the sly1-1 background,
whereas a deletion of UBC1, which is also implicated in the degradation of certain
ERAD substrates, did not considerably affect the turnover. Temperature-sensitive mu-
tants of CDC48 and of PRE1, encoding a proteasome subunit, influenced degradation
of Ufe1 to a lesser but still significant extent. A minor stabilization effect could be ob-
served for mutants of UFD1 and SHP1, which are alternate substrate-recruiting factors
of Cdc48. In contrast, deletion of PEP4, encoding a vaculoar protease, left Ufe1 turn-
over essentially unaffected. Although these mutants show varying degree of stabili-
zation, these data suggest that Ufe1 down-regulation proceeds largely by ERAD in-
volving the E2 enzymes Ubc6 and Ubc7, proteasomes, the Cdc48Ufd1/Npl4 complex and
probably also the Cdc48Shp1 complex, which has been recently reported to play a sub-
sidiary role in ubiquitin-dependent proteolysis (Schuberth et al., 2004). The variations
observed for the different mutants can be partially explained by the differences in the
experimental setup: Whereas for the Ufe1 decay in deletion mutants a constant degra-
dation rate was observed over the entire time course, temperature-sensitive alleles
usually displayed a significant stabilization effect only after a lag phase. In contrast, the
sly1-1 allele-induced instability of Ufe1 starts without a delay when shifted to the non-
permissive temperature (compare also Figure 2-11).
To conform these data, Ufe1 degradation was in addition studied in ERAD mutants
expressing the Sly1 interaction-deficient ufe1-F9A mutant. ERAD mutants carrying
complete deletions and co-expressing ufe1–F9A6HA were examined at 30°C. As shown
in Figure 2-14B, the double deletion mutant ubc6 ubc7 substantially stabilized the
otherwise short-lived Ufe1–F9A6HA variant. Moreover, also loss of other E2 enzymes
(e.g. ubc1 and especially ubc4 ubc5) and of the vacuolar protease Pep4 affected
the turnover of Ufe1–F9A6HA. A contribution of Shp1 was not observed under these
conditions. Temperature-sensitive strains expressing ufe1–F9A6HA were incubated at the
non-permissive temperature for 2 hours prior to the cycloheximide chase. Under these
conditions, a strong stabilization effect for ufd1-2 and cdc48-6 could be detected as
shown in Figure 2-15B (lower panel). Likewise, the proteasome mutant pre1-1 stabilized
the turnover robustly. The shp1 mutant displays also a temperature-sensitive growth
phenotype and Ufe1–F9A6HA degradation was slightly but significantly affected under
this condition.
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Figure 2-14. Unstable Ufe1 is degraded by ERAD. (A) Expression shut-off (cycloheximide chase) with
WT, sly1-1 cells and ERAD mutants in sly1-1 background. Cells were grown in YPD to an OD600 of 0.5 at
23°C and shifted to 37°C upon addition of cycloheximide. Aliquots were taken at time points indicated and
protein extracts were prepared. The protein level of Ufe1 was analyzed by anti-Ufe1 immunoblots. As a
control blots were reprobed with an antibody against the stable ER membrane protein Dpm1. Shown is a
representative experiment. The graphs present the quantification of the Ufe1 decay resulting from 3-4
independent experiments (symbols and bars represent the mean and the standard error) (B) Cyclohexi-
mide chase with WT cells and ERAD mutants co-expressing epitope-tagged WT UFE1 or ufe1-F9A from
the endogenous promoter. The experimental procedure was similar to (A) except that deletion mutants
were grown to an OD600 of 0.6 at 30°C in SC media and kept at this temperature during the time course
(upper panel), whereas conditional alleles were grown to an OD600 of 0.4 at 23°C, and then shifted for an-
other 2 hours to 37°C before the expression shut-off was started (lower panel). The shp1 strain was
analyzed at both temperatures, since it displays temperature sensitivity as well. The protein levels of the
HA-tagged Ufe1 variants were analyzed by anti-HA immunoblots. Shown is a representative experiment.
The graphs show the quantification of the Ufe1 decay resulting from 3-4 independent experiments (sym-
bols and bars represent the mean and the standard error with the exception of pep4 and shp1 ana-
lyzed at 30° with n= 2; in this case the error bars represent the difference of the single measurements
from the mean).
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The data obtained by co-expressing ufe1–F9A6HA  in ERAD mutants were mostly con-
sistent with the results obtained for endogenous Ufe1 in the sly1-1 background. With
both setups a contribution of Ubc6, Ubc7 and proteasomes could be demonstrated, in-
dicating that Ufe1 is indeed degraded by the ubiquitin-proteasome system. Furthermore
there is also evidence that the Cdc48Ufd1/Npl4 complex is implicated in Ufe1 turnover, as
ufd1-2, cdc48-6 as well as npl4-1 (data not shown) substantially affect the degradation
of Ufe1–F9A6HA. To which extent Shp1 (presumably in complex with Cdc48) contributes
to the turnover of Ufe1 remains to be solved, since shp1 displays only a stabilization
effect at higher temperature. However, an involvement of Pep4 in degradation of Ufe1
was only observed for Ufe1–F9A6HA, suggesting that a pool of this substrate might es-
cape ERAD and is degraded within the vacuole.
To elucidate which E3 ligase participates in degradation of Ufe1, mutants of RSP5,
HRD1, DOA10/SSM4 and TUL1 (Huibregtse et al., 1995; Bays et al., 2001; Swanson et
al., 2001; Reggiori and Pelham, 2002) were tested either in the sly1-1 background or by
expressing ufe1–F9A6HA. However, no significant stabilization could be observed in any
of the mutants examined (data not shown).
Together, these results reveal that a loss of functional Sly1 results in the instability
of Ufe1 and that degradation proceeds largely by components of the ERAD pathway.
Thus, it can be concluded (i) that one particular function of Sly1 is to act as a Ufe1-spe-
cific inhibitor of ERAD and (ii) that with respect to the essential function of Ufe1 as well
as the inviability of the ufe1-F9A mutant, Sly1-binding to Ufe1 is essential for viability.
2.3.2. Function of the Sly1-dependent regulation of Ufe1 stability
2.3.2.1. Lack of Ufe1 regulation impairs viability
The finding that Sly1 prevents the proteasomal degradation of Ufe1 raised the question
whether maintaining Ufe1 at constant levels reflects the crucial function of Sly1.
According to this hypothesis, a block in Ufe1 degradation should result in the sup-
pression of the temperature-sensitive phenotype of the sly1-1 mutant.
To test this idea, several ERAD mutants in combination with the sly1-1 allele were
examined for their ability to grow at the non-permissive temperature of sly1–1. However,
as shown in Figure 2-15, none of the double mutants tested were able to suppress the
temperature sensitivity of sly1-1. In contrast, some of the double mutants, e.g. pre1-1
sly1-1 or ubc1 sly1-1, augmented the growth phenotype. This phenotype might in fact
indicate that absence of any Ufe1 regulation by the simultaneous loss of Sly1 function
and ERAD is detrimental for yeast growth. However, there is no clear correlation with
Ufe1 degradation (e.g. Ubc1 displays only a minor contribution in Ufe1 turnover; see
Figure 2-14). Nonetheless, as the artificial up-regulation of Ufe1 in the absence of Sly1
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is not sufficient to restore viability, Sly1
seems to provide further functions than
its inhibitory role on ERAD of Ufe1.
Indeed, the strict dependency on Sly1
suggests that an appropriate balance
between Ufe1 and Sly1 seems to be
important.
To assess this assumption, the
cellular balance of Ufe1 and Sly1 was
disturbed by overexpressing UFE1 and
SLY1 either solely or in combination in
WT cells (Figure 2-16). Whereas mild
overexpression of UFE1 did not signifi-
cantly affect yeast growth, strong over-
expression resulted in a considerable
growth retardation, which was most pro-
nounced at higher temperatures. Re-
markably, concomitant overexpression of
SLY1 partially suppressed this phe-
notype. Interestingly, overexpression of
ufe1-F9A was found to be less harmful
to cells, and notably this mild phenotype
could not be reverted by co-expression
of SLY1, which is in agreement with the
fact that the mutant allele is not able to
bind Sly1. In contrast, similar overex-
pression of another ERAD substrate,
Deg1SEC62FLAG (DSF), did not cause any
significant growth retardation in this
setup, confirming that the growth defect is specific for UFE1 overexpression.
In conclusion, these data demonstrate that Ufe1 levels have to be kept tightly
regulated, and that this function is mediated by the presence of Sly1. Thus, excess of
Ufe1 is detrimental to cellular growth as long as the balance between Ufe1 and Sly1 is
not redressed by an up-regulation of Sly1.
Figure 2-15. A restore of Ufe1 levels does not
suppress the sly1-1 temperature sensitive
phenotype. WT cells and the following mutants
pre1-1, ubc1, ubc6 ubc7, ufd1-2 and pep4
were analyzed in the sly1-1 and WT (SLY1)
background. Cells were plated in 5-fold dilutions
on full media (YPD) plates and incubated for 2-3
days at the temperature indicated.
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Figure 2-16. Imbalance between cellular
levels of Ufe1 and Sly1 causes a slow
growth defect. DF5 WT cells overexpressing
different UFE1 variants (left) or together with
SLY1 (right) were plated in 5-fold dilutions on
synthetic media (SC) containing glucose (as a
control) or galactose and incubated for 2-3
days at the temperatures indicated. Empty
vectors are denoted as "-". Overexpression of
the unrelated ERAD substrate Deg1SEC62FLAG
(DSF) was analyzed as negative control. All
variants were strongly overexpressed from
high copy 2µ plasmids under the control of the
GAL1-10 promoter except 'UFE1' (second row
of each panel) that was mildly overexpressed
from a 2µ plasmid using its own promoter.
2.3.2.2. Ufe1 competes with Sed5 for Sly1 interaction
Sly1 not only interacts with Ufe1 but also with the essential Golgi SNARE Sed5
(Yamaguchi et al., 2002). Thus it appears conceivable that overproduced Ufe1 might
interfere with the recruitment of Sly1 to Sed5, particularly since the cellular pool of Sly1
is rather limited (i.e. only 1-2 fold higher than that of Ufe1; data not shown). Further-
more, overexpression of the Sly1 interaction-deficient ufe1-F9A mutant displays only a
slight growth defect in WT cells (Figure 2-17).
To investigate both Ufe1 and Sed5 concerning their requirements for Sly1, a genetic
experiment was conducted with cells overexpressing either UFE1, or SED5, or both
SNAREs combined using high-copy number plasmids that express the respective gene
from the strong GAL1-10 promoter (Figure 2-17). Overproduction of Ufe1 was found to
result in a rather mild growth defect in the genome background used in this study
(W303). For unknown reasons, overproduced Ufe1-F9A did not differ significantly from
WT Ufe1 overproduction and caused a similar phenotype. Surprisingly, however,
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overproduced Sed5 was strongly cytotoxic and almost no colonies could be detected
even after several days. Intriguingly, when UFE1 was co-expressed with SED5, the
growth defect was slightly but significantly reduced. This effect was not observed when
ufe1-F9A was co-expressed instead. In conclusion, these results suggest that Ufe1 and
Sed5 might interfere with their respective functions when present in high amounts, pre-
sumably via their interaction with Sly1.
Figure 2-17. Overexpression of SED5 is highly cytotoxic but can be partially suppressed by con-
comitant overexpression of UFE1. W303 WT cells overexpressing WT SED5 solely or in combination
with either UFE1 or ufe1-F9A were plated in 5-fold dilutions on synthetic media (SC) containing glucose
(as a control) or galactose and incubated at 30°C for several days as indicated. Empty vectors are de-
noted as "-". All variants were overexpressed from a high copy 2µ plasmid under the control of the GAL1-
10 promoter. The slow growth phenotype mediated by UFE1 overexpression is weaker in W303 than in
the DF5 background, and WT and mutant UFE1 do not considerably differ concerning the growth defect.
2.3.2.3. Sly1 interacts genetically and physically with Cdc48 and Shp1
Besides its role in regulating the stability of Ufe1, it is attractive to speculate that Sly1
might also be required for the SNARE function of Ufe1 in membrane fusion. Support for
this possibility comes from the finding that Ufe1-F9A results in a mild, but still significant,
growth defect when overproduced in DF5 cells. Since this mutant shows only a weak
binding to Sly1 (Figure 2-12A) it seems rather unlikely that the growth defect caused by
Ufe1-F9A results from a competition with endogenous Sed5 as seen with overproduced
WT Ufe1. In agreement with this notion, the Ufe1-F9A-mediated phenotype is not re-
verted by simultaneous overexpression of SLY1 (see Figure 2-16). Thus, overproduced
Ufe1-F9A may rather act as a dominant negative mutant in other processes, e.g. in the
SNARE assembly of Ufe1 molecules and/or Ufe1-mediated membrane fusion process.
Interestingly, when ufe1-F9A was overexpressed in mutants of CDC48 and SHP1, the
growth defect was found to be even more pronounced than in WT cells (Figure 2-18A).
Moreover, when mutants of CDC48 and SHP1 were directly combined with a
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Figure 2-18. SLY1 interacts genetically and physically with CDC48 and SHP1. (A) Mutants of the
Cdc48Shp1 complex are more sensitized toward overexpression of ufe1-F9A than WT cells. WT and mu-
tant cells (DF5 background) overexpressing WT UFE1 or ufe1-F9A were plated in 10-fold dilutions on
synthetic media (SC) containing glucose (as a control) or galactose and incubated for 2-3 days at the
temperatures indicated. All variants were strongly overexpressed from high copy 2µ plasmids under the
control of the GAL1-10 promoter except 'UFE1' (first row of each panel) that was moderately overex-
pressed from a 2µ plasmid using its own promoter. (B) sly1-1 displays a synthetic temperature sensitivity
with mutants of the Cdc48Shp1 complex. The respective single and double mutants were plated in 5-fold
dilutions on full media (YPD) and incubated for 1-2 days at the temperatures indicated. WT background
(SLY1) is denoted as "-" (C) Ufe1 and Sly1 co-immunoprecipitate components of the Cdc48Shp1 complex.
Whole cell lysates of cells expressing chromosomally respectively UFE16HA and SLY19myc or UFE19myc and
SLY16HA were fractionated by ultra-centrifuging and microsomal fractions were solubilized in presence of
1% Triton X-100. After a second ultra-centrifugation step, the supernatant of the solubilized material was
subjected to an anti-HA immunoprecipitation in presence of 0.3% Triton X-100. The input (1.5% of the
soluble fraction used for the IP) and the immunoprecipitated material were analyzed by immunoblotting
with an anti-HA antibody to visualize the efficiency of the IP. The immunoblot membrane were subse-
quently reprobed with an anti-myc antibody to analyze the co-immunoprecipitation of Ufe19myc and
Sly19myc, respectively (upper panels). In parallel, the immunoprecipitated material was examined for co-
immunoprecipitation of components of the Cdc48Shp1 complex using Cdc48- and Shp1-specific antibodies
(lower panels). Strains expressing respectively non-tagged UFE1 or SLY1 were used as controls.
Results
48
deficiency in Sly1, the respective double mutants displayed an augmented temperature
sensitivity (Figure 2-18B).
The observed genetic interaction suggests that Sly1, Cdc48 and Shp1 (probably in
complex with Cdc48) act together on Ufe1. In order to examine the physical interaction
between Sly1 and Cdc48Shp1, co-immunoprecipitation experiments were performed.
Microsomal fractions of strains expressing either chromosomally tagged UFE16HA and
SLY19myc or SLY16HA and UFE19myc, respectively, were solubilized and subjected to anti-
HA immunoprecipitations (IP). Reciprocal analysis of the IP material demonstrated that
under these conditions Ufe16HA and Sly16HA are still efficiently bound to their cognate
partners Sly19myc and Ufe19myc, respectively (Figure 18C, top panel). Ufe1 was reported
to be associated with Cdc48 (Latterich et al., 1995). Notably, analysis of the IP material
with Cdc48- and Shp1-specific antibodies revealed that Cdc48 (and to a lesser extent
Shp1) was weakly but specifically co-immunoprecipitated not only by Ufe16HA but also
by Sly16HA (Figure 18C, bottom panel). Whether the interaction between Sly16HA and
Cdc48 or Shp1, respectively, is direct or bridged via Ufe1 could not be resolved by this
experiment. However, these data strongly suggest that Sly1 is associated with Ufe1
molecules being recruited to Cdc48 or the Cdc48Shp1complex. As Cdc48 (presumably
together with Shp1) has been assumed to operate in homotypic membrane fusion by
disassembling Ufe1-SNARE complexes (Latterich et al., 1995; Patel, S. K. et al., 1998),
the genetic and physical interaction shown here supports the view that Sly1 might be
required not only for maintaining Ufe1 stability but also during the process of homotypic
membrane fusion.
In conclusion, Sly1 seems to fulfill a dual function with respect to Ufe1: On one
hand, Sly1 may regulate the stability of Ufe1 molecules. Since the cellular pool of Sly1
is rather limited, those Ufe1 SNAREs non-engaged with Sly1 are destined for degrada-
tion. As a consequence, the cellular pool and thus the activity of fusion processes medi-
ated by Ufe1 seem to be indirectly controlled through this mechanism. On the other
hand, Sly1 may be directly involved in the SNARE function of Ufe1, probably together
with Cdc48 and Shp1, although the precise function remains to be resolved.
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3. DISCUSSION
This study focused on two different aspects: firstly, the isolation of novel factors
implicated in ER-associated degradation (ERAD), and secondly, the identification of
novel, non-abnormal substrates regulated by ERAD. In addition, emphasis was placed
on the mechanisms and the relevance of regulated degradation with respect to the cel-
lular physiology.
3.1. Novel components of the ERAD pathway
Substrate recognition and ubiquitylation of proteins residing in the ER lumen or at the
ER membrane were known to occur by components of a specific machinery referred to
ER-associated degradation (ERAD). But how these substrates are relocated from the
ER to the cytosol and delivered to the 26S proteasome has been remained enigmatic.
This study identifies a number of novel factors implicated in the dislocation and protea-
some targeting of several ERAD substrates: Relocation of luminal and membrane pro-
teins of the ER was found to rely on the ubiquitin-selective chaperone Cdc48Ufd1/Npl4. Af-
ter retrotranslocation to the cytosol, the degradation of several substrates involves the
action of the multiubiquitylation enzyme (E4) Ufd2 and of the soluble ubiquitin receptors
Rad23 and Dsk2, which target substrates to the 26S proteasome. In addition, certain
substrates may take a parallel route via the proteasome targeting factor Rpn10, which
acts independently from Cdc48 and Ufd2. In the following, the action of these factors
will be discussed in detail.
3.1.1. The Cdc48Ufd1/Npl4 complex promotes the relocation of ERAD substrates
The Cdc48Ufd1/Npl4 complex was previously shown to exhibit a pronounced specificity
towards ubiquitin conjugates. In particular, it promotes the mobilization of the ubiquityl-
ated, processed Spt23 transcription factor from the ER membrane in dependence of
ATP (Rape et al., 2001). This ability made Cdc48Ufd1/Npl4 likely to be also involved in the
mobilization of ERAD substrates. Indeed, membrane as well as luminal substrates of
ERAD were found to require all components of this complex for their efficient degra-
dation (Figure 2–7). Furthermore, the ERAD substrate Ole1 was found to accumulate at
the membrane in a ufd1 mutant (Figure 2-6), consistent with the previous finding that a
significant fraction of Cdc48Ufd1/Npl4 localizes to ER membranes (Rape et al., 2001). In
view of its ubiquitin-selectivity, it seems plausible that the Cdc48Ufd1/Npl4 complex
operates downstream of the ubiquitin conjugation machinery and prior to proteasomal
degradation as a general constituent of the ERAD machinery. Since the ho-
mohexameric, ring-shaped Cdc48 molecule was shown to undergo a dramatic rotational
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outward movement upon ATP hydrolysis (Zhang et al., 2000), the Cdc48Ufd1/Npl4 complex
might act as ubiquitin-selective chaperone in untethering ubiquitylated substrates from
non-modified partners. Thus, according to its function in ERAD, an attractive possibility
would be that Cdc48Ufd1/Npl4 might segregate ubiquitylated ERAD substrates from the
translocation channel. Similar results were discovered by other groups (Bays et al.,
2001; Ye et al., 2001; Jarosch et al., 2002; Rabinovich et al., 2002).
But how does the chaperone ( segregase ) cooperate with the ERAD machinery? It
was reported that the activity of Cdc48Ufd1/Npl4 is sufficient to mobilize ERAD substrates
into the cytosol (Jarosch et al., 2002). However, the data of this study and others (Lee
et al., 2004) support a model, by which a successful membrane removal of ERAD sub-
strate requires both Cdc48Ufd1/Npl4 and proteasome activity. According to this view,
ubiquitylation, mobilization and degradation would be tightly physically and mechanisti-
cally coupled. Whereas an independently acting Cdc48Ufd1/Npl4 complex might result in
the overflow of the cytosol with aberrant proteins, a coupled mechanism would ensure
that substrates once trapped by the ERAD machinery would be efficiently targeted to
the proteasome.
3.1.2. Ubiquitin-binding proteins escort ERAD substrates to proteasomes
A mechanistic coupling in ERAD was indeed recently shown by the discovery of a pro-
teolytic pathway that includes Cdc48Ufd1/Npl4, the multiubiquitylation enzyme (E4) Ufd2,
and soluble ubiquitin receptors of the Rad23 family, which operates in proteasome
targeting of proteolytic substrates (Richly et al., 2005). Interestingly, all ubiquitin-binding
factors of this pathway cooperate with each other by making contacts to their respective
up- and downstream acting partners (Richly et al., 2005; Figure 2-8D). Furthermore,
interaction of all of these factors with ubiquitin-conjugates requires the presence of the
respective upstream factors, indicating that substrates are handed over sequentially to
their way to the proteasome (Richly et al., 2005; Figure 2-8A - C). This escort pathway
is not restricted to the turnover of cytosolic substrates but also participates in ERAD as
demonstrated by this study.
3.1.2.1. The role of the multiubiquitylation enzyme (E4) Ufd2 in ERAD
Multiubiquitin chain assembly is often a processive and rapid reaction that does not rely
on further factors. However, some reactions require the assistance of an E4 enzyme,
probably since further attachment of ubiquitin moieties by the initiate E3 might be
sterically hindered (Koegl et al., 1999; Saeki et al., 2004). This two-step reaction, e.g.
mono- or oligo-ubiquitylation followed by E4-catalyzed multiubiquitylation, could offer
another layer of control. In particular, this might be favorable to separate mono-
ubiqutiylation from subsequent multiubiquitylation reactions mediating distinct functions
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as it has been assumed for the activation and degradation of certain transcription fac-
tors as for instance Spt23 (Hoppe et al., 2000; Rape et al., 2001; Richly et al., 2005).
So far the only known E4 in yeast is Ufd2, which is able to recognize mono-ubiq-
uitylated proteins and to elongate the ubiquitin chain by the addition of ubiquitin moieties
(Koegl et al., 1999). In view of a possible switch of function from mono- to multi-
ubiquitylation, the participation of Ufd2 in ERAD was not anticipated, or at least a func-
tion for mono-ubiquitylation of ERAD substrates could not be addressed so far. How-
ever, deletion of UFD2 was found to result in a prolonged half-life of several ERAD sub-
strates by a factor of about 2 (Figure 2-9). Thus Ufd2 seems to be implicated in ERAD
although the protein is not absolutely required. This might be due to a partial redun-
dancy over other existing degradation pathways. Indeed, the double deletion mutant
ufd2 rpn10 exhibits an almost complete block in the degradation of Deg1Sec62, but not
of Hmg2 (Figure 2-9), indicating that certain substrates can take alternative degradation
routes. However, Rpn10 was shown to act as a ubiquitin receptor in proteasomal tar-
geting (Elsasser et al., 2004; Verma et al., 2004; see also below) and to bind preferen-
tially to multi- but not oligo-ubiquitylated substrates (Richly et al., 2005). Since Rpns10
seems to receive its substrates independent of Ufd2 (see below), apparently redundant
Figure 3-1. Interaction domains in the multiubiquitylation enzyme Ufd2 and the ubiquitin receptors
Rad23, Dsk2, and Rpn10.
The Rad23 and Cdc48 interactions domains in Ufd2 have been mapped by yeast two-hybrid data (this
study). The C-terminal U–box mediates binding to E2 analogous to the RING finger domain of E3
enzymes. The ubiquitin-binding motif has so far not been identified.
Ubiquitin receptors are assumed to shuttle substrates to the proteasome. Whereas binding to ubiquitin-
conjugates is mediated by UBA and UIM domains (shown in light grey), association with the proteasome
is mediated by the UBL domain of Rad23/Dsk2 and presumably by the VWA (van Willebrand A) domain
of Rpn10, respectively (shown in dark grey). The UBL domain can also bind in a mutually exclusive
manner to Ufd2.
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multiubiquitylation mechanisms act during ERAD. However, this alternative route(s)
might work less efficiently in chain elongation of oligo-ubiquitylated substrates, thereby
explaining the prolonged half-life of ERAD substrates in the ufd2 mutant.
Besides its role in increasing the efficiency of ERAD, the Ufd2 pathway may provide
another important function. Cdc48 and Ufd2 are able to form a ternary complex with
substrates. Notably, in vitro studies demonstrated that in the presence of Cdc48, the
reaction of the Ufd2-mediated chain elongation is restricted to the addition of only a few
ubiquitin moieties. Nonetheless, the size of the multi-ubiquitin chain formed by this size-
restricted catalysis is still sufficient for proteasome targeting (Richly et al., 2005). Thus,
the use of a limited multiubiquitin chain would prevent superfluous ubiquitylation
reactions, which would not only be economical but also facilitate the disassembly of the
ubiquitin chain at the proteasome. Therefore, the preferential use of the Ufd2 pathway
by ERAD would also account for these advantages.
3.1.2.2. Alternate soluble ubiquitin receptors mediate proteasome targeting
Rad23 and its close relative Dsk2 were shown to bind ubiquitylated proteins via their
UBA domain and to target them to the proteasome through association with their UBL
motif via Rpn1 (Schauber et al., 1998; Wilkinson, C. R. et al., 2001; Chen, L. and
Madura, 2002; Elsasser et al., 2004; Verma et al., 2004). Interestingly, the UBL motif of
Rad23 is also engaged in binding to Ufd2, indicating that the interactions of Ufd2 with
Rad23 and the proteasome are mutually exclusive (Kim et al., 2004). In particular the
detection of a ternary complex of Cdc48-Ufd2-Rad23 in vivo suggests that Rad23 (and
presumably Dsk2) functions as proteasome targeting factors in the pathway down-
stream of Cdc48 and Ufd2 (Richly et al., 2005). Consistently, integral membrane
substrates tested in this study were found to be moderately stabilized in single mutants
of RAD23 and DKS2 but were hardly degraded in the double mutant (Figure 2-9), un-
derscoring that both proteins have overlapping functions in ERAD. Conversely, double
mutants of either ufd2 rad23 or ufd2 dsk2 did not display any stronger defect in
ERAD than the single ufd2 mutant, which confirms that Rad23 and Dsk2 act down-
stream of Ufd2 in the same pathway. This pathway seems to be used also for the deg-
radation of luminal proteins (Medicherla et al., 2004). Remarkably, multiubiquitin chains
generated by size-restriction in the presence of Cdc48 and Ufd2 possess precisely the
binding property needed for being collected by Rad23 and Dsk2 (Richly et al., 2005).
However, since degradation is significantly less affected by the lack of Ufd2 than by the
simultaneous loss of Rad23 and Dsk2 (Figure 2-9), ERAD substrates might be partially
collected by Rad23 and Dsk2 also independently of Ufd2.
3.1. Novel components of the ERAD pathway
53
Rpn10 binds ubiquitin conjugates via its UIM domain and was found to act as an
alternative proteasome targeting factor (van Nocker et al., 1996; Elsasser et al., 2004;
Verma et al., 2004). Rpn10 also contributes to a certain extent to ERAD, since the
combined block of the Rpn10 and the Ufd2 pathway results in a nearly complete stabili-
zation of certain ERAD substrates (Figure 2-9; see also above). Due to the property of
Rpn10 to bind preferentially to longer ubiquitin chains (Richly et al., 2005), this ubiquitin
receptor seems to function independently from the Cdc48/Ufd2 pathway generating
size-restricted ubiquitin chains (see above). However, with respect to the weak degra-
dation deficiency caused by the single rpn10 mutant compared with the strong defect
observed in the double mutant rad23 dsk2, the degradation via Rpn10 seems to play
only a subsidiary role in ERAD.
All together this study demonstrates that ERAD proceed by an escort pathway of
several ubiquitin-binding factors acting downstream of ubiquitin conjugation (Figure 3-2).
This pathway strongly depends on Cdc48Ufd1/Npl4 for mobilization of (oligo-) ubiquitylated
substrates but employs in subsequent steps different partially redundant factors that are
involved in further ubiquitylation events and proteasome targeting. Which route is taken
might depend primarily on the nature of the substrates and on the E3 enzyme(s)
Figure 3-2. Model for substrate delivery to the proteasome by an escort pathway during ERAD.
Oligo-ubiquitylated substrates are recognized by Cdc48Ufd1/Npl4 at the cytosolic side of the dislocation
channel and extracted upon ATP consumption. Subsequent multiubiquitylation by Ufd2 or other E3/E4
enzymes target them for proteasome delivery accomplished by the soluble ubiquitin receptors Rad23,
Dsk2, or Rpn10. Multiubiquitylation mediated by Ufd2 in the presence of Cdc48 leads to the attachment of
only a few ubiquitin molecules ('size restriction'), which are only recognized by Rad23 and Dsk2. Dashed
lines indicate possible alternative routes between the parallel pathways.
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involved in ubiquitin chain initiation. The guidance mechanism may ensure efficient
degradation by coupling the events of multiubiquitylation and proteasome targeting.
Furthermore, all ubiquitin-binding proteins may contribute to shield ubiquitin conjugates
against the activity of ubiquitin hydrolases. However, the distinct factors apparently
differ substantially concerning their binding properties: Ufd2 recognizes readily mono-
ubiquitylated proteins, whereas Rad23 and Dsk2 preferentially bind to four or more
ubiquitin moieties and Rpn10 even needs longer chains. Thus, ERAD may also take
use of a loose 'ubiquitin number code' (Richly et al., 2005), by which directionality may
be provided.
3.2. Novel substrates of ERAD
Two novel substrates of ERAD could be identified by this study: the fatty acid de-
saturase Ole1 and the t-SNARE Ufe1, both implicated in essential cellular functions, i.e.
fatty acid homeostasis and ER membrane fusion. Notably, both proteins do not repre-
sent abnormal proteins but are natural substrates of ERAD. Hence, ERAD of these sub-
strates provides rather a function in regulation of physiological processes than a func-
tion in quality control.
3.2.1. Regulation of the fatty acid desaturase Ole1
3.2.1.1. Ole1 is a naturally short-lived protein and ERAD substrate
The fatty acid desaturase activity of Ole1 is exclusively regulated by adjusting the
abundance of the ER protein Ole1, which takes place by a sophisticated regulon coined
the OLE pathway. The expression of the OLE1 gene is controlled via a negative feed-
back mechanism by UFAs (i.e. palmitoleic acid, 16:1 and oleic acid, 18:1), which are the
products of the enzymatic reaction of the desaturase. Both transcription and mRNA
decay are subject to this negative regulation (Choi et al., 1996; Gonzalez, C. I. and
Martin, 1996; Hoppe et al., 2000). Thus, in order to ensure a rapid adaptation to cellular
UFA requirements, Ole1 was assumed to be steadily turned over. Indeed, Ole1 was
found to be short-lived in vivo (Figure 2-1) and to be degraded by ERAD (Figure 2-4).
These findings substantiate the emerging view that ERAD is not restricted to quality
control but also regulates the degradation of physiological substrates.
Interestingly, degradation of Ole1 resembles partially the pathway required for
controlling its gene expression (see Figure 3-3): both the desaturase and the
transcription factor Spt23 controlling the transcription of OLE1 are mobilized by
Cdc48Ufd1/Npl4 from the ER membrane (Figure 2-5; Rape et al., 2001). Furthermore, deg-
radation of both substrates involves E4 activity provided by Ufd2 and proteasome tar-
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geting mediated by Rad23 and Dsk2 as well as Rpn10 (data not shown; Richly et al.,
2005). However, degradation of Spt23 is temporally and spatially separated from mono-
or oligo-ubiquitylation at the ER membrane leading to its activation. Degradation of
Spt23 is assumed to occur in the nucleus after the transcription of the OLE1 gene has
been initiated and may prevent hyperactivation of the OLE pathway (Richly et al., 2005).
Whether substrate ubiquitylation and segregation by Cdc48Ufd1/Npl4 result immediately in
proteasomal degradation or in disassembly of oligomeric complexes may rely not only
on the nature of the substrate but also on the mechanism of ubiquitylation (i.e. mono- or
multiubiquitylation) and/or the requirement of accessory factors preventing the prema-
ture degradation.
Figure 3-3. Proteolytic routes in the OLE pathway.
Upon ubiquitylation the fatty acid desaturase Ole1 is recognized by Cdc48Ufd1/Npl4 and extracted from the
membrane. The transcription factor Spt23 is synthesized as a membrane-bound precursor (p120), which
upon dimerization becomes ubiquitylated and subsequently processed by the 26S proteasome into the
mature form (p90). Ubiquitylated, processed p90 is still bound to its uncleaved partner protein. Upon
recognition by Cdc48Ufd1/Npl4, p90 becomes mobilized and and transported into the nucleus where it
promotes the transcription of the OLE1 gene. Both, Ole1 and processed Spt23 are multiubiquitylated and
targeted to the 26S proteasome by similar pathways involving cytosolic and nuclear Ufd2 and
Rad23/Dsk2, or Rpn10, respectively. Degradation of Spt23 probably takes place within the nucleus after
the transcriptional activation of OLE1. Unsaturated fatty acids (UFAs) regulate both Ole1 degradation
(positively) and Spt23 processing (negatively).
Discussion
56
3.2.1.2. Ole1 turnover is regulated by unsaturated fatty acids
Besides the OLE1 transcription and mRNA decay, degradation of Ole1 was also found
to be subject to a negative feedback regulation by UFAs. Interestingly, depletion of
UFAs or supplementation with saturated acids displayed a reciprocal effect. The rate of
the turnover of Ole1 is modulated by a factor between 0.5 and 2 in the presence of
palmitoleic acid (16:1) or its saturated counterpart palmitic acid (16:0), respectively
(Figure 2-2 and data not shown). Such minor alterations in the degradation rate may still
result in striking changes in the steady state levels of Ole1. Thus, the tight regulation of
the entire OLE pathway highlights the importance of cellular homeostasis of fatty acids.
The control of the degradation of Ole1 by UFAs is reminiscent of the regulation of
another yeast ERAD substrate, HMG CoA reductase (Hmg2). This enzyme plays a key
role in setting the rate for the biogenesis of sterols and its derivatives and thus deter-
mines membrane composition along with Ole1 (for a review see Hampton, 1998). Inter-
estingly, an intermediate of the mevalonate pathway, FPP (farnesyl pyrrophosphate),
which is produced downstream of the enzymatic reaction of Hmg2 and localizes to the
ER membrane, stimulates the turnover of Hmg2. This indicates that a negative feed-
back mechanism exists for Hmg2 degradation analogous to Ole1 (Gardner and Hamp-
ton, 1999b). Hampton and colleagues demonstrated that entry of Hmg2 into the regu-
lated degradation pathway requires the entire set of transmembrane domains and
therefore referred to this structural property as 'distributed degron' (Gardner and
Hampton, 1999a). According to this finding, they proposed a 'structural transition
model', by which in the presence of FPP the normally stable protein Hmg2 undergoes
structural changes within its transmembrane regions leading to its recognition as a
quality control substrate by the ERAD machinery (Gardner et al., 2001b).
It is tempting to speculate that Ole1 might be similarly regulated. However, one may
pose the question what signal might be sensed by Ole1. Since exogenous fatty acids
are taken up and incorporated into the phospholipid membrane (Bossie and Martin,
1989), UFAs might exert their regulatory effects either directly by interacting with the
transmembrane domains of Ole1 or by changing the physical property of the membrane
(i.e. fluidity, thickness). The fluidity of the lipid bilayer membrane is influenced by both
the degree of saturation as well as the length of its fatty acid constituents. Thus, an en-
hanced fluidity may directly affect the diffusion of membrane proteins and thereby result
in stochastically more frequent interactions between Ole1 and proteolytic factors (e.g.
E3 ligases). Conversely, a reduced thickness of the membrane due to the incorporation
of shorter fatty acids may affect the solvent exposure of membrane-buried residues
within the transmembrane domains. This might induce a structural change of Ole1
leading to its recognition by ERAD similar to the 'structural transition model' proposed
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by Hampton and colleagues. Intriguingly, Ole1 regulation is found to be more affected
by shorter UFAs (i.e. 16:1 versus 18:1; Figure 2-2).
Besides the possibility that Ole1 functions as a direct sensor in the fatty acid
composition of the ER membrane, other sensors might exist and contribute to Ole1
regulation. In particular, the processing of the ER membrane-anchored proteins Spt23
and Mga2 is similarly regulated by UFAs and thus requires also means of UFA sensing.
Remarkably, degradation of Ole1 and its regulation by UFAs were found to be signifi-
cantly affected in the spt23 mga2 mutant (Figure 2-3 and data not shown). This ob-
servation may give rise to the attractive hypothesis that Ole1 is directly associated with
its transcription factors at the ER membrane and that UFA sensing is accomplished in a
concerted manner through a multimeric signaling complex.
3.2.1.3. Implications of Ole1 on the fatty acid homeostasis
The importance of the homeostasis of fatty acid pools for the functional integrity and
plasticity of the cellular vesicular system becomes evident by the depletion of en-
dogenous unsaturated fatty acids (UFAs). A genetic screen in yeast for mutants with
defects in mitochondrial distribution and morphology (mdm mutants) identified MDM2
that encodes a fatty acid desaturase and is identical with OLE1 (Stewart and Yaffe,
1991). The 2.5-fold decline of UFA levels associated with the temperature-sensitive
mdm2 allele correlates with a fragmentation of the reticular network of mitochondria and
an accumulation of defective mitochondrial vesicles in the mother cell during cell divi-
sion, which is reversible by supplementation with exogenous UFAs. Conversely, the ex-
cess of UFAs has also been found to be detrimental (Stukey et al., 1990; Hoppe et al.,
2000). Thus, the intracellular UFA level has to be tightly controlled not only by the tran-
scriptional activation of the OLE1 gene by the OLE pathway but obviously also by
regulating the turnover of the Ole1 protein by ERAD.
3.2.2 Regulation of the syntaxin SNARE Ufe1
The essential protein Ufe1 belongs to the family of syntaxin SNAREs and mediates the
retrograde transport from the Golgi to the ER as well as homotypic membrane fusion of
ER vesicles (Downing and Storms, 1996; Lewis et al., 1997; Patel, S. K. et al., 1998).
Interestingly, whereas retrograde transport involves classical hetero-oligomeric SNARE
complexes formed by one v-SNARE and three different t-SNAREs, homotypic
membrane fusion requires the presence of Ufe1 molecules on both fusing vesicles,
suggesting that Ufe1 forms homo-tetrameric complexes (Patel, S. K. et al., 1998). An-
other significant difference in homotypic membrane fusion is the specific requirement for
Cdc48 that is presumably engaged in disassembling Ufe1 SNARE complexes (Patel, S.
K. et al., 1998) similar to the function of Sec18Sec17 (NSF SNAP in mammals). Cdc48 might
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cooperate in this process together with its adaptor Shp1, analogous to mammalian p97,
which works in conjunction with p47 in the reassembly of Golgi vesicles (Kondo et al.,
1997). In contrast to Ufe1 and Cdc48, Shp1 is not an essential protein, suggesting that
either additional, redundant factors exist, or that the late step of homotypic membrane
fusion (i.e. SNARE disassembly) is dispensable for viability. However, other factors that
are directly involved in homotypic membrane fusion have not been identified in yeast so
far. Previously, protein kinase C (Pkc1) was shown to be important for homotypic mem-
brane fusion but the target of phosphorylation remains unknown. However, Ufe1 has
been reported to be unstable in a pkc1 mutant and to be turned over in a Ubc7-depend-
ent manner, suggesting an involvement of ERAD (Lin, A. et al., 2001).
The Sec1/Munc18 (SM) family member Sly1 is an essential, soluble hydrophilic
protein and binds specifically to Ufe1 and the Golgi syntaxin Sed5 (Yamaguchi et al.,
2002). SM proteins were initially thought to function as negative SNARE regulators,
since the vertebrate SM protein Munc18-1 binds to and stabilizes the so-called 'closed
formation' of Syntaxin 1, in which the SNARE protein is incapable to assemble into
trans-SNARE complexes (Dulubova et al., 1999). However, various SM proteins were
found to differ concerning the mode of interaction with their cognate SNARE partners. In
fact, SM proteins seem to diverge with respect to their functions (Dulubova et al., 2003).
For instance, Sly1 fulfills a positive rather than negative function in ER to Golgi traffick-
ing. The gain-of-function mutant SLY1-20 was originally identified as a suppressor of
the deletion of YPT1 (suppressor of loss of YPT1 function), which encodes a Rab
GTPase involved in the early stage of vesicle tethering prior to SNARE assembly and
membrane fusion (Dascher et al., 1991; Ossig et al., 1991). Besides its possible role in
vesicle docking, Sly1 seems to be implicated in later stages of membrane fusion, i.e.
assembly of Sed5 into Golgi trans-SNARE complexes (Kosodo et al., 2002; Peng, R.
and Gallwitz, 2002) and disassembly of cis-SNARE complexes mediated by Sec18Sec17
(Kosodo et al., 2003). Very recent results have demonstrated that Sly1 is also involved
in the Ufe1-mediated retrograde transport (Li et al., 2005), indicating that Sly1 might
also be required in other membrane transport processes. However, whether Sly1 also
takes part in the Ufe1-mediated homotypic ER membrane fusion could not be ad-
dressed so far. Likewise, the molecular mechanism by which Sly1 contributes to mem-
brane fusion remains obscure.
3.2.2.1. Sly1 protects Ufe1 from degradation
The previously reported requirement of protein kinase C for the stability of Ufe1
suggested that Ufe1 might be proteolytically regulated in response to environmental
stimuli or during the cell cycle (Lin, A. et al., 2001). The results presented here indicate
that a cellular pool of Ufe1 is indeed constitutively ubiquitylated (Figure 2-10), however,
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the majority of Ufe1 appears to be rather stable in WT cells. In contrast, Ufe1 is highly
unstable in the conditional sly1-1 mutant at its non-permissive temperature (Figure 2-
11). Such a pronounced destabilization effect was not observed with a pkc1-2 allele with
the strain background used in this study (data not shown). Ufe1 was known to interact
with Sly1 via a short stretch at its N-terminus and the phenylalanine residue at position
9 is crucial for this association (Yamaguchi et al., 2002). Binding to this phenylalanine
residue of Ufe1 is mediated by a hydrophobic pocket of Sly1 (Bracher and Weissen-
horn, 2002). The generation of reciprocal mutations in the interaction face demonstrated
that a stable interaction is necessary to confer Ufe1 stability (Figure 2-12), suggesting
that Sly1 prevents degradation directly through binding to Ufe1. This was further con-
firmed by overproducing Ufe1. Whereas an excess of Ufe1 is ultimately degraded, si-
multaneous overexpression of SLY1 significantly stabilized the overproduced levels of
Ufe1 (Figure 2-13). By introducing ERAD mutants into sly1-1 cells or by transforming a
short-lived Sly1 interaction-deficient ufe1 variant into WT cells, it could be demonstrated
that turnover of destabilized Ufe1 proceeds largely by ERAD (Figure 2-14). Thus, one
essential role of Sly1 in Ufe1-mediated membrane fusion is to regulate the stability of
Ufe1 by preventing its breakdown through ERAD. This function is an intrinsic property of
Ufe1 since Sed5 was not found to be destabilized in sly1-1 cells in accordance with pre-
vious findings (Peng, R. and Gallwitz, 2002).
Remarkably, a similar stabilizing function has been reported for another SM protein.
In cells lacking the non-essential SM protein Vps45, the corresponding SNARE protein
Tlg2 is degraded by the 26S proteasome. Blocking proteasomal activity restored levels
of Tlg2 but stabilized Tlg2 is non-functional and unable to bind to its cognate SNARE
partners (Bryant and James, 2001). Thus, stabilization of Tlg2 seems to be not the only
crucial function of Vps45 and a chaperone-like activity was proposed for this SM protein
(Bryant and James, 2001). According to this, a similar requirement of Sly1 for Ufe1
besides its stabilization could also be assumed (see below).
One possibility by which the degradation of a proteolytic target can be regulated
through a partner protein is to mask an internal degradation signal. This type of regu-
lated proteolysis is found for example for the yeast MAT 2 repressor. The degradation
signal within the Deg1 sequence of 2 overlaps with a binding motif for its partner pro-
tein a1. Thus, in the presence of a1 the degron is not recognized by the E2/E3 enzymes
and 2 is not degraded (Johnson, P. R. et al., 1998). To assess whether a similar
mechanism might be employed for the regulated degradation of Ufe1, different variants
were generated by fusing N-terminal parts of Ufe1 to the stable ER protein Sec62. Cer-
tain fusion proteins were indeed found to be degraded in the absence of Sly1, indicating
that a transferable degron in Ufe1 seems to exist (data not shown). However, the very
N-terminal stretch carrying primarily the Sly1 interaction motif was not sufficient to con-
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fer instability. Thus, Sly1 binding is supposed to prevent ERAD by another mechanism,
for example by avoiding access through steric hindrance or by affecting the folding of
Ufe1.
3.2.2.2. Sly1 availability balances the cellular pool of Ufe1
The strict regulation of Ufe1 through its binding to Sly1 suggests that Ufe1 levels have
to be properly balanced within the cell. Indeed, when Ufe1 was stabilized in sly1-1 by
blocking proteasomal activity, the temperature sensitivity of the mutant was found to be
augmented (Figure 2-15). In accordance with this finding, strong overexpression of
UFE1 caused a growth defect, which was partially reversible by concomitant overex-
pression of SLY1 (Figure 2-16). This suggests that not the absolute amount of Ufe1 but
the balance between Ufe1 and Sly1 might be important for cellular homeostasis.
This idea raised the question which cellular functions might be impaired by a surplus
of Ufe1. The finding that overexpression of a Sly1 interaction-deficient ufe1 mutant is
less toxic than WT UFE1 suggested that overexpression might affect specific cellular
functions that particularly rely on Sly1. Thus, an excess of Ufe1 might result in the titra-
tion of the available cellular pool of Sly1 that normally is engaged with other partners,
e.g. Sed5, which is also essential for viability. Reciprocally, overproduced Sed5 would
be equally expected to interfere with the essential functions of Ufe1. Indeed, overex-
pression of SED5 caused an even stronger cytotoxic effect (Figure 2-17), probably
since Sed5 is intrinsically stable and cannot be proteolytically down-regulated contrary
to Ufe1. Intriguingly, concomitant overexpression of UFE1 but not of the Sly1 interac-
tion-deficient ufe1 mutant reduced the growth defect caused by the surplus of Sed5
(Figure 2-17). Likewise, the Sed5-mediated cytotoxicity could be compensated directly
by overexpression of SLY1 (data not shown). Since both SNAREs reside in different
compartment – Ufe1 in the ER, Sed5 in the Golgi apparatus – it is unlikely that they in-
teract directly with each other. Instead the attractive possibility could be envisaged that
Ufe1 and Sed5 might communicate via a competition for available cellular pools of Sly1.
This would provide an elegant mechanism by which both SNARE proteins and their re-
spective vesicle fusion processes could be reciprocally regulated. However, whereas
superfluous Ufe1 is disposed by ERAD, a similar mechanism does not seem to exist for
Sed5.
Interestingly, Sly1 was found to be associated more tightly with Sed5 than with Ufe1
when examined by co-immunoprecipitations (data not shown) in agreement with
previous findings (Yamaguchi et al., 2002). This may suggest that under normal growth
conditions the Sly1-dependent function of Sed5 (anterograde transport) may dominate
over the Sly1-dependent function of Ufe1 (retrograde transport and homotypic fusion).
Based on this assumption, an upregulation of Ufe1 and Sly1, or a downregulation of
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Sed5 might result in a balance shift towards the Ufe1-mediated functions. Such a
mechanism would ensure to coordinate the need for an increase in ER vesicle fusion
under particular conditions, e.g. during/after mitosis, karyogamy, or sporulation. Intri-
guingly, Ufe1 and Sed5 were indeed found to be reciprocally regulated on the transcrip-
tional level during sporulation (Chu et al., 1998).
Figure 3-4. Hypothetical model for reciprocal
regulation of Ufe1- and Sed5-mediated membrane
fusion by the availability of Sly1.
Sed5 and Ufe1 may compete for cellular pools of Sly1
to mediate their respective functions, i.e. anterograde
transport and retrograde transport/homotypic mem-
brane fusion, respectively. The thickness of black
arrows indicates the respective strength of the
interaction between Sed5 or Ufe1 with Sly1, and the
thickness of the grey arrows indicate the resulting
activity of the respective transport pathways. Non-
engaged (free) Ufe1 is turned over by ERAD.
3.2.2.3. A putative function of Sly1 in homotypic membrane fusion
The requirement of Sly1 for the stability of Ufe1 suggests that it may act in a chaperone-
like manner by avoiding an unfavorable fold through its binding and thereby preventing
the degradation of the SNARE protein. However, albeit Sed5-mediated transport also
relies on Sly1, the stability of Sed5 is not regulated by the SM protein, suggesting that
Sly1 may provide additional functions. It was therefore attractive to speculate that Sly1
might be also directly involved in the Ufe1-mediated processes of retrograde transport
or homotypic membrane fusion (Lewis et al., 1997; Patel, S. K. et al., 1998). Indeed, a
requirement of Sly1 for the Sec18-dependent retrograde transport has been reported
recently (Li et al., 2005). Conversely, homotypic membrane fusion involves Cdc48
(Latterich et al., 1995; Patel, S. and Latterich, 1998). According to this, the observation
of the synthetic temperature sensitivity of sly1-1 cdc48-6 and sly1-1 shp1 double
mutants (Figure 2-18B) suspected Sly1 also to participate in ER homotypic membrane
fusion. Furthermore, cdc48-6 and shp1 cells were found to be sensitized towards an
excess of Sly1-unengaged Ufe1, which may act as dominant negative mutant in fusion
(Figure 2-18A). Finally, Cdc48 and Shp1 were also found to be physically associated
with Sly1 in vivo (Figure 2-18C). It remains to be clarified whether Sly1 interacts with the
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single components or the assembled Cdc48Shp1 complex and whether this interaction is
direct or bridged by Ufe1. Nonetheless it is tempting to speculate that Sly1 might be still
bound to cis-SNARE complexes of Ufe1 and to assist in the late stage of membrane
fusion.
Support for this notion comes from recent genetic data linking SLY1 to SEC18  and
the finding that the Sec18-dependent disassembly of Golgi SNAREs is retarded in sly1-
1 cells (Kosodo et al., 2002). The mammalian NSF SNAP complex has been shown be
sufficient to disassemble ternary SNARE complexes in vitro. However, Sly1 might still
participate at this stage in vivo, e.g. by maintaining a favorable fold of the SNARE or by
facilitating the recruitment of the disassembling ATPases (i.e. Sec18Sec17, Cdc48Shp1) to
the SNARE complex.
3.2.2.4. Does Ufe1 ubiquitylation provides a link to SNARE disassembly?
Cdc48Ufd1/Npl4 has been primarily linked to ubiquitin/proteasome proteolysis. Conversely,
p97p47 was originally assumed to mediate ubiquitin-independent functions. However,
p47 and its yeast homolog Shp1 have recently been shown to bind to ubiquitylated
proteins via their ubiquitin-associated (UBA) domains (Meyer et al., 2002; Hartmann-
Petersen et al., 2004; Schuberth et al., 2004). This and other findings revealed a
functional link of ubiquitylation also to membrane fusion (for a review see Meyer, 2005).
Still, neither the targets nor the function of ubiquitylation could be identified so far.
However, the observation that Ufe1 (this study) and certain other SNARE proteins
(Peng, J. et al., 2003) are modified by ubiquitin gives rise to the attractive possibility that
one function of ubiquitylation might be to target SNAREs in order to become specifically
recruited to p97p47 and Cdc48Shp1, respectively.
Interestingly, whereas Ufe1 was found in vivo to be partially associated with Cdc48
and Shp1 as judged by co-immunoprecipitation, no interaction could be demonstrated
by yeast two-hybrid assays (data not shown). Furthermore, no specific interaction was
detected between recombinant proteins, i.e. GST-Shp1 and Ufe1 (data not shown).
These findings suggest that recruitment of Ufe1 by Cdc48Shp1 may either rely on the
localization of Ufe1 to the membrane or require additional factors and/or modifications,
for example ubiquitylation. Remarkably, ubiquitylated Ufe1 was found to be pre-
dominantly modified by only a few ubiquitin moieties in WT cells (Figure 2-10B). This
finding may suggest a specific function for this type of ubiquitylation (e.g. in protein-
protein interaction) besides the proteasome targeting role during ERAD, which requires
exclusively longer chains. Cdc48 is assumed to act specifically on ubiquitylated sub-
strates in order to segregate a modified protein from its non-modified partner(s). Inter-
estingly, whereas cis-SNARE complexes disassembled by NSF/Sec18 are usually
hetero-oligomers, Ufe1 SNARE complexes seem to exist as homo-oligomers. However,
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a dissimilarity between the homomeric SNARE proteins could be accomplished by tag-
ging only one specific Ufe1 molecule with ubiquitin. It may be possible that this distinc-
tion between the single SNARE partners may be required to allow the successful
segregation of the Ufe1 SNARE complexes by Cdc48Shp1.
3.3. General implication of ERAD in regulatory pathways
The growing number of native (i.e. not aberrantly folded) substrates emphasizes the
view that ERAD is not solely a protein quality pathway involved in the elimination of
misfolded or misassembled proteins of the ER. Contrary, ERAD seems to be implicated
in different cellular pathways being mostly essential for viability. What might be the ad-
vantage of having this elaborate process? It might be the coupling of signal emitting,
transducing and receiving directly at the place of action. As Hmg2 is the rate-limiting
enzyme in the mevalonate pathway andable to sense the amount of produced sterols by
its transmembrane domains (Hampton, 2002), the fatty acid desaturase Ole1 apparently
employs a related mechanism to discern the content of unsaturated fatty acids (UFAs).
The SNARE protein Ufe1 is regulated by the availability of its partner Sly1. Thus, all
different pathways are able to regulate their activity by a direct feedback loop, and the
surplus of the respective crucial factor is subject to degradation.
Intriguingly, despite the fact that these ERAD substrates do not represent abnormal
proteins, the way by which they are degraded resembles the hallmarks of quality
control. This surveillance mechanism utilizes primarily parameters that discriminate the
folding state, the exposure of hydrophobic patches or the failure of protein-protein inter-
actions in a long time scale. This is in contrast to the fast and temporally precise
mechanisms used in signaling cascades such as phosphorylation (Laney and
Hochstrasser, 1999). Hmg2 for instance is assumed to alter the conformation of its
transmembrane domains upon high concentrations of the mevalonate intermediate
FPP. Thus it enters the quality control pathway by changing its structure that now is
recognized by Hrd1/Hrd3 (Hampton, 2002). It is very likely that Ole1 is regulated in a
similar way since its four transmembrane domains are the most suitable candidates for
sensing the UFA content within the membrane. Finally, the interaction of Sly1 with Ufe1
may prevent an unfavorable folding state of the SNARE protein that might tend to ag-
gregate in isolation and thus be recognized by ERAD. Hence, regulated ERAD might
have evolved from the ancient mechanism of protein quality control, as its substrates
seem to adopt the characteristics of misfolded proteins in a controlled manner.
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4. MATERIALS AND METHODS
The subsequent microbiological, molecular biological and biochemical are based on standard
techniques (Sambrock et al., 1989; Asubel et al., 1994) or follow the manufacturers' instructions.
When protocols have been modified, detailed information is provided. For all methods de-
scribed, de-ionized sterile water, sterile solutions and sterile flasks were used.
Unless otherwise noted, chemicals and reagents (pro analysis grade) were purchased from
Amersham-Pharmacia, Applied Biosystems, Biomol, Biorad, Difco, Fluka, Invitrogen, Kodak,
Merck, New England Bioloabs, Promega, Roth, Roche, Riedel de Haen, Serva, or Sigma.
4.1. Computer-based analyses
For database researches (sequence search and comparison, literature research) electronic
services were used provided by Saccharomyces Genome Database (htttp://www.
yeastgenome.org/) and National Center for Biotechnology Information (htttp://www.ncbi.
nlm.nih.gov/). DNA and protein sequence analyses (DNA restriction enzyme maps, DNA
sequencing analyses, DNA primer design, protein sequence comparison) were done with DNA-
Star (DNA Star Inc.). Chemiluminescence signals of immunoblots were detected by a CCD
camera (LAS 1000, Fujifilm) and processed with the software programs Image Reader LAS
1000 V1.1 (Fujifilm), Image Gauge V3.01 (Fujifilm), and Adobe Photoshop (Adobe Systems
Inc.). Autoradiography was detected by a phosphoimger (BAS 2500, Fujifilm) using the software
Image Reader BAS 2500 V1.4E (Fujifilm). For the presentation of texts, tables and figures,
software programs of the Microsoft Office packet (Microsoft Corp.) were used. For graph
presentations and curve fits Kaleidagraph (Synergy software) was used.
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4.2.1. E.coli techniques
E.coli strains
XL1-Blue: hsd R17 rec A1 end A1 gyrA46 thi-1 sup E44 relA1 lac
[F' pro AB lacIqZ M15 Tn10 (Tetr)] (Stratagene)
BL21 (DE3)/RIL: B F- ompT hsdS(rB- mB-) dcm+ Tetr gal  (DE3) EndA
Hte [argU ileY leuW Camr] (Stratagene)
E.coli vectors
pet28a-c (Novagen)
pQE30 (Qiagen)
pGEX-4T1-3 (Amersham)
E.coli media
LB-medium (agar plates): 1% Trypton (Difco)
 0,5% yeast extract (Difco)
1% NaCl
(1,5% agar)
sterilized by autoclaving
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Cultivation and storage of E.coli
Liquid cultures were grown in LB media shaking at 200 rpm at 37°C except for protein expres-
sion (23° or 30°C). Cultures on agar plates were incubated at 37°C. For the selection of trans-
formed bacteria, the following antibiotics were added to the media: ampicillin (50µg/ml),
chloramphenicol (24µg/ml) or kanamycin (30µg/ml). The culture density was determined by
measuring the absorbance at a wavelength of 600 nm (OD600). Cultures on solid media were
stored at 4°C up to 7 days. For long-term storages, stationary cultures were frozen in 15% (v/v)
glycerol solutions at –80°C.
Preparation of competent bacteria
E.coli vectors were transformed into competent cells either with calcium chloride or with electro-
poration for yielding higher efficiencies. For the preparation of competent cells, 1 l liquid LB me-
dium was inoculated with 10 ml of an overnight culture derived from a single E.coli colony and
grown to an OD600 of 0.6-0.8 at 37°C. After chilling the culture flask in ice-cold water for 1 h,
cells were harvested by centrifugation (5 min, 5000 g, 4°C). All following steps were performed
with prechilled sterile materials and solutions at 4°C. For the preparation of chemically compe-
tent cells, sedimented cells were carefully resupended in 200 ml MgCl2 solution (100mM). The
resuspended ells were pelleted by centrifugation, resuspended in 400 ml CaCl2 solution
(100mM) and after incubation of in ice-cold water for 20 min pelleted again. Finally, the compe-
tent cells were resuspended in 20 ml 100 mM CaCl2 solution containing 10% (v/v) glycerol and
stored in 100 µl aliquots at –80°C. For the preparation of electrocompetent bacteria, sedimented
cells were washed once with 1 l water and once with 0,5 l water containing 10% (v/v) glycerol.
After the last centrifugation step, cells were resuspended in 3 ml 10% (v/v) glycerol and stored
in 100 µl aliquots at –80°C.
Transformation of plasmid DNA into bacteria cells
Competent cells were thawed on ice. For chemical transformation, 50 µl competent cells were
mixed with 10 ng plasmid DNA and incubated on ice for 40 min. A heat shock was performed at
42°C for 20-90 s. Subsequently, the cell suspension was incubated on ice for 2 min and after
adding 1 ml LB medium without antibiotics incubated on a shaker at 37° for 1 h. After recovery,
transformed cells were selected by streaking out the cell suspension on LB agar plates con-
taining the respective antibiotic(s) and incubated over night at 37°.
For electroporation, 25 µl competent cells were mixed with 10 ng plasmid DNA or 2 µl ligation
sample dialyzed against water. The suspension was electroporated in a pre-chilled cuvette
(0.1 cm elcetrode gap) with a pulse of 1.8 kV and 25 µF at a resistance of 200 . After adding 1
ml LB medium without antibiotics, the suspension was transferred into a 12 ml polystyrene tube
and incubated on a shaker at 37° for 1 h. Selection of transformants was carried out on antibi-
otic-containing LB agar plates over night at 37°.
Expression of proteins in E.coli
For the expression of recombinant proteins exclusively, the E.coli strain BL21(DE3)/RIL was
used. Liquid LB medium was inoculated at a dilution of 1:100 with an overnight culture of a
freshly transformed colony. The culture was incubated at either 23° or 37° depending on the ex-
pression construct and expression of the protein was induced by addition of IPTG (0.1-1 mM
final concentration) at an an OD600 of 0.6. Cells were harvested after 3-6 h after IPTG addition,
and samples were taken before and after induction and analyzed for protein expression by SDS
PAGE and coomassie staining. For purification of the expressed protein, cells were harvested
by centrifugation (10 min, 5000 g, 4°C), washed in ice-cold PBS containing protease inhibitors
and stored after shock freezing in liquid nitrogen at –80°C.
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4.2.2. S.cerevisiae techniques
S.cerevisiae strains
Unless otherwise indicated all strains are isogenic to DF5. Mutant alleles from other strain
backgrounds were introduced into DF5 by repetitive mating and tetrade dissection.
For the pGAL1-10-mediated overexpression experiments with SED5, the W303 wildtype strain
(ade2-1, his3 200, leu2-3,2-112, trp1-1(am), ura3-52; source: Kim Nasmyth) was used, which
is better suited for growth on galactose-containing medium, especially in combination with cel-
lular stress.
For Yeast-Two-Hybrid assays, the strain PJ69-4a was used:
MATa, trp901-, leu2-3,112, ura3-53, his3-200, gal4, gal80, GAL1::HIS3, GAL2-ADE2,
met2::GAL7-lacZ (James et al., 1996)
Table 4-1: yeast strains
S. cerevisiae  DF5 derivates genotype source
DF5
diploid wt
Y0001 his3 200, leu2-3,2-112, lys2-801, trp1-1(am), ura3-52
his3 200, leu2-3,2-112, lys2-801, trp1-1(am), ura3-52
Finley et al., 1987
haploid wt Y0002 MAT , derived from Y0001 by sporulation
haploid wt Y0003 MATa, derived from Y0001 by sporulation
ufd1-2 Y0473 ufd1-2 Hoppe et al., 2000
pre1-1 Y0484 pre1::TRP1, pTX49pre1-1 Mayer et al., 1998
ubc6 ubc7 Y0571 MAT , ubc6::HIS3, ubc7::HIS3 Mayer et al., 1998
rpn10 Y0581 MATa, rpn10::HIS3 Kögl et al., 1999
ufd2 Y0598 MAT , ufd2::LEU2 Johnson et al., 1995
ufd2 rpn10 Y0598 ufd2::LEU2, rpn10::HIS3 Kögl et al., 1999
cdc48-6 Y0649 cdc48-6 Kai-Uwe Fröhlich
spt23 mga2 Y0749 spt23::hisG, mga2::LEU2 Hoppe et al., 2000
ole1 Y0778 ole1::LEU2 Hoppe et al., 2000
npl4-1 Y0801 npl4-1 DeHoratious and Silver,
1996
shp1 Y0843 MATa, shp1::kanMX Braun et al., 2002
cue1 Y0885 MAT , cue1::HIS3 Biederer et al., 1997
hrd1 Y0886 MATa, hrd1::TRP1 Friedlander et al., 2000
rad23 Y1043 MAT , rad23::kanMX Richly et al., 2005
ufd2 rad23 Y1101 ufd2::LEU2, rad23::kanMX Richly et al., 2005
dsk2     - MAT , dsk2::kanMX Richly et al., 2005
rad23 dsk2     - MAT , rad23::kanMX, dsk2::kanMX Richly et al., 2005
ufd2 dsk2     - MAT , ufd2::LEU2, dsk2::kanMX Richly et al., 2005
prc1-1 SGY001 MAT , prc1-1 this study
prc1-1 ufd1-2 SGY002 MAT , prc1-1, ufd1-2 this study
prc1-1 npl4-1 SGY003 MAT , prc1-1, npl4-1 this study
UFE1 SGY017 MAT , ufe1::kanMX, pUFE1-UFE1 (CEN/URA3) this study
UFE16HA SGY068 MAT , ufe1::UFE16HA::TRP1 this study
UFE19myc SGY072 MAT , ufe1::UFE19myc::TRP1 this study
sly1-1 cdc48-6 SGY147 MAT , sly1::kanMX, pSLY1-sly1-1 (CEN/URA3), cdc48-6 this study
sly1-1 ufd1-2 SGY149 MAT , sly1::kanMX, pSLY1-sly1-1 (CEN/URA3), ufd1-2 this study
SLY16HA SGY170 MAT , sly1::sly16HA::TRP1 this study
SLY1 SGY179 MAT , sly1::kanMX, pSLY1-SLY1 (CEN/URA3) this study
sly1-1 SGY180 MAT , sly1::kanMX, pSLY1-sly1-1 (CEN/URA3) this study
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Table 4-1: yeast strains (continued)
S. cerevisiae  DF5 derivates genotype source
sly1-1 ubc1 SGY184 MATa, sly1::kanMX, pSLY1-sly1-1 (CEN/URA3),
ubc1::HIS3
this study
sly1-1 ubc6 ubc7 SGY186 MAT , sly1::kanMX, pSLY1-sly1-1 (CEN/URA3),
ubc6::HIS3, ubc7::HIS3
this study
sly1-1 shp1 SGY191 MAT , sly1::kanMX, pSLY1-sly1-1 (CEN/URA3),
shp1::kanMX
this study
sly1-1 pre1-1 SGY325 MAT , sly1::kanMX, pSLY1-sly1-1 (CEN/URA3) this study
sly1-1 pep4 SGY336 MAT , sly1::kanMX, pSLY1-sly1-1 (CEN/URA3),
pep4::HIS3
this study
UFE16HA SLY19myc SGY340 MAT , ufe1::UFE16HA::TRP1, sly1::SLY9myc::TRP1 this study
UFE19myc SLY16HA SGY342 MAT , ufe1::UFE19myc::TRP1, sly1::SLY6HA::TRP1 this study
UFE16HA SGY380 MAT , ufe1::kanMX, pUFE1-UFE16HA (CEN/LEU2) this study
sly1-19myc SGY381 MAT , sly1::kanMX, pSLY1-sly1-19myc (CEN/LEU2) this study
sly1-V156P9myc SGY382 MAT , sly1::kanMX, pSLY1-sly1-V156P9myc (CEN/LEU2) this study
sly1-L137R6HA SGY383 MAT , sly1::kanMX, pSLY1-sly1-L137R6HA (CEN/LEU2 this study
SLY19myc SGY384 MAT , sly1::kanMX, pSLY1-SLY19myc (CEN/LEU2) this study
other S. cerevisiae strains
cim5-1 Y0355 MAT , cim5-1, ura3-52, leu2 1, his3 200 Carl Mann
sec61-R2 Y1015 MAT , sec61::HIS3, ade2-1, can-100, his3-11,15, leu2-3,
trp1 1, ura3-3, pSEC61-sec61-R2, pUPRE-lacZ (pMZ11)
Zhou and Schekman,
1999
S.cerevisiae vectors
CEN plasmids: pYCplac33 (URA3), pYCplac22 (TRP1), pYCplac111 (LEU2)
2µ plasmids: pYEplac195 (URA3), pYEplac112 (TRP1), pYEplac181 (LEU2)
integrative plasmids: YIplac211 (URA3), pYIplac204 (TRP1), pYIplac128 (LEU2)
(Gietz and Sugino, 1988)
Yeast-Two-Hybrid vectors: pGAD-C1-3, pGBD-C1-3 (James et al., 1996)
S.cerevisiae plasmids
The OLE1 ORF was amplified from a cDNA library and cloned into YIplac211 containing three
N-terminal myc-tags (3myc). Expression was driven by the GAL1-10 promoter. The ole1-AA
mutant expressing the physiologically inactive desaturase was constructed by site-directed
mutagenesis exchanging the two conserved, essential histidine residues with alanine (H161A
and H166A; see Figure 1B). Both constructs were inserted into the URA locus of ura3-52 strains
by linearizing the vectors with EcoRI. The protein Deg1SEC62 expressed from a GAL1-10 pro-
moter is analogous to the Deg1SEC62FLAG construct described previously (Mayer et al., 1998), ex-
cept that it has a FLAG tag N-terminal of SEC62 (Deg1-FLAGSEC62). The 6mycHMG2 construct
(pRH244) was a gift by R. Hampton. The prc1-1 construct (pRS306-prc1-1) used for the ex-
pression of CPY* was obtained by T.Sommer and was originally described by D.Wolf. It was in-
serted into the PRC1 locus by linearizing the vector with BglII. Myc-tagged ubiquitin was ex-
pressed from a 2µ plasmid (YEp96) under the control of cupper promoter obtained by
M.Hochstrasser. The plasmid expressing Ub-Probgal (Bachmair and Varshavsky, 1989) was a
gift by A. Varshavsky. Plasmids expressing UFE1, SLY1, and SED5 were cloned by PCR
amplification of genomic DNA. For examination of expression at the endogenous level, the
respective ORF was cloned with its 5 UTR usually covering the upstream sequence until the
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next stop codon. However, for the expression of UFE1 the upstream 247 bp sequence has been
shown to be sufficient for appropriate expression (Lewis et al., 1997) and, hence, was used for
cloning pUFE1-UFE16HA and pUFE1-ufe1-F9A6HA. C-terminal epitope-tagged variants of UFE1
and SLY1 were cloned by genomic PCR with chromosomally tagged strains.
S.cerevisiae media and solutions
YPD / YPGal (agar plates):     1% (10 g/l) yeast extract (Difco)
    2% (20 g/l) bacto-peptone (Difco)
    2% (20 g/l) D-(+)-glucose or galactose
(  2% (20 g/l) agar)
sterilized by autoclaving
YPD G418 plates: After autoclaving, YPD medium including 2% agar
was left at room temperature until cooled to 50°C. Just prior to pouring,
G418 (geneticine disulphate; Sigma) was added as powder (final
concentration 200 mg/l).
YPD oleic acid plates: as above, but instead oleic acid (Sigma) was
mixed with an equal volume of Nonidet P40 (NP40) and added to the
medium prior to pouring to a final concentration of 0.2% (v/v) each.
SC-media/plates:    0.67% (6,7 g/l) yeast nitrogen base (Difco)
   0.2% (2 g/l) drop out amino acid mix
(according to the requirements)
   2% (20 g/l) carbon source
(glucose, raffinose, or galactose)
  (2% (20 g/l) agar)
SC-5'FOA plates:    0.67% (6,7 g/l) yeast nitrogen base (Difco)
   0.2% (2 g/l) drop out amino acid mix
(according to the requirements)
  3% (30 g/l) adenine
  3% (30 g/l) uracil
  2% (20 g/l) carbon source
(glucose, raffinose, or galactose)
solved in 500 ml water
2% 20 g/l agar / 500 ml water, autoclaved
After medium and molten agar were mixed and left until cooled to 50°C,
1 g 5'FOA was added (final concentration 1 g/l) and stirred up to
complete dissolving prior to pouring.
drop out amino acid mix: 20 mg Ade, Ura, Trp, His; 30 mg Arg, Tyr, Leu, Lys
50 mg Phe
100 mg Glu, Asp
150 mg Val
200  mg Thr
400 mg Ser
Sporulation medium:  2% (w/v) potassium acetate (in sterile water)
SORB: 100 mM LiOAc
  10 mM Tris-HCl, pH 8.0
    1 mM EDTA, pH 8.0
    1    M sorbitol
sterilized by filtration
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PEG: 100 mM LiOAc
  10 mM Tris-HCl, pH 8.0
    1 mM EDTA, pH 8.0
  40 % (w/v) PEG-3350
sterilized by filtration, stored at 4°C
Zymolase 20T solution:    0.9 M sorbitol
   0.1 M Tris-HCl, pH 8.0
   0.1 M EDTA, pH 8.0
 50 mM DTT (add freshly)
0.5 mg/ml zymolase 20T (ICN Biochemicals)
Cultivation and storage of S.cerevisiae
Liquid starter cultures were usually inoculated with a single yeast colony from strains freshly
streaked on plates and grew at 30°C in a shaking incubator over night or for 2 days (tempera-
ture sensitive strains at 23°C). The main culture was inoculated with the starter culture at a dilu-
tion of 1:100 – 1:1000, and growth was carried out in a shaking incubator at 150-250 rpm (de-
pending on the volume of the culture) until the culture had reached the mid-log phase growth
(1–5x107 cells/ml). The culture density was determined by measuring the absorbance at a
wavelength of 600 nm (OD600). An OD600 of 1 is equal to 1.5x10
7 cells/ml. Cultures on solid me-
dia were stored at 4°C up to 1-2 months. For long-term storages, stationary cultures were fro-
zen in 15% (v/v) glycerol solutions at –80°C.
Preparation of competent yeast cells
For transformation by the lithium acetate method, competent yeast cells were prepared as fol-
lows: 50 ml of a mid-log phase growing culture was harvested by centrifugation (500 g, 5 min,
room temperature), washed once with 1/5 volume sterile water, once with 1/10 volume SORB
solution and resuspended in 360 µl SORB solution. After adding of 40 µl carrier DNA (salmon
sperm DNA, 10 mg/ml, Invitrogen), competent cells were stored in 50 µl aliquots at –80°C.
Transformation of yeast cells
For transformation  0.2 µg of circular or  2 µg linearized plasmid DNA (or PCR products) were
mixed with 10 µl or 50 µl competent cells, respectively. After adding 6 volumes of PEG solution,
the cell suspension was incubated at 30°C for 30 min. Subsequently, DMSO (final concentration
10%) was added and a heat shock performed at 42°C for 15 min. After that, cells were sedi-
mented by centrifugation (400 g for 3 min at room temperature) and resuspended in 100 µl ster-
ile water. Selection of transformants was carried out on the respective SC medium plates for 2-3
days at 30°C (or room temperature in case of temperature sensitive strains). When the antibiotic
G418 was used for selection, transformed cells were incubated for 3-12 hours in liquid YPD
medium before they were streaked out onto plates containing G418. If necessary, transformants
were replica-plated on G418 containing YPD plates to dissect true positive transformants from
false-positive clones expressing the G418/Kan resistance marker only transiently.
Genomic integration by homologous recombination
For the stable integration of a plasmid-encoded gene (integrative transformation), the ORF was
cloned together with the respective promoter (endogenous, conditional, or constitutive) and a
yeast terminator (usually 200 bp of the sequence 3' downstream from the stop codon of ADH1)
into the multiple cloning site of integrative vectors of the YIplac series (Gietz and Sugino, 1988).
These vectors contain no autonomous replication (ARS/CEN) elements, thus only stably inte-
grated vectors are propagated in yeast. In addition, integrative vectors encode selectable mark-
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ers conferring auxotrophy for nutrients, which after transformation and stable integration into the
chromosomal locus can complement mutant alleles. To increase the efficiency of the integration
event, vectors are usually linearized by introducing double strand breaks within the auxotrophy
marker gene with the help of restriction enzymes (i.e. EcoRV, StuI). After transforming into
yeast cells, the free DNA ends of the marker gene on the linearized plasmid recombine with the
homologous DNA sequences at the endogenous locus of the marker gene and enable the vec-
tor to integrate. This results in the duplication of the auxotrophy marker and the insertion of the
gene of interest in between on the chromosomal locus.
A similar strategy was applied for the replacement of the endogenous locus by mutant alleles
(transplacement). This method was used for the replacement of the PRC1 locus encoding the
vacuolar protease carboxypeptidase Y (CPY) by the prc1-1 allele carrying a point mutation,
which results in the expression of the mutant unstable variant CPY*. In this case, the integrative
plasmid harbors the prc1-1 allele besides the URA3 gene as a selectable marker. But contrary
to the method described above, homologous recombination is not targeted to the marker gene
but to the PRC1 locus by linearizing the integrative plasmid within the prc1-1 allele with the re-
striction enzyme BglII. Recombinant cells were selected by their ability to grow in the absence
of Ura within the medium, revealing that the URA3 marker and the prc1-1 allele have been in-
serted into the PRC1 locus ('pop-in'). Subsequently, cells were selected on a second recombi-
nation event that resembles in principle a reversion of the first one, by which the URA3 marker
and parts of the PRC1/prc1-1 gene have been lost ('pop-out'). This type of recombination event
is monitored by negative selection in presence of the pyrimidine analogue 5'FOA (5'-fluoroorotic
acid), which results in a toxic intermediate only when URA3 is expressed. Since the second re-
combination event can take place at any position within the PRC1/prc1-1 locus, recombinants
can be screened for being URA3 negative but still harboring the point mutation of the prc1-1 al-
lele. This was accomplished by isolation of the PRC1 locus via PCR of genomic DNA combined
with restriction analysis of the PCR product with BstXI, which yields an additional cleavage
product for the prc1-1 encoded sequence.
The insertion of gene deletions or epitope tags on chromosomes was accomplished by a PCR
strategy (Longtine et al., 1998; Knop et al., 1999). Besides the sequences for amplification of
the PRC cassette, the oligonucleotides contain the flanking sequences of the target gene to al-
low homologous recombination within the endogenous locus. For gene deletions, usually 50 bp
of the promoter sequence 3' of the start ATG (S3 primer), and 50 bp of the terminator sequence
5' of the stop codon (S2 primer), respectively, serve as complementary sequences to the target
gene. For the insertion of C-terminal epitope tags, the S3 primer contains 50 bp 3' of the stop
codon instead. The PCR cassette includes the respective tag with the ADH1 terminator as well
as a marker gene for selection with promoter and terminator. After amplification of the cassette,
the PRC product was precipitated with ethanol and transformed into competent yeast cells.
Recombination occurs alike the insertion of integrative plasmids. In the case of epitope tag
insertion, the endogenous stop codon of the endogenous target gene is replaced by the epitope
sequence enclosing a separate stop codon. The recombination event was analyzed either by
PCR, immunological methods, or tetrad dissection of spores derived from diploid transformants.
Mating type analysis of haploid strains
For the analysis of the mating type, the tester strains RC634a and RC75-7  were used for
growth assays. These strains are hypersensitive to the pheromone secreted by the opposite
mating type strain. 75 µl of an aqueous cell suspension of each tester strain was mixed with 7.5
ml of a molten 1% (w/v) agar solution that has been cooled down to 45°C, and poured on YPD
plates as top agar. Strains to be analyzed were replica plated on the a- and -tester top agar
plates. After 1-2 days of incubation, the tester strains were grown densely within the top agar
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unless the colonies of the replica-plated strain displayed the opposite mating type. In this case,
halos appeared around the colonies according to the hypersensitivity of the tester strain against
the secreted pheromone Diploid cells do not secrete any mating type pheromones, therefore no
halo formation is seen with both mating type tester strains.
Mating of haploid S.cerevisiae strains
Haploid strains of opposite mating types (MATa, MAT ) grown to mid-log growth phase were
mixed together by spotting 10 µl of each on a pre-warmed YPD plate. After incubation at 30°C
for 3-4 h, mated yeast cells (zygotes) became distinguishable from haploid cells by their specific
morphology ('mexican hut': a polar lobe with a bud in the middle). Zygotes were isolated by a
micromanipulator (Singer MSM Systems). Alternatively, when the original haploid strains display
different auxotrophy markers, cells were streaked after mating onto the respective selection
plates to select diploid cells.
Sporulation and tetrad analysis of diploid S.cerevisiae strains
Diploid cells of a stationary culture (500 µl) were harvested by centrifugation (500 g, 3 min),
washed 4-5 times with sterile water and resuspended in 5 ml sporulation medium. After incuba-
tion on a shaker at 23°C for 3 days, 10 µl sporulated cells were mixed with 10 µl zymolase-20T
solution and digested at 23°C for 10 min. The spores of the sporulated cells (asci) were dis-
sected in tetrads by the use of a micromanipulator (Singer MSM Systems). Germination and
growth of the spores were carried out on non-selective YPD plates for 2-3 days. Subsequently,
tetrads were analyzed genotypically by replica plating on selection plates and/or incubating at
the permissive and non-permissive temperatures.
Analysis of protein-protein interactions with the Two-hybrid-system
Proteins being analyzed by two-hybrid interaction assays were fused at their N-terminus to the
DNA-binding and activation domain of the Gal4 protein by cloning the respective full-length or
truncated ORFs into pGAD424 and pGBD vectors, respectively. Various combinations of 'bait'
and 'prey' plasmids were transformed into PJ69-7A cells (James et al., 1996) and were plated
on SC-Leu-Trp plates. Transformants were streaked onto SC-Leu-Trp-His and SC-Leu-Trp-Ade
plates. A successful Interaction of bait and prey results in the reconstitution of the Gal4 tran-
scription activator and thus the expression of reporter genes under the control of Gal4 (i.e.
HIS3, ADE2) and allow yeast cells to grow on the respective selection media.
Phenotype analysis by growth tests
To analyze the phenotype (e.g. temperature sensitivity) of yeast strains, serial dilutions of yeast
cultures were spotted onto YPD plates and incubated at different temperatures for several days.
This method allows comparing colony growth and formation of cells from different strains spot-
ted at equal numbers and gives more reliable results than streaking out a single colony. Yeast
cultures grown in YP or selective media to mid -log growth phase were diluted with sterile water
to an OD600 of 0.1 that is equal to 1.5x10
6 cells. With this starter dilution, 4-5 following dilutions
were prepared in a ratio of 1:5 or 1:10 (five- or ten-fold dilution) usually in 96-well microtiter
plate. The cell suspension dilutions were plated onto YP or selection plates by the use of a
stamp with a pin array corresponding to the grid of the 96-well plate (either 48 or 96 pins). The
stamp was briefly dipped into the wells, taken out quickly to avoid loosing the cell suspension
drops on the pins, put onto the medium plate and left there for 20-30 s to ensure that the cell
suspension drops are efficiently come off the pins. The amount of cell suspension put onto the
plate by this method equals a volume of 3 µl.
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Promoter shut-off and cycloheximide chase experiments
To determine the stability of proteins either the transcription of the particular gene was selec-
tively turned off by using a repressible promoter (shut-off experiments), or the total cellular
translation was blocked by addition of the translation inhibitor cycloheximide (cycloheximide
chase), or both approaches were combined (expression shut-off experiment). By this method,
any de novo protein synthesis is blocked that allows studying exclusively the decay of the given
protein in a time course experiment.
For expression shut-off experiments, usually the gene of interest was fused to the inducible
GAL1-10 promoter, which is only active in presence of galactose but repressed in presence of
glucose in the medium. Strains of the DF5 background require being adapted to galactose as
carbon source. Usually they were let grown on raffinose/galactose plates (both 2% w/v) before
they were inoculated in only galactose-containing liquid medium (in presence of raffinose the
GAL1-10 promoter is de-repressed but still not active). Starter cultures under these conditions
need several days to grow to saturation. For preparation of the main culture, usually 25 ml
YPGal or SC-Gal medium (2% v/w galactose) was inoculated with 100 µl or 300 µl of a satu-
rated starter culture grown in the respective medium (in the case of yeast strains displaying a
substantially prolonged cell cycle even at 23°C, the inoculation volume was accordingly in-
creased). After 12-15 h shaking at 23°C, the culture was grown to mid -log growth phase
(OD600 = 0.5). Whereas yeast strains without any temperature sensitivity were incubated at 30°C
for 1-2 h, temperature sensitive mutants were shifted to the non-permissive temperature (usu-
ally 37°C) for 2-3 h prior to the start of the shut-off experiment (except when the protein stability
of Ufe1 was examined in strains carrying sly1 mutant alleles; in this case cells were shifted to
37°C directly at the beginning of the kinetic). The time course was started by sedimenting the
cells (500 g, 5 min, 23°C) and resuspending them in YPD containing 0.5 mg/ml cycloheximide in
an appropriate volume corresponding to OD600 = 1. After taking the zero point sample (normally
1 ml corresponding to 3x106 cells) cultivation was continued and further samples were har-
vested at the time-points indicated. Note that in order to avoid a dilution effect the same volume
but not the same cell number compared to the zero point sample was taken (even when cells
momentarily continue to divide, the amount of the given protein does not increase due to the
transcriptional and translational block). Proteins extracts were performed by NaOH lysis and
TCA precipitation as described (Knop et al., 1999) and analyzed by immunoblots.
For studying the turnover of proteins encoded by genes under the control of the endogenous or
the constitutive ADH1 promoter, cycloheximide chase experiments were performed. For prepa-
ration of the main culture, usually 25 ml YPD or selective medium containing glucose (2% v/w)
was inoculated with 25 µl or 100 µl of a saturated starter culture grown in the respective me-
dium. Translational arrest was induced by adding cycloheximide to the medium to a final con-
centration of 0.5 mg/ml. Cell lysis and sample preparation were done as described above.
Pulse chase assays
Metabolic labeling of cells with radioactive [35S]-methionin allows studying the decay of exclu-
sively de novo synthesized proteins during the pulse period and thus to determine directly the
half-life of a protein. This method was applied for studying the turnover of the ERAD substrate
CPY*.
To induce efficiently the expression of the PRC1 gene encoding the vacuolar protease CPY or
its mutant variant CPY* (by the mutant allele prc1-1), late-log phase cells were starved for nitro-
gen following the protocol modified from M.Knop (see Finger et al., 1993):
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labeling medium: 6.7 g/l yeast nitrogen base w/o (NH4)2SO4 w/o amino acids
20 g/l glucose
2 g/l drop out mix, pH adjusted to 6.0; sterilized by filtration
25 µCi [35S]-methionine (Amersham-Pharmacia)/per OD600.cells
added separately
chase medium: as labeling medium but with:
6 mg/ml methionine (40 mM)
2 mg/ml BSA (fraction V, Sigma)
Synthetic medium (10 ml) was inoculated with a saturated starter culture resulting in an OD600
= 0.4 and was let grown for 5-6 h at the respective temperature. Cells grown to an OD600 = 2.0-
2.8 (corresponding to a cell amount of 10 OD600) were sedimented (500 g at 23°C for 5 min) and
carefully washed 3 times with labeling medium (without radioactive [35S]-methionine). After the
final wash step cells were resuspended in labeling medium corresponding to an OD600 = 10 and
incubated at the respective temperature for 1 h. Subsequently, cells were metabolically labeled
by adding 25 µCi [35S]-methionine per 1 OD600. After 15 min the chase was initiated by adding
an equal volume of pre-warmed chase medium. Samples corresponding to 2 OD600 were taken
at time-points indicated and cell pellets frozen in liquid nitrogen. Proteins extracts were per-
formed by NaOH lysis and TCA precipitation and subjected to immunoprecipitation under de-
naturing conditions with an antibody against CPY. Finally, samples were analyzed by SDS-
PAGE and autoradiography (see 4.4.3.).
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General buffers and solutions
TE buffer 10 mM Tris-HCl, pH 8.0
1 mM EDTA
sterilized by autoclaving
TBE buffer 5x stock 90 mM Tris
90 mM boric acid
2.5 mM EDTA, pH 8.0
sterilized by autoclaving
DNA loading buffer 10x 0.5% (w/v) SDS
0.25% (w/v) bromophenol blue or orange G
0.25% (v/v) glycerol
25 mM EDTA, pH 8.0
4.3.1. Isolation of DNA
Isolation of plasmid DNA from E.coli
LB medium (usually 4 ml) containing the appropriate antibiotic was inoculated with a single
E.coli colony harboring the DNA plasmid of interest and shaken for 8-14 h at 37°C. Plasmids
were isolated using kits from the companies Qiagen (plasmid mini kit) or Macherey-Nagel
(nucleospin plasmid quick pure) according to the manufacturers' instructions.
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Isolation of plasmid DNA from S.cerevisiae
Breaking buffer 2% (v/v) Triton X-100
1% (v/v) SDS
100 mM NaCl
10 mM Tris-HCl, pH 8.0
1 mM EDTA, pH 8.0
Plasmid DNA was released from a yeast transformant along with chromosomal DNA by a rapid
isolation protocol for direct propagation in E.coli. A yeast culture (1.5 ml) grown to saturation
was transferred to an microcentrifuge tube and spun 5 s at high speed at room temperature.
The sedimented cells were resuspended in 200 µl breaking buffer. After adding of 0.3 g acid-
washed glass beads (  200 µl volume;  425-600 µm; Sigma) and 200 µl phe-
nol/chloroform/isoamyl alcohol (24:24:1 v/v/v; Roth) cells were lysed by vortexing 2 min at high-
est speed. Centrifugation at high speed for 5 min at room temperature yielded an aqueous
phase containing the DNA, of which 0.5 µl were used for transformation of E.coli for plasmid
propagation.
Isolation of chromosomal DNA from S.cerevisiae
Chromosomal yeast DNA was isolated as template for the amplification of yeast genes via PCR.
Cells from a saturated yeast culture (10 ml) were sedimented by centrifugation (1500 g, 5 min,
23°C), washed once in 0.5 ml water and resuspended in 200 µl breaking buffer. After adding of
0.3 g acid-washed glass beads (  200 µl volume;  425-600 µm; Sigma) and 200 µl phe-
nol/chloroform/isoamyl alcohol (24:24:1 v/v/v; Roth) cells were lysed by vortexing 3 min at high-
est speed. The lysate was mixed with 200 µl TE buffer, centrifuged for 5 min at high speed at
23°C and the aqueous layer transferred to a microcentrifuge tube. DNA was precipitated by
adding 1 ml ethanol (100%) and centrifugation at high speed for 3 min at 23°C. The pellet was
resuspended in 0.4 ml TE buffer. RNA contaminants were eliminated by adding 30 µl of DNase-
free RNase A (1 mg/ml) and incubated for 5 min at 37°C. Afterwards, DNA was precipitated by
adding 10 µl of ammonium acetate (4 M) and 1 ml ethanol (100%), briefly centrifuged and the
pellet resuspended in 100 µl TE buffer. The yield of the DNA isolation was estimated by analyti-
cal restriction digestion and visualizing of the fragments on an agarose gel.
Precipitation of DNA
For ethanol precipitation 1/10 volume sodium acetate (3 M, pH 4.8) and 2.5 volume ethanol
were added to the DNA solution and incubated at –20°C for 30 min. Subsequently, the DNA
solution was centrifuged at 16000 g at 4°C for 20 min. The DNA pellet was washed once with
0.5 ml 70% ethanol. After centrifugation the DNA was air-dried and resuspended in an appro-
priated volume of TE buffer or sterile water.
Determination of DNA concentration in solution
The DNA concentration was photometrically determined by measuring the absorbance at a
wavelength of 260 nm (OD260). An OD260 = 1 equals a concentration of 50 µg/ml double-
stranded DNA.
4.3.2. Molecular cloning methods
Restriction digestion of DNA
The sequence-specific cleavage of DNA with restriction enzymes was performed according to
standard protocols (Sambrock et al., 1989) and the instructions of the manufacturer (NEB).
Usually, 5-10 units restriction enzyme was used for the digestion of 1 µg DNA. Reaction sam-
4.3. Molecular biological methods
75
ples were incubated in the appropriate buffer at recommended temperature for 30-60 min or
>2 h for analytical and preparative purposes, respectively. To avoid the recirculation of
linearized vectors the 5' end of vector DNA was dephosphorylated by adding 5-10 units shrimp
alkaline phosphatase (Roche) and incubating at 37°C for 30 min. Subsequently, the alkaline
phosphatase was heat-inactivated at 70°C for 15 min.
Separation of DNA fragments by gel electrophorese
For analytical and preparative isolation DNA fragments were electrophoretically separated on
0.8 - 2% agarose gels containing ethidium bromide (final concentration 0.5 µg/ml). DNA sam-
ples were mixed with 6x DNA loading buffer and electropheritically separated at 100 volts in
TBE buffer. DNA fragments could be visualized by the intercalation of ethidium bromide into
DNA by using a UV transilluminator (324 nm). The size of the fragments was estimated by
standard size markers (1 kb DNA ladder, Invitrogen).
Isolation of DNA fragments from agarose gels
After gel electrophesis the DNA fragment was isolated by excising the respective piece of aga-
rose using a razor blade. The DNA was extracted from the agarose block using kits of the com-
panies Qiagen (QIAExII, QIAquick gel extraction kit) or Macherey-Nagel (nucleospin extract II)
according to the manufacturers' instructions and eluated with an appropriated volume of elution
buffer (10 mM Tris-HCl, pH 8.5).
Ligation of DNA fragment
The respective amounts of isolated DNA fragments ('insert') and linearized vectors were esti-
mated on an ethidium bromide-containing agarose gel viewed with UV light. For the ligation re-
action a ratio of 1:3 – 1:10 of vector to insert was used. The reaction sample (10 µl) usually
contained 100 ng of vector DNA and 10 units T4 DNA ligase (NEB). The reaction was per-
formed either at 23°C for 1 h or at 16°C for 4-20 h. In case of transformation of E.coli via elec-
troporation, the ligation sample was dialyzed against de-ionized water for 15 min using a nitro-
cellulose filter (pore size: 0.05 µm, Millipore).
Sequencing of DNA
DNA sequencing reactions were carried out by the institute with an Abi-Prism 377 sequencer.
Sample preparations and sequencing reactions were performed with the DYEnamic ET termi-
nator cycle sequencing kit according to the manufacturers' instructions (Amersham-Pharmacia).
The sample usually contained 0.5 µg plasmid DNA and 5 pmol primer.
4.3.3. Polymerase chain reaction (PCR)
The PCR method was applied for cloning of plasmid constructs, for amplification of PCR cas-
settes for chromosomal epitope-tagging or gene disruptions, or for analysis of recombination
events after chromosomal integration into yeast strains.
PCR reactions were usually performed in a volume of 50 µl with 50 ng plasmid DNA or 0.2 µg
genomic DNA, 0.6 µM of the respective forward and reward oligonucleotide primers, 1.75 µl de-
oxynucleotide mix (each 10 mM, NEB) and 0.2-5 units DNA polymerase (Pfu turbo, Stratagene,
a mixture of 4:1 taq/vent polymerase, NEB, or for analytical purpose taq polymerase only) in the
respective PCR buffer (Pfu turbo, Stratagene; Thermopol buffer, NEB). For amplification a PCR
Mastercycler (Eppendorf) was used. The reaction profile was adjusted according to the quantity
and quality of the template DNA, the length and G/C content of the oligonucleotides and the
length of the amplified sequence. If necessary, the temperatures for primer annealing and
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primer extension have been optimized. In general, the following program was used, in which the
polymerase was added after the initial denaturation step:
initial denaturation 94°C 3 min
10 amplification cycles 94°C 30 s
46°C 30 s
68°C 120 s
25 amplification cycles 94°C 30 s
54°C 30 s
                +20 s / cycle 68°C 120 s
final extension 68°C 10 min
cooling 4°C
For the verification of chromosomal integration events (e.g. gene disruptions), usually the
colony PCR method was applied: Cells from a single yeast colony (approximately of a pinhead
size) were resuspended in 20 µl NaOH (20 mM), to which a spatula tip of acid-washed glass
beads (  425-600 nm, Sigma) was added, and shaken in a thermomixer at 100°C at maximum
speed for 5 min. After brief centrifugation (15 s) 4 µl of the supernatant was used as template
DNA for the PCR reaction carried out in a volume of 50 µl with 0.6 µM of the respective forward
and reward oligonucleotide primers, 1.75 µl deoxynucleotide mix (each 10 mM, NEB) and 2
units taq polymerase in thermopol buffer (NEB) with the following program in a Mastercycler
(Eppendorf):
initial denaturation 94°C 5 min
30 amplification cycles 94°C 30 s
55°C 30 s
68°C 60 s
final extension 68°C 5 min
cooling 4°C
4.3.4. Site-directed mutagenesis
For the insertion of point mutations, a PCR-based strategy was developed according to the
QuickChange method (Stratagene). This method uses two complementary oligonucleotide
primers with the codon to be mutated in the middle flanked by 15 additional base pairs each
corresponding to the target sequence. The reaction was performed in a volume of 25 µl with 50
ng plasmid DNA as template, 62.5 ng of each primer, 0.625 µl deoxynucleotide mix (each 10
mM, NEB) and 5 units Pfu turbo (Strategene) in Pfu turbo buffer (Stratagene) with the following
program in a Mastercycler (Eppendorf):
initial denaturation 94°C 30 s
19 amplification cycles 94°C 30 s
55°C 60 s
68°C 2 min / 1 kb plasmid
final extension 68°C 5 min
cooling 4°C
The PCR results in the amplification of both strains of the total plasmid that immediately anneal.
To eliminate the template DNA, the reaction was subsequently digested with DpnI at 37°C for 1-
2 h. This restriction enzyme cleaves specifically methylated template DNA. After dialysis the
PCR product can directly be used for transformation. The efficiency of the PCR amplification
and DpnI digestion was estimated by comparing the number of clones with a sample having
been incubated either without primers in the PCR reaction (negative control) or without enzyme
in the digestion step (positive control). The mutagenesis was verified by DNA sequencing usu-
ally of 2-6 clones.
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4.4. Protein and biochemical methods
4.4.1. Preparation of cell extracts and microsomal fractions
Preparation of denatured yeast extracts
For examination of post-translational modifications and cellular protein levels denatured protein
extracts were prepared in order to avoid proteolysis during the lysis procedure. Usually, 1 ml of
mid-log phase yeast cells corresponding to an OD600 = 1 were harvested by centrifugation and
resuspended in 1 ml ice-cold water. Subsequently, 150 µl 1.85 M NaOH, 7.5% -mercapto-
ethanol was added and placed on ice for 15 min. Then 150 µl 55% trichloroacetic acid (TCA,
w/v) was added and the mixture was incubated for 10 min on ice. The cells were pelleted
(20000 g at 4° for 20 min) and the supernatant removed. After a second brief centrifugation and
the removal of residual traces of TCA, the pellet was resuspended in 50 µl HU sample buffer
(200 mM phosphate buffer, pH 6.8, 8 M urea, 5% w/v SDS, 1 mM EDTA, 1.5% v/v DTT, bromo-
phenol blue).
Preparation of native yeast extracts
Native proteins extracts were usually prepared for microsome preparations and immunopre-
cipitations under native conditions. Yeast cells of mid-log phase culture were harvested by cen-
trifugation and washed once with ice-cold PBS (Tris-HCl, pH 7.4, 150 mM NaCl). The cell pellet
was resuspended in 200-400 µl lysis buffer per cell amount corresponding to 100 OD600 in a 15
ml Falcon tube (lysis buffer: PBS containing protease inhibitors: complete mix, Roche; 20 mM
NEM, 5 mM benzamidine, 6 µg/ml antipain, 6 µg/ml leupeptin, 4.5 µg/ml aprotinin, 5 µg/ml tryp-
sin inhibitor, 5 µg/ml pepstatin, 6 µg/ml chymostatin, all purchased from Sigma; 4 mM pefablock,
Roche). After adding an equal volume of acid-washed glass beads (  425-600 µm, Sigma) the
cells were lysed by vortexing 4-5 times for 30 s. The cell lysate was collected by centrifugation
trough a small whole in the tube made with a 23 gauge syringe. After transferring the lysate into
a microcentrifuge tube, the cell debris was removed by pelleting at 720 g at 4°C for 5 min. The
supernatant (whole cell extract) contains the soluble fraction (including cytosolic and nuclear
proteins) as well as microsomes from the nuclear envelope, the ER and other organelles. Pro-
teins normally residing in the lumen of organelles might have been partially leaked off into the
soluble fraction due to the partial disruption of membrane-enclosed compartments by the glass
bead lysis.
Preparation of microsomal fractions
For crude separation of microsomes from the soluble phase, whole cells extracts were fraction-
ated by high spin centrifugation at 20,000 g according to standard techniques (Rape et al.,
2001). For a refined fractionation, whole cell extracts were subjected to ultracentrifugation with
100.000 g at 4°C for 1 h (OptimaTM Max Ultracentrifuge, Beckmann). Subsequently, the micro-
somal fraction containing also small membrane vesicles was solubilized in presence of 1% Tri-
ton X-100 constantly rotating on a falcon roller for 60-90 min at 4°C. Afterwards, non-solubilized
material was removed by a second ultracentrifugation step. For immunoprecipitations (see be-
low), the solubilized protein fraction was usually diluted with lysis buffer resulting in a final con-
centration of Triton x-100 below 0.4%.
Determination of protein concentration solution
Protein concentrations were determined by using the Bradford method (BioRad protein assay;
BioRad) and compared to a BSA standard dilution series by measuring the OD595.
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4.4.2. Immunoprecipitation
Immunoprecipitation under denaturing conditions
For examination of post-translational modifications and metabolically [35S]-pulsed proteins,
whole cell extracts were subjected to immunoprecipitations under denaturing conditions. Cell
amounts corresponding to 2-3 OD600 were lysed by NaOH/ -mercaptoethanol and proteins were
precipitated by TCA addition (see 4.2.1.). Subsequently, the protein pellet was resolved in a
modified HU buffer containing less SDS and no reducing agents (200 mM phosphate buffer, pH
6.8, 8 M urea, 1% w/v SDS, 1 mM EDTA) and incubated at 65°C for 30-60 min. After removal of
the unsolved material by centrifugation (16000 g at 23°C for 15 min), the protein solution was
diluted in lysis buffer (see 4.2.1.) resulting in a final concentration of SDS below 0.05%. Occa-
sionally, Nonidet P40 or Triton X-100 was added to a final concentration of 0.1% to avoid un-
specific binding. Immunoprecipitation was carried out with 25 µl slurry anti-HA IgG (3F10,
Roche) coupled to agarose beads or 2 µg anti-CPY IgG (A-6248, Invitrogen-Molecular Probes)
bound to proteinG sepharose constantly rotating on a falcon roller for 90-180 min at 4°C. Un-
specific bound material was removed by 4-5 wash steps with lysis buffer containing detergent in
a centrifuge using spin columns (MoBiTec). Usually, a final wash step was performed with lysis
buffer without detergent. The specific bound material was eluted from the column by adding 50
µl 1% SDS, incubating at 65°C for 15 min shaking on a thermomixer and subsequent centrifu-
gation at high speed for 30 s. The eluate was concentrated in a speed vac and resuspended in
25-50 µl HU sample buffer (200 mM phosphate buffer, pH 6.8, 8 M urea, 5% w/v SDS, 1 mM
EDTA, 1.5% v/v DTT, bromophenol blue).
Immunoprecipitation under native conditions
For examination of protein-protein interactions whole cell extracts or solubilized membrane frac-
tions (see 4.2.1.) were subjected to immunoprecipitations under native conditions. After glass
bead lysis and preparation of extracts, Nonidet P40 or Triton X-100 was added to a final con-
centration of 0.1-0.4% to avoid unspecific binding. Immunoprecipitation was carried out with 25
µl slurry anti-HA IgG (3F10, Roche) or anti-myc IgG (9E10, Santa Cruz) coupled to agarose
beads constantly rotating on a falcon roller for 90-180 min at 4°C. Unspecific bound material
was removed by 4-5 wash steps with lysis buffer containing detergent in a centrifuge using spin
columns (MoBiTec). Usually, a final wash step was performed with lysis buffer without deter-
gent. The specific bound material was eluted from the column by adding 50 µl 1% SDS, incu-
bating at 65°C for 15 min shaking on a thermomixer and subsequent centrifugation at high
speed for 30 s. The eluate was concentrated in a speed vac and resuspended in 25-50 µl HU
sample buffer (200 mM phosphate buffer, pH 6.8, 8 M urea, 5% w/v SDS, 1 mM EDTA, 1.5%
v/v DTT, bromophenol blue).
4.4.3. Gel electrophoresis and immunoblot techniques
SDS polyacrylamide gel electrophorese (SDS-PAGE)
For the standard separation of proteins under denaturing conditions SDS-PAGE was performed
using a discontinuous buffer system (Laemmli, 1970) in mighty smal/ or tall electrophoresis
chambers (Hoefer) or similar chambers made by the institute. The percentage of the resolving
gels varied between 10 and 15% acrylamide, depending on the desired resolution range. The
stacking gel was usually made of 4% acrylamide. The accurate composition is listed below.
Electrophoresis was carried out at a constant current of 15-15 mA in 25 mM Tris base, 250 mM
glycine, 0.1% SDS.
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Table 4-2: Laemmli SDS-PAGE gels
resolving gel stacking gel
% acrylamide 10% 12% 15% 4%
H2O [ml] 4.0 3.3 2.3 1.7
30% acrylamide/ 0.8% bis-acrylamide [ml] 3.3 4 5 1.7
1.5 M Tris-HCl, pH 8.8 [ml] 2.5 2.5 2.5 -
1 M Tris-HCl, pH 6.8 [ml] - - - 1.25
10% SDS [µl] 100 100 100 100
10% ammonium peroxodisulfate [µl] 50 50 50 50
TEMED [µl] 4 4 4 4
The separation of the SNARE protein Ufe1 required a gel system with a higher resolution
(SNARE proteins generally tend to 'smear'). Therefore, usually tricine gels (Schagger and von
Jagow, 1987) were used, which were originally developed for the resolution of especially small
polypeptides but which are also applicable for proteins up to 100 kD. The percentage of the re-
solving gels was either 6.5% or 8.5% The pH of the stacking and resolving gel is actually set by
the cathode buffer (0.1 M Tris base, 0.1 M tricine, 0.1% SDS) and the anode buffer (0.2 M Tris-
HCl, pH 8.9). Electrophoresis was carried out at a constant current of 15-20 mA at 4°C.
Table 4-3: Tricine SDS-PAGE gels
resolving gel stacking gel
% acrylamide 6.5% 8.5% 4%
H2O [ml] 4.0 2.7 3.85
30% acrylamide/ 0.8% bis-acrylamide [ml] 2.1 2.8 0.85
3 M Tris-HCl, pH 8.45 [ml] 3.33 3.33 1.55
87% glycerol [ml] 1.15 1.15 -
10% ammonium peroxodisulfate [µl] 100 100 75
TEMED [µl] 6 6 10
Alternatively, 4-12% gradient Bis-Tris PAGE pre-cast (Invitrogen) or self-poured gels were ap-
plied, which allow a high resolution over large range of different sized proteins (10-200 kD) and
do not require a stacking gel. Electrophoresis was carried out at a constant voltage of 140 V in
MOPS buffer (50 mM 3-N-Morpholinopropane sulfonic acid, 50 mM Tris base, 3.5 mM SDS,
1 mM EDTA).
Coomassie staining of protein gels
After electrophoresis, SDS-PAGE gels were stained with a Coomassie solution (0.1% Coomas-
sie Brilliant Blue R-250, 20% methanol, 10% acetic acid) for 30-60 min and destained by incu-
bation in fixing solution (20% methanol, 10% acetic acid) until unspecific stain was removed.
Autoradiography
After electrophoresis, SDS-PAGE gels were incubated for 15 min in fixing solution (20% metha-
nol, 10% acetic acid) followed by 15 min incubation in amplifier solution (AmplifyTM fluorographic
reagent, Amersham-Pharmacia) to increase the detection efficiency. Subsequently, gels were
dried on a 3MM whatman paper in a slab gel dryer (GD2000, Hoefer) and exposed to a phos-
phoimager plate. Autoradiography was detected by a phosphoimager (BAS 2500, Fujifilm) using
the software Image Reader BAS 2500 V1.4E (Fujifilm).
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Immunoblotting
After proteins were resolved by SDS-PAGE they were transferred to a polyvinylidene fluorid
(PVDF) membrane (Immobilon P, Millipore) in a tank blot system in 250 mM Tris base, 1.92 M
glycine, 0.1% SDS, 20% methanol) at a constant voltage at 70 V for 60-120 min preferentially at
4°C. The PVDF membrane was blocked with TBST-milk (25 mM Tris-HCl, pH 7.5, 137 mM
NaCl, 2.6 mM KCl, 0.1% v/v Tween 20, 5% w/v low fat milk powder) at least for 20 min, followed
by the incubation with the primary antibody in the same buffer for 90 min at 23°C or overnight at
4°C. Subsequently, the blot membrane was washed 4 times at least for 10 min in TBST and af-
terward incubated with the secondary antibody coupled to horseradish peroxidase (Dianova) at
a dilution of 1:5000 in TBST-milk for 60-90 min. The blot membrane was washed as before and
detection was carried out as described in the protocol for the chemiluminiscence kit (ECL or
ECL plus, Amersham) followed by exposure to ECL hyperfilm (Amersham) or to a CCD camera
(LAS, Fuji).
Digitalized images acquired by a CCD (charged-coupled device) camera were processed and
quantified with the software programs Image Reader LAS 1000 V1.1 and Image Gauge V3.01
(Fujifilm), respectively. For detection of chemiluminiscence signals with the Image Reader pro-
gram, the iris of the lens (URF 20L, Fuji) was set at 0.85, and signal exposure was done in the
precision mode with dark frame subtraction and flat frame correction usually for 2-10 min de-
pending on the signal intensity (longer exposure times were not used due to the time-dependent
decay of the chemiluminiscence intensity). Optionally, the binning mode (2x2) was used to in-
crease the signal intensity when a lower image resolution was tolerable. For quantification of the
relative intensity of the chemiluminiscence with the Image Gauge program, all specific signals
reflecting the protein at the expected size as well as the typical high molecular weight 'smear'
(most probably ubiquitylated species) were used for determination of the AU (area under curve)
values, from which the background was subtracted. The background subtraction is ac-
complished by the software program irrespective of the area size; only in cases when the sig-
nal:noise ratio was substantially low, the background area was individually adapted.
Table 4-4: antibodies used in this study
antibody clone, source dilutions in TBST milk
commercial primary antibodies:
monoclonal anti-c-myc 9E10 sc-40, Santa Cruz 1:2000
polyclonal anti-c-myc A-14 sc-789, Santa Cruz 1:2000 – 1:5000
monoclonal anti-HA F-7 sc-7392, Santa Cruz 1:2000
monoclonal anti-FLAG M2, Sigma 1:10000
monoclonal anti-Dpm1 Invitrogen-Molecular Probes 1:5000
monoclonal anti-CPY A-6248, Invitrogen-Molecular Probes
non-commercial primary antibodies:
polyclonal anti-Ufe1 serum 6His-Ufe1 Sn Tm, this study 1:10000 – 1:50000
polyclonal anti-Ufe1 aff. purif. 6His-Ufe1 Sn Tm, this study 1:2000
polyclonal anti-Sed5 aff. purif. Gallwitz lab 1:10000
polyclonal anti-Cdc48 aff. purif. GST-Cdc48, Jentsch lab 1:10000 – 1:20000
polyclonal anti-Shp1 aff. purif. GST-Shp1, Jentsch lab 1:10000 – 1:20000
commercial secondary antibodies:
HRP-coupled anti-rabbit IgG (H+L) Dianova 1:5000
HRP-coupled anti-mouse IgG (H+L) Dianova 1:5000
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For the generation of anti-Ufe1 specific polyclonal antibodies, the UFE1 ORF was cloned with-
out the terminal 709-1041 bp encoding the SNARE and the transmembrane domain and re-
combinantly expressed in bacteria. The recombinant fusion protein His6-Ufe1 Sn Tm was af-
finity purified under denaturing conditions and subsequently dialyzed against PBS (see 4.4.4.).
For the immunization, 250 µg of the purified protein solved 750 µl PBS was mixed with an equal
volume of Freud adjuvant (TiterMax complete, Sigma) to a homogeneous emulsion and injected
at different positions subcutaneously into the rabbit. The first immunization was followed by two
boosts with an equal amount of protein emulsified in Freud adjuvant incomplete by intervals of 6
and 2 weeks, respectively (Sigma). 10 days after the second boost the rabbit was bled. The
serum (200 ml) was recovered by first incubating at 37°C for 1 h and then at 4°C for 16 h,
followed by centrifugation (20000 g, 4°C). The serum was stored at –80°C prior to affinity
purification or used directly for immunoblots.
4.4.4. Purification of recombinant proteins
Purification of recombinant proteins from E.coli
Recombinant Ufe1 proteins were employed for raising polyclonal antibodies and GST pulldown
experiments. For bacterial expression the UFE1 ORF was cloned without the terminal 709-1041
bp encoding the SNARE and the transmembrane domain to increase the expression affinity.
The respective constructs were expressed in E.coli (BL21 pRIL) and the recombinant proteins
subsequently affinity purified by their introduced tags (His6 or GST-epitope).
For the purification of His6-Ufe1 Sn Tm, 1 l bacteria culture of an OD600 of 3 was harvested by
centrifugation and the pellet was resuspended in 40 ml denaturing lysis buffer (100 mM
NaH2PO4, 10 mM Tris base, 8 M urea, pH 8.0). Cell lysis was performed by repetitively freezing
and thawing the cell suspension and the bacterial DNA was sheared by pressing the lysate
several times through a 23 gauge syringe. After removal of the cell debris by centrifugation
(20000 g, 23°C, 60 min), the supernatant was incubated with 2 ml slurry of a 50% NiNTA aga-
rose solution (Qiagen) with gentle agitation for 2 h at 23°C. Bound material was washed 5 times
with wash buffer (100 mM NaH2PO4, 10 mM Tris base, 8 M urea, pH 6.3) and subsequently
eluted in fractions with elution buffer (100 mM NaH2PO4, 10 mM Tris base, 8 M urea, pH 5.9;
100 mM NaH2PO4, 10 mM Tris base, 8 M urea, pH 4.5). The elution of the recombinant proteins
was monitored by measuring the protein concentration and by SDS-PAGE. Positive fractions
were pooled and step-wise dialyzed against PBS (Tris-HCl, pH 7.4, 150 mM NaCl).
For the purification of GST-Ufe1 Sn Tm, 2 l bacteria culture of an OD600 of 2.5 were harvested
by centrifugation and the pellet was resuspended in 50 ml ice-cold PBS buffer containing prote-
ase inhibitors (6 µg/ml antipain, 6 µg/ml leupeptin, 4.5 µg/ml aprotinin, 5 µg/ml trypsin inhibitor,
5 µg/ml pepstatin, 6 µg/ml chymostatin, all purchased from Sigma; 4 mM pefablock, Roche).
Cell lysis was performed with an Emulsiflex C5 cell disruptor. Subsequently, Triton X–100 was
added to a final concentration of 1% and the cell lysate was incubated at 4° for 30 min. After
removal of the non-solubilized material by centrifugation (20000 g, 23°C, 30 min), the lysate was
incubated with 6 ml slurry of 50% glutathione sepharose solution (Amersham-Pharmacia) with
gentle agitation for 2-3 h at 4°C. Material bound to the glutathione resin was washed 3 times
with PBS and thereafter eluted in fractions with elution buffer (PBS containing 300 mM NaCl,
0.1% Triton X-100 and 10 mM glutathione. The elution of the recombinant proteins was moni-
tored by measuring the protein concentration and by SDS-PAGE.
Affinity purification of polyclonal antibodies
For the purification of the polyclonal antibody raised against His6-Ufe1 Sn Tm, the serum (see
Material and Methods
82
4.4.3.) was immunoaffinity chromatography purified. The purification included two successive
columns. As an unrelated antigen, whole cell lysate of BL21 cells, in which GST was expressed,
was coupled to a pre-column, whereas purified recombinant GST-Ufe1 Sn Tm was used as
specific antigen for the main column. For covalent binding, CnBr sepharose 4CLB (Amersham-
Pharmacia) was used as matrix for the columns. The respective antigens were first dialyzed
against coupling buffer (100 mM NaHCO3 pH 8.3, 0.5 M NaCl) and subsequently coupled onto
CnBr sepharose. Free binding sites were blocked with glycine (0.2 M glycine, pH 8.0). Both col-
umns were prepared by several wash steps (6 volumes 100 mM NaAc pH 4.0, 0.5 M NaCl; 3
volumes PBS; 3 volumes PBS, 1% SDS; denaturation at 65° for 40 min; 2 volumes PBS, 1%
SDS; pre-column only: 6 volumes PBS, 1% Triton X-100; main column only: 3 volumes PBS,
1% Triton X–100; 3 volumes PBS, 1% Triton X-100, 1% BSA). After washing, both columns
were connected with each other and the serum was applied and passed 3 times over both col-
umns. Subsequently, the columns were washed with 2 volumes PBS, and after disconnecting
the main column was washed with 6 volumes PBS, 1% Triton X-100 and 6 volumes PBS. Spefi-
cally bound IgGs were eluted in fractions first with glycine buffer (0.2 M glycine pH 2.5, 1 mM
EGTA) and immediately neutralized with 1 M Tris-HCl, pH 8.0. High affinity-bound IgGs were
eluted with guanidinium hydrochloride buffer (4 M GnHCl, pH 7.0). Positive fractions of both
eluates were pooled and dialyzed against PBS. After addition of glycerol to a final concentration
of 50%, the purified IgGs were stored at –80°C.
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ABBREVIATIONS
ADP adenosine 5 -diphosphate
Amp ampicillin
ATP adenosine 5 -triphosphate
Gal -galactosidase
bp base pairs
BSA bovine serum albumin
cDNA complimentary DNA
CCD camera charged-coupled device camera
Ci Curie
C-terminal carboxyterminal
C-terminus carboxy terminus
dATP deoxyadenosine triphosphate
DMSO dimethylsulfoxide
DNA deoxyribonucleic acid
dNTP deoxy nucleoside triphosphate
DTT dithiothreitol
E1 ubiquitin activation enzyme
E2 ubiquitin conjugation enzyme
E3 ubiquitin ligase
E4 multiubiquitylation factor
EDTA ethylenediaminetetraacidic acid
ER endoplasmic reticulum
g gram
g gravitational constant (6.6742x10-11 N m2 kg-2)
h hours
Ig immunoglobulin
IP immunprecipitation
IPTG isopropyl- -D-thiogalactopyranoside
k kilo (x103)
kan kanamycine
kb kilo base pairs
kDa kilo dalton
LB Luria-Bertani
M molar
m milli (x10-3)
µ micro (x10-6)
MAT mating type
min minutes
MOPS 3-N-Morpholinopropane sulfonic acid
mRNA messenger RNA
MW molecular weight
n nano (x10-9)
NEM N-ethylmaleimide
Abbreviations
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NSF NEM sensitive factor
N-terminal aminoterminal
N-terminus amino terminus
NP-40 Nonidet P-40
O/E overexpression
ODx optical density at x nm
OLE-pathway regulon for the transcription of the OLE1 gene
PAGE polyacrylamide gel electrophoresis
PBS phosphate-buffered saline
PCR polymerase chain reaction
PEG polyethylene glycol
RING really interesting new gene (E3 enzyme)
rpm rounds per minute
RT room temperature
S sedimentation coefficient(Svedberg)
s seconds
SDS sodium dodecylsulfate
SNAP soluble NSF attachment protein
SNARE soluble NSF attachment protein receptor
TCA trichloro acidic acid
t1/2 half time
TBST Tris-buffered saline with Tween-20
TEMED N,N,N´,N´-tetramethylethylenediamin
Tet tetracycline
Tris Tris(hydroxymethyl)aminomethane
U Unit
Ub ubiquitin
UBC ubiquitin conjugating enzyme
Ubi-Pro Gal ubiquitin-proline-lacI- -galactosidase
UFD ubiquitin fusion degradation
UV ultraviolet light
V Volt
v/v volume per volume
w/v weight per volume
WT wild type
YNB yeast nitrogen base
YPD yeast bactopeptone dextrose
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